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PGE2: prostaglandin E2  
PGF2α: prostaglandin F2α 
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1. Introduction 
Spreading depolarization (SD) is a wave of massive depolarization of neurons and presumably 
glia cells, which – together with a concomitant depression of spontaneous brain electrical 
activity and accompanying cerebral blood flow (CBF) changes – propagates across the cerebral 
grey matter at a low rate of 2-8 mm/min (Leão, 1944; Somjen, 2001). Cellular depolarization 
appears on local field potential (LFP) or electrocorticogram (EcoG) recordings filtered in DC 
mode as a transient negative shift of the DC potential trace, while the concomitant depression 
of neuronal activity is visualized as a transient local depression of the ECoG. 
Since the first observation made by Leão (Leão, 1944), the pathophysiological role of SD has 
been recognized in several neurological diseases. SD corresponds to migraine aura and likely 
contributes to headache evolution (Ayata, 2010), whereas accumulating clinical and 
experimental evidence suggest that SD contributes to  secondary injury following both ischemic 
and hemorrhagic stroke (Helbok et al., 2017; Mun-Bryce et al., 2001; Pinczolits et al., 2017; 
Woitzik et al., 2013), traumatic head injury (TBI) (Hinzman et al., 2014; Toth et al., 2016) and 
subarachnoid hemorrhage (SAH) (Dreier et al., 2009; Hamming et al., 2016).  
1.1. Neurophysiological aspects of SD 
1.1.1. SD elicitation and evolution 
In the healthy mammalian brain, extracellular K+ concentration is kept close to 3-4 mM, 
independent of fluctuations in blood serum levels (Somjen, 1979), but local changes in 
extracellular K+ levels do occur following neuronal activity. In the injured brain, the 
concentration of K+ (10-15 mM) sufficient to induce SD is presumably determined by the 
balance between K+ efflux and the efficacy of K+ clearance (Spong et al., 2016). When a critical 
threshold of both K+ levels is reached, the self-propagating SD cycle takes off and invades 
neighboring tissue (Grafstein, 1956) (Matsuura & Bureš, 1971; Y. T. Tang et al., 2014). The 
mass cellular depolarization reflects then a near-complete breakdown of neuronal 
transmembrane potential (Somjen, 2001). More specifically, at any point of the tissue involved 
in SD, the influx of Na+ leads the depolarization, causing a reduction of extracellular Na+ 
concentration from 140-150 to 50-70 mM, accompanied by a sudden extracellular surge of K+ 
from 2.7-3.5 to 30-60 mM, a concurrent decrease of extracellular Ca2+ levels from 1-1.5 to 
0.2- 0.8 mM and that of Cl- from 130 to 74 mM (Hansen & Zeuthen, 1981; Pietrobon & 
Moskowitz, 2014). Intracellular ion concentrations obviously change in the opposite direction 
(Fig. 1.).  
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The channels mediating K+ efflux during depolarization are still to be explored, but it is 
reasonable to suggest that voltage-gated potassium (Kv) channels must be involved, as the wide 
spectrum K+ channel blocker tetraethylammonium and 4-aminopyridine partially limited K+ 
efflux during SD (Aitken et al., 1991; Somjen, 2001). Recent evidence indicates that large-
conductance Ca2+-activated K+ (BK) channels contribute to the K+ surge with SD (Menyhart et 
al., 2018), and it is suspected that during ischemia or anoxia, massive nonselective 
Na+(Ca2+)/K+ conductance take place with SD, via a yet unidentified channel (Czeh et al., 1992; 
Gagolewicz, 2017). Finally, in case of acute brain injury, the reduced availability of ATP may 
open ATP-sensitive K+ channels in an attempt to hyperpolarize neurons via K+ efflux (Sun & 
Hu, 2010), contributing to the extracellular K+ accumulation (Somjen, 2001).  
The limited availability of ATP reduces the efficiency of neuronal Na+/K+-ATPase and thus K+ 
reuptake (Hajek et al., 1996). In addition, extracellular levels of K+ typical of the ischemic 
penumbra were shown also to decrease Na+/K+-ATPase activity by 50% (Major et al., 2017), 
therefore K+ itself may amplify its extracellular accumulation. The central role of 
Na+/K+-ATPase in SD initiation is clearly supported by the fact that tissue exposure to ouabain, 
a Na+/K+-ATPase inhibitor, readily produces SD (Balestrino et al., 1999). Ultimately, the excess 
K+ in the extracellular space amounts to a depolarizing stimulus that, by the gradual shift in 
membrane potential, opens voltage-gated Na+ channels to give way to Na+ influx. The 
Figure 1. Changes in the extracellular concentrations of 
K+ ([K+]e), Na+ ([Na+]e), Cl− ([Cl−]e), Ca2+ ([Ca2+]e) and 
glutamate during spreading depolarization. The rapid 
tissue depolarization during the early phase of spreading 
depolarization (SD) is accompanied by a rapid [K+]e 
increase to 30–60 mM (from a baseline value of 2.7–3.5 
mM), a [Na+]e and [Cl–]e decrease to 50–70 mM (from 
140–150 mM) and a [Ca2+]e decrease to 0.2–0.8 mM 
(from 1.0–1.5 mM). SD and the associated ionic changes 
are shown to propagate across the cerebral cortex from 
right to left; the red dashed line represents the SD wave 
front. SD is labeled as CSD (i.e.: cortical spreading 
depression). Source: (Pietrobon & Moskowitz, 2014). 
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experimental elicitation of SD with high concentration KCl or electrical stimulation takes 
advantage of the artificial elevation of extracellular K+ as well.  
Ca2+ influx with SD may take place through P/Q type voltage-gated calcium (Cav) channels, 
which was tested by the application of gabapentine, an anticonvulsant agent, with P/Q type Cav 
channel inhibitory potential. Gabapentin infusion effectively suppressed SD susceptibility in 
the intact rat cortex (Hoffmann et al., 2010).  
In addition to the ion dislocations, interstitial glutamate concentration also increases (Fig. 1.) 
from 3-3.5 to 10-11 M with SD induced by KCl in healthy rat cortex (Hinzman et al., 2015), 
or well over 100 µM during anoxia (Satoh et al., 1999). The SD-related glutamate efflux may 
be mediated by intracellular Ca2+ accumulation through P/Q type Cav channels (Ayata et al., 
2000; Pietrobon & Moskowitz, 2014) or presynaptic N-methyl-D-aspartate (NMDA) receptor-
dependent vesicular exocytosis (Zhou et al., 2013). Further on, SD has been found to open 
neuronal pannexin-1 channels (Karatas et al., 2013) that may also mediate the release of 
glutamate to some extent (Cervetto et al., 2013; Di Cesare Mannelli et al., 2015). Glutamate 
may also originate from astrocytes through pathological processes, including the possibility that 
increased extracellular K+ concentration reverses excitatory amino acid transporters (EAATs) 
(Harada et al., 2015; Malarkey & Parpura, 2008; Nicholls & Attwell, 1990). 
Glutamate accumulation may overstimulate NMDA receptors, deepening depolarization, and 
contributing to SD propagation by further increasing K+ and glutamate release (Harreveld, 
1959). Besides post-synaptic NMDA receptors, there is evidence for the role of α-amino-3-
hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors (Costa et al., 2013) and 
extrasynaptic NMDA receptors (Hardingham & Bading, 2010) as well. The involvement of the 
NMDA receptor in the sustenance of SD is underscored by influential clinical studies disclosing 
that the administration of ketamine, an NMDA receptor antagonist, to patients of acute brain 
injury inhibits SD occurrence effectively (Carlson et al., 2018; Sakowitz et al., 2009). It must 
be noted, however, that SD evolving in response to anoxia cannot be blocked by NMDA 
receptor antagonism, suggesting the negligible involvement of NMDA receptors in SD 
propagation under severe metabolic stress (Pietrobon & Moskowitz, 2014). 
The volume of the extracellular space also adjusts the concentration of substances present in 
the extracellular fluid. Water passively follows the fluxes of Na+ and especially Cl- via 
Cl--coupled transporters (Steffensen et al., 2015) to cause swelling of dendrites (termed 
“dendritic beading”) and astrocytes (Risher et al., 2012), with a concomitant shrinkage of the 
9 
extracellular space. This may increase the concentrations of extracellular K+ and glutamate even 
further (Hansen & Olsen, 1980; Phillips & Nicholson, 1979). 
All these results testify that once SD has been elicited, the levels of K+ and glutamate, which 
facilitate SD, progressively rise. The propagation of SD, therefore, is thought to be self-
sustained, advocated by the volume transmission of high concentration K+ and glutamate 
generated by SD itself. 
1.1.2. Recovery from SD 
SD is a transient event – although its duration depends on the metabolic conditions of the tissue. 
The repolarization phase of SD, or recovery of the tissue from SD is mediated by neuronal 
Na+/K+-ATPase to serve K+ reuptake (Major et al., 2017). Importantly, surplus K+ is also 
removed effectively by astrocytes, utilizing various mechanisms including, for instance, 
astrocytic Na+/K+-ATPase, and K+ siphoning via inwardly rectifying K+ channels (Kir 4.1)  or 
water flux mediated through aquaporin-4 channels (Leis et al., 2005) (Yao et al., 2015). Similar 
to K+ clearance, glutamate buffering is an equally important factor in SD evolution.  
Glutamate clearance is mainly mediated by excitatory amino acid transporters 1 and 2 (EAAT1 
and EAAT2), which are ion- and voltage- dependent and as such the predisposing glutamate 
reuptake is highly susceptible to changes in the ionic composition of the cellular environment 
and transmembrane potential. Among EAAT subtypes, the glial specific EAAT2 appears to be 
responsible for more than 90% of glutamate reuptake in the forebrain (Rimmele & Rosenberg, 
2016). EAAT2 is not only co-localized with Na+/K+-ATPase, but is also highly dependent on 
the ion gradient it generates (Cholet et al., 2002), thus it is of no surprise that, EAAT2-mediated 
glutamate clearance was hampered in the absence of the α2 subunit of the astrocytic Na+/K+ 
ATPase and was associated with the facilitation of SD initiation (Capuani et al., 2016). 
Moreover, mice carrying the genetic knock-in of an astrocytic Na+/K+ ATPase α2 subunit 
loss-of-function mutation – as it occurs in familial hemiplegic migraine type 2 (FHM2) patients 
– were prone to decreased SD threshold and increased rate of SD propagation (Leo et al., 2011). 
Conversely, ceftriaxone, one of the β-lactam antibiotics, stimulated the expression of EAAT2 
in astrocytes and concurrently raised SD threshold in the FHM2 mutant mice, while inhibition 
of EAAT2 in wild type mice lowered SD threshold (Capuani et al., 2016). These results 
collectively suggest that EAAT2 – in tight coupling with Na+/K+ ATPase – is essential for 
glutamate clearance by astrocytes with SD. 
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1.1.3. Cerebral blood flow response to spreading depolarization 
SD is coupled by typical changes in CBF, mediated by the various vasoactive agents released 
during cellular depolarization(Ayata & Lauritzen, 2015). In the rat - and most probably in 
humans - the physiological pattern of the SD-associated CBF response includes four sequential 
components: (i) an initial, brief hypoperfusion; (ii) a marked, transient peak hyperemia; (iii) a 
less obvious late hyperemia; and (iv) a sustained hypoperfusion also known as spreading or 
post-SD oligemia (Ayata & Lauritzen, 2015). The occurrence, duration and magnitude of these 
elements is variable, with the peak hyperemic component being the most conspicuous and most 
extensively studied. The share of each element in the CBF response is prone to the level of 
baseline cerebral perfusion and the metabolic state of the tissue (Ayata & Lauritzen, 2015; 
Dreier, 2011; Pietrobon & Moskowitz, 2014). 
Under physiological conditions (i.e. normal cerebral perfusion), the rise of extracellular K+ at 
the wave-front of an SD episode is the main vasoactive agent responsible for initial 
hypoperfusion (Menyhart et al., 2018). K+ is thought to be directly depolarizing vascular 
smooth muscle cells, leading to vasoconstriction (Ayata & Lauritzen, 2015), with astrocytic 
K+-release likely contributing to perivascular K+ accumulation (Filosa et al., 2006). 
Hypoperfusion is then transformed into peak hyperemia which, even though being the most 
conspicuous and well-studied part of SD related CBF response, is incompletely understood. 
Nitric oxide (NO), a potent vasodilator, is released abundantly during SD (Obrenovitch et al., 
2002), with concomitant upregulation of neuronal nitric oxide synthase (nNOS) (Ayata & 
Lauritzen, 2015; Busija et al., 2008). Thus, NO has been in the center of investigations, with 
highly conflicting results. As such, various pharmacological inhibitions of NO synthesis in 
rabbits and cats led to reduced peak hyperemia, which could not be reproduced in rats (Ayata 
& Lauritzen, 2015; Busija et al., 2008). In physiological neurovascular coupling, NO is 
increasingly regarded as a permissive factor rather than the primary vasodilator. The direct 
contribution of NO to hyperemia persists only for the initial few seconds after the onset of 
neuronal activation, and becomes negligible under longer-lasting activation (Cauli & Hamel, 
2010). This is underscored by the observation, that inhibition of nNOS increases initial 
hypoperfusion with SD, rather than attenuating peak hyperemia (Ayata & Lauritzen, 2015; 
Busija et al., 2008). Thus, NO may have a permissive role in the SD coupled CBF responses, 
counteracting vasoconstrictors (K+ and 20-Hydroxyeicosatetraenoic acid (20-HETE)) and 
potentiating other vasodilators, like prostanoids (especially prostaglandin E2 (PGE2)), 
calcitonin-gene related peptide, serotonin, reactive oxygen species and lactate (Ayata & 
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Lauritzen, 2015; Busija et al., 2008). Finally, peak hyperemia is followed by long-lasting (20-
60 min) oligemia, believed to be mediated by vasoconstrictive arachidonic acid metabolites 20-
HETE and prostaglandin F2α (PGF2α) (Ayata & Lauritzen, 2015). 
As discussed, prostanoids are emerging as important mediators of the SD related CBF response. 
They are potent vasoactive metabolites of versatile effects, with acknowledged role in 
physiological neurovascular coupling. They are derived of arachidonic acid by two rate limiting 
enzymes: the constitutively expressed – astrocytic – cyclooxygenase-1 (COX-1) and the 
inducible – neuronal – cyclooxygenase-2 (COX-2). Spreading depolarization coincides with a 
considerable accumulation of arachidonic acid in the cortex (Lauritzen et al., 1990), and a 
significant elevation of prostanoid concentration (e.g. PGF2α and PGE2) in the cerebrospinal 
fluid (Masaaki Shibata et al., 1992). Arachidonic acid metabolites released due to SD were 
found to be vasoconstrictive: First, the non-selective inhibition of COX enzymes (i.e. 
application of indomethacin) caused pial vasodilation with SD, and diminished vasoconstriction 
underlying post-SD oligemia (Masaaki Shibata et al., 1992). Nonetheless, the selective effect 
of COX-1 or COX-2 products on the SD-associated CBF response has not been revealed, 
although the potential involvement of COX-2 is conceivable, because COX-2 mRNA and 
protein were found upregulated in cortical neurons in association with SD (Miettinen et al., 
1997). Second, synthesis of the vasoconstrictive  20-HETE by the P450 epoxygenase enzyme 
located in vascular smooth muscle cells was demonstrated in response to SD, and the 
pharmacological blockade of its synthesis ameliorated post-SD oligemia (Fordsmann et al., 
2013). In physiological neurovascular coupling however, PGE2 was shown to cause 
vasodilation by binding to its receptors (EP2 and EP4 receptors) located in the vascular wall in 
the brain (Cauli & Hamel, 2010; Lacroix et al., 2015; Myren et al., 2010). 
In ischemic settings, with decreasing residual blood flow approaching the ischemic core, the 
CBF response to SD is increasingly dominated by vasoconstrictive elements, leading to 
diminished hyperemia and more prevalent hypoemia (Feuerstein et al., 2016; Hoffmann & 
Ayata, 2013; Menyhart et al., 2015; Woitzik et al., 2013) (Fig. 2.). In the most severe form, the 
hypoemic element completely outweighs hyperemia, and the CBF response to SD turns into 
spreading ischemia(Dreier, 2011). This atypical SD-associated CBF variation in the injured 
brain aggravates metabolic supply-demand mismatch in the tissue, and can delay recovery from 
SD thereby increasing the risk of irreversible depolarization, neuronal cell death and the 
expansion of the ischemic core. 
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Figure 2. The CBF response to SD in focal cerebral ischemia. A hypothetical diagram shows the transformation 
of the CBF response to SD (top graphs) against the increasing perfusion deficit (bottom graph). In non-ischemic 
tissue, SD (a horizontal bar of a length representing SD duration) evokes a predominantly hyperemic response (A), 
whereas in mildly ischemic penumbra, a biphasic CBF response is observed (B). In the more seriously ischemic 
penumbra, the CBF response is transient hypoperfusion (i.e. spreading ischemia) (C). At the severely ischemic 
core-penumbra junction (D), SD becomes terminal, and there is no recovery from the associated hypoperfusion. 
Source: (Ayata & Lauritzen, 2015).   
1.2. Secondary injury mediated by SD 
Typically, recurrent SD waves with long cumulative duration may increase neuronal injury  
(Pinczolits et al., 2017; Woitzik et al., 2013) (Hartings et al., 2017; Nakamura et al., 2010) by 
(i) NMDA glutamate receptor over-activation that induces Ca2+ overload and neuronal 
excitotoxicity (Hinzman et al., 2015); (ii) the insufficiency of the CBF response to replenish 
ATP necessary for the uptake of K+ by the Na+/K+ ATPase (Hartings et al., 2017); or (iii) 
causing persistent tissue acidosis, particularly in aged animals (Menyhart et al., 2017).  
The coincidence between the severity of ischemic damage and SD occurrence was corroborated 
by the linear correlation between the total depolarization time or SD frequency with infarct 
maturation in rodent focal cerebral ischemia models (Back et al., 1996; Back et al., 1994; 
Dijkhuizen et al., 1999; K. Takano et al., 1996). Causality was confirmed, when SDs elicited 
experimentally distant to ischemic foci were shown to propagate to penumbra-like tissue and 
increase the size of the ischemic infarct (Busch et al., 1996). 
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1.3. Susceptibility of the nervous tissue to SD 
Taken that SD emerges as a potent mechanism of secondary brain injury in patients, it is of 
great interest to explore which conditions favor the occurrence of SD.  
Experimentally, SDs can be triggered in the intact cortex in various ways: chemically (topical 
or intraparenchymal application of KCl, NMDA agonists, Na+/K+ ATPase blockers) or 
electrically (epi-or subdural repetitive or anodal electrical stimulation) (Ayata, 2009; Pietrobon 
& Moskowitz, 2014). SD susceptibility for evoked SDs may be quantified by implementing 
cathodal stimulation with direct current and measuring the electrical charge (by using 
Coulomb's law) necessary for SD evolution (Leo et al., 2011) or as a function of the time 
required to trigger SD with high-frequency tetanic stimulation or by stepwise raising the 
amplitude of the stimulus. In contrast, SDs are readily provoked by cerebral injuries (ischemia, 
cerebral contusion or hemorrhage), in which case SDs develop spontaneously and 
unpredictably. In focal cerebral ischemia, repetitive SDs are thought to arise from the border of 
the penumbra and the ischemic core (Bere et al., 2014b; Kao et al., 2014), probably initiated by 
hypotensive or hypoxic transients (von Bornstadt et al., 2015). Further, the flow threshold was 
estimated as the lower range of the brain’s autoregulatory capacity in global ischemia (Bere et 
al., 2014a) or defined accurately as being around 40 ml/g/min in focal ischemia (Takeda et al., 
2011). Yet, the ultimate, direct cause of SD elicitation is the critical, elevated concentration of 
extracellular K+ and/or glutamate (Somjen, 2001), both of which accumulate in the ischemic 
brain due to increased release from neural elements and altered clearance by astrocytes (Leis et 
al., 2005). 
In addition to calculating the strength of the minimum stimulus to trigger SD as described 
above, various parameters can be taken to express SD susceptibility, such as (i) the latency of 
SD occurrence with respect to the stimulus, (ii) the frequency of recurrent SD events, (iii) the 
rate of SD propagation, (iv) the distance SD covers over its course of propagation, and (v) the 
duration of ECoG depression. Some of these parameters concern SD initiation (i.e. latency with 
respect to igniting stimulus), others essentially characterize propagation (i.e. rate and distance 
covered, duration of ECoG depression), or represent a mixture of both initiation and 
propagation (i.e. frequency of recurrent SDs). The capability of the nervous tissue to recover 
from SD may be a relevant factor to consider as well, since delayed repolarization may postpone 
the occurrence of subsequent SD events, and is expected to reduce SD frequency. The network 
of astrocytes is thought to contribute to this process. In addition, the buffering capacity of 
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astrocytes may also modulate the delay necessary to reach the neurochemical threshold of SD 
elicitation.  
In migraine with aura, the progressive accumulation of K+ to high concentration as it takes place 
in injured tissue is unlikely, therefore an increased sensitivity or hyperexcitability of neurons 
may stand in the center of SD elicitation (Vinogradova, 2018). In addition, hyperexcitability 
may be relevant for ischemia-related SDs as well, since theoretically such a condition may 
predict SD occurrence at a lower threshold. Neuronal excitability is partly regulated by neuronal 
voltage-dependent Na+ (Nav), Kv, and Cav channels (Misonou, 2010). Structural variations, 
modulation by secondary messengers and genetic dysfunction of these channels might influence 
SD threshold, the latter being implicated, for example, in FHM type 1 (FHM1) and 3 (FHM3) 
(Dichgans et al., 2005; van den Maagdenberg et al., 2004). As such, FHM3 has been linked to 
a mutation of the α1 subunit of Nav 1.1 (encoded by the SNCA1A gene), which elicits neuronal 
hyperexcitability and might decrease SD threshold (Dichgans et al., 2005). Neuronal 
hyperexcitability, on the other hand, may be prevented by the activation of various Kv channels, 
like Kv 1.1, Kv1.2 (Hille, 1992) (G. Chen et al., 2005) and Kv7.2 (KCNQ2) ion channel (Wulff 
& Zhorov, 2008), probably via membrane hyperpolarization (Wu et al., 2003).    
Neuronal excitability may be modulated by Cav channels as well. FHM1 is characterized by a 
mutation in the CACNA1A gene encoding the P/Q type Ca2+ channel (van den Maagdenberg 
et al., 2004), increasing its opening probability at presynaptic terminals (Tottene et al., 2009). 
Taken together, these experimental data suggest, that voltage-gated cation channels tuning 
neuronal excitability also contribute to setting the threshold of SD elicitation. 
1.4. Age as a risk factor for neurological diseases in which SD is relevant 
In neurological disorders implicating SD (i.e. migraine with aura, or acute brain injury including 
TBI, SAH, and malignant ischemic stroke), age is known as an independent risk factor for the 
incidence and prevalence of the disorders. For example, the age-dependent prevalence of 
migraine has been shown to be bimodal, as migraine incidence peaks at the age of 19 and 48 
years in men, and at the age of 25 and 50 in women (Victor et al., 2010). Among the general 
population, TBI has a peak incidence during childhood (falls), adolescence (motor-vehicle 
accidents) and geriatric age (falls) (Bruns & Hauser, 2003). Further, SAH is one of the most 
common types of stroke in young adults, and younger age is an established risk factor for 
secondary lesion progression in SAH, caused by proximal large artery vasospasm (Charpentier 
et al., 1999; Rabb et al., 1994) and delayed cerebral ischemia (Crobeddu et al., 2012; de Rooij 
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et al., 2013; Magge et al., 2010). Finally, aging significantly predicts poor patient outcomes 
after ischemic stroke (R. L. Chen et al., 2010; Liu & McCullough, 2012). The incidence and 
poor outcome of stroke steeply rises with age (R. L. Chen et al., 2010). In this context, the 
impact of age on stroke pathophysiology has been the target of intensive research in order to 
understand the reason for the increased susceptibility of the aged brain to stroke-related injury, 
yet the potential contribution of SD has remained largely unexplored. 
2. Goals 
SD has been recognized to contribute to migraine with aura and secondary injury following 
acute brain injuries (Sections 1.1. and 1.2.). The peak prevalence of migraine and traumatic 
brain injury, for instance, concerns young adulthood (Section 1.4.). Finally, the CBF response 
to SD is compromised by old age, but less is known about the impact of age over adulthood. 
Accordingly, our goals were: 
I. to determine the innate susceptibility of the cerebral cortex to SD, under non-ischemic 
and ischemic condition, over the age range from adolescence to young adulthood in rats 
(7 to 30 weeks) (Sengupta, 2013);  
II. to investigate the possible link between the threshold of SD elicitation and the 
histological organization of the cortex at this age;  
III. to explore, whether the CBF response to SD is subject to any age-related modification 
over the age range investigated; 
IV. to identify specific frequency bands of the electrocorticogram that may be selectively 
affected by SD or age.  
SD related CBF changes are the cornerstone of SD related secondary injury. Since prostanoids 
have been strongly implicated in physiological neurovascular coupling, in a separate study we 
aimed:  
I. to explore the role of vasodilator prostanoids on the SD related CBF response.  
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3. Materials and methods 
3.1. Surgical procedures 
The experimental procedures were approved by the National Food Chain Safety and Animal 
Health Directorate of Csongrád county, Hungary. The procedures were performed according to 
the guidelines of the Scientiﬁc Committee of Animal Experimentation of the Hungarian 
Academy of Sciences (updated Law and Regulations on Animal Protection: 40/2013. (II. 14.) 
Gov. of Hungary), following the EU Directive 2010/ 63/EU on the protection of animals used 
for scientiﬁc purposes and reported in compliance with the ARRIVE guidelines. 
For the examination of the age-dependence of SD threshold, young and middle-aged male 
Sprague-Dawley rats were used (n=38, Table 1). Additional, young, adult, male Sprague-
Dawley rats were treated with pharmacological agents to study the regulation of the CBF 
response to SD (n=60, Table 2). The animals were purchased from the Charles River 
Laboratories, Hungary, were group-housed under a normal 12/12 h light/dark cycle, and had 
free access to food and drinking water. 
Age of rats 
included in the 
study (weeks) 
Body weight (g) n 
Age groups 
defined for 
data analysis 
n 
7 276±14 5 
7-10 weeks 21 
8 332±11 4 
9 348±11 5 
10 377±10 7 
12 403±19 6 
12-16 weeks 12 
16 465±12 6 
30 608±37 5 30 weeks 5 
Table 1. Composition of experimental age groups in the threshold determination study. (Data are given as 
meanstdev.) 
On the day of experiments, the animals were anesthetized with 1.5–2% isoﬂurane in N2O:O2 
(70%:30%) and were allowed to breathe spontaneously throughout the experiment. Body 
temperature was maintained at 37°C with a servo-regulated heating pad. Atropine (0.1%, 
0.05 ml) was administered intramuscularly shortly before surgical procedures to avoid the 
production of airway mucus. A catheter was inserted into the right femoral artery to monitor 
the mean arterial blood pressure (MABP) continuously and the arterial blood gas levels before 
the elicitation of the ﬁrst SD and before termination of the experiment (i.e., anesthetic 
overdose). Next, a midline incision was made in the neck and both common carotid arteries 
were delicately separated from the surrounding tissue, including the vagal nerves. Lidocaine 
(1%) was administered topically before opening each tissue layer. A silicone coated ﬁshing line 
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used as occluder was looped around each artery for later induction of cerebral ischemia. Rats 
were transferred to a stereotactic frame and ﬁxed in prone position. 
In the study to determine SD threshold, two cranial windows (""3 x 3 mm) 1 mm apart were 
prepared over the right parietal cortex. The bone was carefully thinned using a dental drill 
(Technobox, Bien Air 810) and gently peeled away to reveal the dura surface. In the caudal 
window, a small hole was carefully cut on the dura for the positioning of an intracortical 
microelectrode and an adjacent laser-Doppler probe positioned above the cortical surface (see 
3.2 below). SDs were triggered at a regular pattern with electric stimulation (see 3.4 below). 
Similarly, in the pharmacological study two craniotomies (5 mm lateral from midline, -3 mm 
and -7mm caudal from bregma) were prepared over the right parietal cortex using a dental drill. 
A doughnut shape ring of acrylic dental cement was built around the rostral craniotomy for the 
latter topical application of drugs to the cortical surface. The dura in each craniotomy was 
carefully dissected, and the craniotomies were regularly irrigated with artificial cerebrospinal 
fluid (aCSF; mM concentrations: 126.6 NaCl, 3 KCl, 1.5 CaCl2, 1.2 MgCl, 24.5 NaHCO3, 6.7 
urea, 3.7 glucose bubbled with 95% O2 and 5% CO2 to achieve a constant pH of 7.4). The 
rostral window was used to confirm SD evolution with electrophysiological recording, and to 
assess local changes of CBF (see 3.2 below). SDs were elicited in the caudal craniotomy 
chemically (see 3.5 below). 
3.2. Recording of electrophysiological parameters and cerebral blood flow  
For the concomitant recording of ECoG and slow cortical or direct current (DC) potential, a 
glass capillary electrode (20 µm outside tip diameter) ﬁlled with physiological saline was 
inserted 800–1000 µm deep into the cerebral cortex at the recording window. An Ag/AgCl 
reference electrode was implanted under the skin of the animal’s neck. DC potential and ECoG 
were recorded via a high input impedance pre-ampliﬁer (NL102G, NeuroLog System, 
Digitimer Ltd., United Kingdom), connected to a diﬀerential ampliﬁer (NL106, NeuroLog 
System, Digitimer Ltd., United Kingdom) with associated ﬁlter and conditioner systems 
(NL125, NL530, NeuroLog System, Digitimer Ltd., United Kingdom). Potential line frequency 
noise (50 Hz) was removed by a high quality noise eliminator (HumBug, Quest Scientiﬁc 
Instruments Inc., Canada) without any signal attenuation. The resulting signal was digitalized 
by an analog/digital (A/D) converter (MP150, Biopac Systems Inc., USA) and continuously 
acquired at a sampling frequency of 1 kHz using the software ACQKNOWLEDGE 4.2.0 
(Biopac Systems Inc., USA). 
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SD-associated changes in local CBF were recorded using laser-Doppler ﬂowmetry (LDF). A 
laser Doppler needle probe (Probe 403 connected to PeriFlux 5000; Perimed AB, Sweden) was 
positioned right above the cortical surface at the penetration site of the glass capillary electrode 
with a micromanipulator, avoiding any large pial vessels. The signal was digitized and acquired, 
together with the DC potential and ECoG, essentially as described above. 
3.4. Experimental protocol to determine SD threshold  
Following a baseline period of over an hour, persistent incomplete global forebrain ischemia 
was induced by occluding both common carotid arteries permanently (‘‘2-vessel occlusion,’’ 
2VO): occluders were pulled on until resistance was felt and then secured in place. Successful 
ischemia induction was conﬁrmed by a sharp drop of the LDF signal. A concentric bipolar 
needle electrode (tip size: 40 µm, Neuronelektród Kft., Hungary) was placed upon the dura in 
the rostral window for SD elicitation. It was connected to an opto-coupled stimulus isolator 
with a constant current output (NL 800, Digitimer Ltd., United Kingdom), a pulse generator 
(NL301), a with-delay panel (NL405), and a pulse buﬀer (NL510), which enabled the 
adjustment of amplitude and duration of the stimuli at will. Stimulation was implemented with 
a single, cathodal, and rectangular pulse. The charge delivered was quantiﬁed as 𝑄[𝜇𝐶] =
𝐼[𝑚𝐴] × 𝑡[𝑚𝑠], and it was raised  stepwise with an interstimulus interval of 2 min until SD was 
observed. Whenever necessary, the position of the needle electrode was adjusted to optimize 
the contact between the electrode tip and the tissue. Successful elicitation of SD was conﬁrmed 
by a negative DC- shift of an amplitude greater than 5 mV acquired by the recording electrode 
or by obvious ECoG depression. 
Three SDs were elicited during the baseline period, at an inter-SD interval of at least 20 min. 
Additional three SDs were generated during ischemia, the ﬁrst triggered 20-min after ischemia 
onset or after the spontaneous occurrence of an SD event associated with ischemia induction 
(Fig. 3.). 
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Figure 3. Representative, synchronous traces of the ECoG, DC potential, and CBF, acquired from an 8-week-old 
animal from the threshold determination study. Depression of the ECoG synchronous with a transient, negative 
shift of the DC potential and associated functional hyperemia together indicate SD occurrence. The label 2VO 
(bilateral common carotid artery occlusion, ‘‘2-vessel occlusion’’) designates ischemia induction. Short vertical 
lines on the DC potential trace show the delivery of current to evoke SD (upward gray arrows). Ischemia induction 
was immediately followed by the occurrence of a single spontaneous SD in this experiment. 
3.5. Experimental protocol for pharmacological investigation 
Drug solutions or vehicle of equal volume (1.5% DMSO in 10 ml aCSF) were superfused on 
the cortical surface free of dura in the rostral cranial window after taking DC potential and CBF 
baseline for 5 min under aCSF. Drug concentrations were carefully selected based on dose 
response curves, selectivity and efficacy reported previously (Lacroix et al., 2015; Myren et al., 
2010; Niwa et al., 2000; Niwa et al., 2001). The following drugs were applied topically: the 
selective COX-2 inhibitor NS-398 (100 μM; Cayman) (Niwa et al., 2000), the selective COX-
1 inhibitor SC-560 (25µM; Cayman)(Niwa et al., 2001), or the selective PGE2 receptor (EP4) 
antagonist L161,982 (1 µM; Sigma) (Hall et al., 2014; Lacroix et al., 2015). The 
pharmacological treatment was initiated 40 min prior to ischemia induction or the elicitation of 
the first SD event (i.e. sham-operated group) (Niwa et al., 2000), and incubation persisted till 
the end of the experimental protocol. 
Following the 40-min incubation period, persistent incomplete global forebrain ischemia was 
induced in half of the animals by 2VO (see 3.4 above). As control for ischemia, the remaining 
animals were used as a sham-operated group (SHAM), in which the occluders were not pulled 
but left in place. 
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Forty minutes after the start of drug incubation, 4 SDs with an inter-SD interval of 15 minutes 
were triggered by placing a 1M KCl-soaked cotton ball on the exposed cortical surface in the 
caudal cranial window. The cotton ball was removed and the caudal cranial window rinsed with 
aCSF immediately after each successful SD elicitation. Experiments were terminated by the 
overdose of the anesthetic agent, 20 min after triggering the last SD. The combination of 
pharmacological treatment and ischemia induction resulted in 8 experimental groups (Table 2.). 
Higher prevalence of severe ischemia, terminal depolarization and mortality in the ischemic 
animals treated with L161,982 was noted, requiring higher numbers in that experimental group.  
Experimental 
group 
Pharmacological 
treatment 
Cerebral blood flow 
(Intact or Ischemia) 
n 
1 Vehicle 
(1.5% DMSO in 
aCSF) 
Intact 8 
2 Ischemia 7 
3 100 µM NS-398 
(COX-2 inhibition) 
Intact 7 
4 Ischemia 6 
5 25 µM SC-560 
(COX-1 inhibition) 
Intact 7 
6 Ischemia 7 
7 1 µM L161,982 
(EP4 receptor 
antagonism) 
Intact 6 
8 Ischemia 12 
Table 2. Composition of experimental groups in the pharmacological study. 
3.6. Histology 
In order to assess whether dendritic spine density changes with advancing age are related to SD 
susceptibility, additional 8-week-old (n=5) and 30-week-old (n=5) rats were deeply 
anesthetized with an overdose of chloral hydrate (i.p.). The animals were transcardially 
perfused with ice cold saline, decapitated, and the brains quickly removed. The forebrains were 
cut in the coronal plane into two pieces of equal size and immersed in Golgi-COX solution 
mixed of the following stock solutions: (i) 5% potassium dichromate (Molar Chemicals Kft., 
Hungary), (ii) 5% potassium chromate (Molar Chemicals Kft, Hungary), and (iii) 5% mercuric 
chloride (VWR International, LLC)(Glaser & Van der Loos, 1981). The tissue blocks were 
incubated for 10 days at room temperature, the solution being refreshed every 2-3 days. The 
brain samples were then transferred to 30% sucrose to be stored for at least 10 days at 4°C. 
Coronal slices of 200 µm were cut with a vibrating microtome, mounted on gelatin-coated 
microscopic slides, and stored overnight in a dark humidity chamber. Finally, the staining was 
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developed with 30% ammonium hydroxide followed by Carestream Kodak Fixer (Sigma). 
Sections were then dehydrated and cover- slipped with Eukitt (O. Kindler, Germany). 
The stained brain slices were examined by a light microscope (Nikon Eclipse E600). Fifteen-
sixteen cortical pyramidal neurons in layer 3 were studied in samples of each animal. Dendritic 
spine density of second- or third-order dendrites of the proximal apical dendrite was analyzed 
on a 50-µm-long segment. Serial z-stack images of selected dendritic segments were created 
using a SPOT RT Slider digital camera (1600 x 1200 dpi in 8 bits) connected to the light 
microscope (Nikon Eclipse E600) and a computer equipped with an image processing software 
(Image Pro Plus 4.5; Media Cybernetics, Bethesda). Dendritic spines were counted by four 
independent investigators blinded to the experimental groups, using the software IMAGE J 
(v1.44, National Institute of Health, Bethesda). 
3.6. Data analysis 
All variables (i.e., DC potential, ECoG, LDF signal and MABP) were simultaneously acquired, 
displayed live, and stored using a personal computer equipped with a dedicated software 
(AcqKnowledge 4.2 for MP 150, Biopac Systems, Inc., USA). Data analysis was assisted by 
the inbuilt tools of the software, or was transferred into a MATLAB environment (MathWorks 
Inc., USA). 
Raw LDF recordings were down-sampled to 1 Hz and then expressed relative to baseline by 
using the average CBF value preceding the ﬁrst evoked SD (100%) and the recorded biological 
zero obtained after terminating the experiment (0%) as reference points. 
The following elements of the SD-related CBF response were characterized: amplitude and 
duration of early hypoperfusion, amplitude and duration of hyperemia, magnitude of hyperemia 
(area under the curve), and the amplitude of post-SD oligemia. 
The first SD was evaluated separately from subsequent, recurrent SDs, because of the obvious 
differences in the kinetics of the SD-associated CBF response. Data of the 3 recurrent SDs were 
averaged for each animal, thus a single value per animal of each read-out was taken for 
statistical analysis. 
ECoG spectral power analysis was applied for individual frequency bands as described 
previously(Menyhart et al., 2015). The parameters obtained were the following: (i) level of 
baseline (the mean spectral power for the 60s interval preceding the onset of an SD); (ii) level 
of depression (the arithmetic mean between the endpoints of the downward and upward 
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segments); (iii) duration of depression; and (iv) level of recovery (the mean spectral power for 
the 60-s interval following recovery). Along with the 30-week-old group (n=5), six of the 
youngest animals (7/8 weeks) with clean ECoG trace (i.e., minimal noise) were selected for the 
analysis. 
In order to determine dendritic spine density, the spine count of 15-16 dendritic segments 
assessed in each animal was averaged, and, thereby, a single value was taken for each rat for 
further statistical analysis. 
Data are given as mean ± stdev. The software SPSS (IBM SPSS Statistics for Windows, Version 
22.0, IBM Corp.) was used for statistical analysis. A one-way analysis of variance (ANOVA) 
model was used for the evaluation of dendritic spine density, the SD-associated CBF response, 
baseline ECoG power, and the duration of SD-related ECoG depression. A two-way ANOVA 
paradigm was applied for the evaluation of data concerning the electric threshold of SD 
elicitation (factors: age and ischemia) and ECoG power during the SD-related depression 
(factors: age and ischemia). A repeated measures ANOVA (factor: age) was used for the 
analysis of resting CBF, taken at selected time points over the course of experiments, and ECoG 
power variations over the course of experiments. Wherever appropriate, a Fisher post hoc test 
was used to reveal the diﬀerences between the experimental groups. Pearson two-tailed 
correlation analysis was carried out to test potential association between data sets. Levels of 
signiﬁcance were deﬁned as p < 0.05* and p < 0.01**. 
4. Results 
4.1. Investigation of SD susceptibility 
Preliminary screening of the acquired data sets revealed no age-related diﬀerence between the 
7–10-week-old animals and the 12–16-week-old animals (inserts in Figure 5(a)), therefore, 
three age groups were created by uniting the 7–10-week-old and the 12–16-week-old 
populations (Table 1).  
MABP during baseline was statistically not diﬀerent across groups (98 ± 4, 95 ± 3, and 107 ± 
10 mmHg, 7–10-week-old, 12–16-week-old, and 30-week-old, respectively). Ischemia elevated 
MABP slightly but not signiﬁcantly, without any notable impact of age (105 ± 5, 96 ± 4, and 
114 ± 2 mmHg, 7–10-week-old, 12–16-week-old, and 30-week-old, respectively). Arterial 
blood gases were typically within the physiological range, with no signiﬁcant eﬀect of ischemia 
or age on either pCO2 or pH. Arterial blood glucose concentration taken during baseline and 
late ischemia was similar (e.g., 9.23 ± 1.7 vs. 9.20 ± 1.2 mM, ischemia vs. baseline in 7–10- 
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week-old) but signiﬁcantly increased with advancing age (e.g., 11.95 ± 1.6 vs. 10.08 ± 1.0 vs. 
9.2 ± 1.2 mM, 30-week-old vs. 12–16-week-old vs. 7–10-week-old during baseline). 
SDs occurred reliably upon electric stimulation of the cortex. In a number of experiments (25 
of 38), a single, spontaneous SD evolved immediately after ischemia induction (Fig. 3). The 
DC potential signature of SDs demonstrated that the amplitude of spontaneous SDs (23.17.8 
mV) was statistically not different from SDs evoked during baseline (24.53.8 mV) or ischemia 
(28.85.8 mV). However, with spontaneous SDs, the duration at half amplitude of the DC shift 
was considerably longer – albeit with excessive variation (220.9316.0 s), as compared with 
SDs evoked during baseline (19.95.1 s) or ischemia (80.780.8 s). Such spontaneous events 
were not distinctively prevalent for any of the age groups, although only 2 of the 25 events were 
recorded in the 30-week-old group. Spontaneous SDs were not included in further data analysis. 
The CBF response to SDs evoked was invariably hyperemic in all age groups, under both 
baseline and ischemia. The CBF response to the first SD in each experiment differed from 
subsequent SDs in that hyperemia was often preceded by a short drop in CBF, and was always 
followed by long-lasting oligemia. 
4.1.1. Compensation of cerebral blood flow to ischemia  
In order to estimate how compensation for the reduction of CBF evolved following ischemia 
induction, CBF values were obtained prior to and shortly after ischemia onset, and in between 
SD events evoked during ischemia (Fig. 4). In the youngest, 7-10-week-old group, CBF 
dropped to 18±6% immediately after 2VO onset, recovered to 37±12% before the elicitation of 
the first SD under ischemia, and was maintained over 30% throughout the ischemic period. In 
contrast, CBF fell to 11±6% after ischemia induction, recovered to 20±13% before initiation of 
the first ischemic SD, and remained at around only 20% in the 30-week-old group, implying 
significantly less efficient compensation in the 30-week-old group with respect to the 7-10-
week-old group. 
24 
 
Figure 4. Level of local CBF in the youngest (7–10-week-old) and oldest (30-week-old) age groups, taken at 
selected time points of the experimental protocol: (a) prior to bilateral common carotid artery occlusion (2VO), 
after the passage of the last SD elicited during baseline; (b) transient drop immediately after 2VO; (c) shortly 
before the first ischemic SD; (d) shortly before the second ischemic SD; (e) shortly before the third ischemic SD; 
(f) late ischemia, after the passage of the last SD elicited during ischemia. Data are presented as mean±stdev. A 
repeated measures analysis of variance (ANOVA) paradigm considering age as a factor was applied for statistical 
analysis. Level of significance was defined as p<0.01**. Post hoc analysis for group comparison at each time point 
revealed significant difference at (c) and (d). Level of significance was defined as p<0.05*. 
4.1.2. Electric threshold of SD elicitation 
The electric threshold of SD elicitation was expressed as the lowest electric charge sufficient to 
trigger SD in the cortex (Fig. 5A). We chose to trigger SDs by electric stimulation as opposed 
to high concentration K+ application, because the electric charge delivered can be finely tuned. 
This offers the accurate estimation of the electric threshold of SD elicitation to uncover any fine 
variations between age groups of a few weeks difference. 
In all age groups, the threshold of SD elicitation was significantly higher during ischemia, as 
compared with baseline. The initiation of SD required increasingly greater electric charge with 
older age during both baseline (4743±1282 vs. 3076±915 vs. 1661±649 µC, 30-week-old vs. 
12-16-week-old vs. 7-10-week-old) and ischemia (8447±1763 vs. 5343±2170 vs. 2514±1032 
µC, 30-week-old vs. 12-16-week-old vs. 7-10-week-old). Finally, with advancing age, the 
threshold during ischemia progressively departed from the threshold determined for the 
respective baseline: in other words, the difference between ischemia and baseline thresholds 
was approximately 5 times greater in the 30-week-old as compared with the 7-10-week-old 
group (threshold difference of 4278±2352 vs. 853±839 µC, 30-week-old vs. 7-10-week-old). 
Next, we set out to determine any potential association between the electric threshold of SD 
elicitation and CBF, or the cortex’ SD-related electrical activity. Lower CBF taken prior SD 
elicitation predicted higher threshold of SD elicitation (r=-0.403**) (Fig. 5B). The threshold of 
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SD elicitation positively correlated with the duration of SD-related depression of the high 
frequency alpha and beta bands (r= 0.373** and 0.478**, respectively) (Fig. 5C), but not with 
the low frequency delta and theta bands (r= 0.247 and 0.234, respectively). No association with 
any other ECoG variable (i.e. power of baseline, depression or recovery) emerged. 
 
Figure 5. Electric threshold of SD elicitation, and its association with CBF and the SD-related depression of the 
ECoG. (a) Electric threshold of SD elicitation prior and during incomplete forebrain ischemia (baseline: open 
symbols, ischemia: closed symbols). The 7-10-week-old animals and 12-16-week-old animals were treated as 
single groups, because no impact of age was observed on threshold values (see inserts). Data are represented as 
mean±stdev. For the evaluation of statistical significance, a two-way ANOVA paradigm considering age and 
ischemia as its factors was followed by a Fisher post hoc test for age. Level of significance for the ANOVA was 
defined as p<0.01**, and for the post hoc test as p<0.01##, vs. 7-10 week-old and p<0.05++, vs. 12-16 week-old. 
(b) Negative correlation between the electric threshold of SD elicitation and CBF prior SD evolution; each evoked 
SD was considered for the analysis. Pearson two-tailed correlation analysis including all age groups as one data 
pool indicated significant association between the threshold and CBF (p<0.01**). (c) Correlation between the 
electric threshold of SD elicitation and the duration of SD-related depression on the beta frequency band of the 
ECoG. Data acquired from animals selected for ECoG spectral analysis are shown. Pearson two-tailed correlation 
analysis revealed significant association between the data sets (p<0.01**). 
4.1.3. Density of dendritic spines 
We set out to test the hypothesis that the increase in the threshold of SD elicitation due to brain 
maturation is determined – at least in part – by the dynamic structural development of the cortex, 
reflected by the morphological plasticity of dendritic spines. The animals admitted to the 
analysis were naïve (i.e. neither ischemia nor SD was induced prior to sampling), therefore 
potential dendritic spine density changes due to ischemia or SD propagation were not studied. 
Dendritic spines on 2nd or 3rd order dendritic branches of layer 3 pyramidal neuronal apical 
dendrites were investigated (Fig. 6A). In general, dendritic spines tended to be arranged in 
clusters rather than individually, and appeared to be larger and more complex in shape in the 
30-week-old group than in the 8-week-old group (Fig. 6B).  Dendritic spine density 
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significantly increased in the 30-week-old group with respect to the 8-week-old group (554 
vs.512 spines / 50 µm dendritic segment, 30-week-old vs. 8-week-old) (Fig. 6C). 
 
Figure 6. Dendritic spine density on second- or third-order dendritic branches of apical dendrites of layer 3 
pyramidal neurons. (a) Schematic drawing of a cortical pyramidal neuron to illustrate the position of dendritic 
segments investigated. (b) Representative images of 50-µm-long segments of second- or third-order dendrites in 
the 8-week-old and the 30-week-old groups. Images were obtained of original z-stack images by the enhancement 
of contrast and brightness in order to eliminate background. (c) Dendritic spine density on the selected dendritic 
segments. Data are given as mean±stdev. A one-way ANOVA model was used for statistical analysis (n=5 for 
each group, F=6.263, p<0.05*). 
4.1.4. Features of the cerebral blood flow response associated with SD 
For the evaluation of the SD-associated CBF response, SDs were sorted into three distinct 
categories: (i) SD1, (ii) subsequent SDs evoked during baseline, and (iii) SDs initiated under 
ischemia (Fig. 7A). 
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As presented in Figure 8B, CBF prior to the onset of baseline SDs was 10-15% lower than that 
prior to SD1 in all age groups (e.g. 90±30 vs. 102±12%, baseline SDs vs. SD1 in 7-10-week-
old). The CBF response with SDs under ischemia took off from a markedly lower level (39±15 
and 38±11%, 7-10-week-old and 12-16-week-old, respectively), especially in the 30-week-old 
group (23±14%). The SD-associated hyperemia peaked at around 160-170% in all age groups 
during baseline (i.e. 163±45, 160±61 and 170±69%, 7-10-week-old, 12-16-week-old and 30-
week-old, respectively), approximately 20-30% higher than with SD1 (129±23, 131±17 and 
149±24%, 7-10-week-old, 12-16-week-old and 30-week-old, respectively). During ischemia, 
the peak amplitude of the CBF response reached a considerably lower level (59±23 and 
Figure 7. Quantitative analysis of the CBF 
response associated with SD. (a) Schematic 
drawings depicting the variables under study: 
CBF response to SD1, subsequent SDs during 
baseline (baseline SDs), and SDs evoked 
during ischemia (ischemic SDs). CBF level 
prior SD elicitation, peak amplitude, and 
duration at half amplitude were evaluated. (b) 
Peak CBF amplitude (bars) respective to CBF 
baseline prior SD elicitation (base of bars). (c) 
The duration of hyperemia at half amplitude. 
Data are expressed as mean±stdev. For the 
evaluation of statistical significance, a one-way 
ANOVA paradigm followed by a Fisher post 
hoc test was used for each age group. Level of 
significance for the ANOVA was defined as 
p<0.01**, and the F-values are given in each 
bar chart. Level of significance for the post hoc 
analysis is indicated as p<0.05* and p<0.01** 
vs. SD1; and p<0.01## vs. baseline SDs. 
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61±18%, %, in 7-10-week-old and 12-16-week-old, respectively), with the lowest value 
measured in the 30-week-old group (39±22%). Conspicuously, in the 30-week-old group, the 
CBF response with ischemic SDs set off from the lowest CBF level, and reached the lowest 
peak (not even exceeding the resting CBF prior to SD elicitation in the 7-10- or the 12-16-week-
old groups) (Fig. 7B), although with no statistically significant reduction with respect to the 
younger age groups. 
Figure 7C shows that the duration of the SD-related CBF response was shortest with SD1 
(30±12, 33±7 and 39±23 s, 7-10-week-old, 12-16-week-old and 30-week-old, respectively), 
increased with subsequent SDs elicited during baseline (58±14, 56±11 and 50±10 s, 7-10-week-
old, 12-16-week-old and 30-week-old, respectively), and more than doubled with SDs triggered 
under ischemia (154±61, 137±68 and 150±52 s, 7-10-week-old, 12-16-week-old and 30-week-
old, respectively). No impact of age on the duration of the SD-associated CBF response was 
observed. 
4.1.5. Spectral analysis of the distinct ECoG frequency bands 
Baseline ECoG power was assessed at the very beginning of the experiments, prior to any 
intervention, to test whether anesthesia differentially affects the two age groups. No age-related 
difference was observed concerning any of the frequency bands studied (Fig. 8A). ECoG power 
repeatedly sampled prior SD events demonstrated that ischemia itself imposed a considerable 
power decrease on the overall ECoG, which was particularly prominent after the passage of the 
first SD evoked under ischemia. This is illustrated in Figure 9B for the theta band. 
The novel findings of spectral analysis concerned the SD-related transient depression of the 
ECoG. Although the power of the four frequency bands during depression was similar under 
baseline and ischemia (i.e. ischemia exerted no impact), the selectively greater power of the 
alpha and theta bands in the 30-week-old group as compared with the 7/8-week-old group (e.g. 
theta band: 0.0050.003 vs. 0.00250.001 V2, 30-week-old vs. 7/8-week-old) indicated 
incomplete depression of these two bands with the maturation of the brain, under both baseline 
and ischemic conditions (Fig. 8A). 
29 
 
Figure 8. Spectrum analysis of the ECoG for individual frequency bands during SD events. (a) ECoG power of 
each frequency band, for 60 s baseline at the very start of the experimental protocol, prior to any intervention. No 
significant difference between age groups was observed, for any of the frequency bands examined (one-way 
ANOVA). Note that the weight of low frequency bands in the spectrum is greater than that of higher frequency 
waves, which mainly reflects an inherent feature of ECoG spectra. Because the ECoG frequency bands represent 
a power spectrum, their values will vary exponentially, meaning the lower-frequency bands will have 
exponentially greater values than the higher-frequency bands. (b) Baseline ECoG power of the theta band, assessed 
repeatedly prior to events, in order to follow the distribution of baseline over the course of the experimental 
protocol. The first pair of symbols corresponds with theta in Panel A. Repeated measures ANOVA revealed that 
the ECoG power of baseline decreased, especially during ischemia, irrespective of age. (c) ECoG power of distinct 
frequency bands, calculated for the period of SD-related ECoG depression. The power of individual frequency 
bands is represented by bars positioned behind each other. Two-way ANOVA considering age and ischemia as its 
factors revealed that age significantly elevated the power of the alpha and theta bands selectively, irrespective of 
ischemia. Level of significance was defined as p<0.05* and p<0.01**. (d) Duration of ECoG depression with SDs 
evoked under baseline condition. The low frequency bands start to recover significantly sooner than the high 
frequency bands in the 30-week-old group (one-way ANOVA followed by a Fisher post hoc test, p<0.05# vs. 
alpha, p<0.05* and p<0.01** vs. beta). (e) Negative correlation between the duration of the SD-related depression 
on the theta band of the ECoG, and the relative peak of SD coupled hyperemia. Pearson two-tailed correlation 
analysis revealed significant association between these data sets (p<0.01**). (f) Positive correlation between the 
duration of the SD-related depression on the theta band of the ECoG, and the duration of SD coupled hyperemia. 
Pearson two-tailed correlation analysis indicated significant association between the data sets (p<0.01**).  
As expected, ischemia considerably extended the duration of ECoG depression on all four 
frequency bands (e.g. alpha band in the 7/8-week-old: 271±126 vs. 139±40 s, ischemia vs. 
baseline). Curiously, during baseline, the lower frequency delta and theta bands started to 
recover from the SD-related depression sooner than the higher frequency alpha and beta bands 
in the 30-week-old group, in contrast with the 7/8-week-old group (e.g. duration of theta band: 
12352 vs. 13234 s, 30-week-old vs. 7/8-week-old) (Fig. 8B). 
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The duration of the SD-related ECoG depression appeared to be associated with the SD-coupled 
CBF response: the relative peak of SD-associated hyperemia correlated negatively with the 
duration of ECoG depression on all four frequency bands, as illustrated for the theta band in 
Figure 8C (r=-0.550**). At the same time, the longer duration of hyperemia was strongly linked 
to the longer duration of ECoG depression on all four frequency bands, being most prominent 
on the delta and theta bands (r=0.733** and r=0.703**, respectively) (Fig. 8D). 
4.2. Pharmacological manipulations to explore potential mediators of the cerebral 
blood flow response to SD 
4.2.1. Effect of pharmacological manipulation on systemic physiological variables 
and baseline CBF levels  
Topical application of drugs was chosen in order to avoid potential systemic side effects. 
Measured values of MABP and the outcome of blood gas analysis confirmed no difference in 
the systemic variables assessed in various treatment groups. Specifically, Figure 9A 
demonstrates that MABP did not change significantly over the experimental protocol, and was 
similar across experimental groups.  Arterial blood gas analysis showed that all investigated 
variables were within the physiological range at the start of the experiments (i.e. pO2: 133±28 
mmHg, pCO2: 32±6 mmHg, pH: 7.39±0.02, HCO3: 19.19±4.54 mmol/l, glucose: 5.21±1.71 
mmol/l) and prior to the termination of the experiments (i.e. pO2: 125±29 mmHg, pCO2: 38±11 
mmHg, pH: 7.37±0.08, HCO3: 21.49±3.44 mmol/l, glucose: 6.11±1.92 mmol/l). Baseline CBF 
was obviously reduced significantly due to ischemia induction (from 112±15 to 27±13 % as an 
average), but the various treatments did not exert any significant impact (Fig. 9B). 
 
Figure 9. Mean arterial blood pressure (MABP; in A) and drift of local cerebral blood flow (CBF; in B) over the 
experimental protocol. Selected time points for sampling have been defined as follows: (a) at 35 min after the 
initiation of pharmacological treatments; (b) immediately before ischemia induction; (c) MABP (A) or CBF (B) 
minimum after ischemia induction; (d) prior to SD1; (e) prior to SD2; (f) prior to SD3; (g) prior to SD4. Data are 
given as mean±stdev. Statistical analysis relied on a repeated measures paradigm followed by a Fisher post hoc 
test. Ischemia – but not treatment - had a significant effect on the baseline drift of CBF. Level of significance was 
determined as p<0.01** vs. respective Intact group. 
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4.2.2. Pharmacological manipulation of SD related cerebral blood flow response 
The impact of pharmacological treatments on the CBF response could be discriminated in the 
intact – but not in the ischemic - animals. The selective COX enzyme inhibitors NS-398 and 
SC-560 did not exert any clear influence on the evolution of the SD-related CBF response, as 
all the examined variables remained unaltered by the treatments. On the other hand, the EP4 
receptor blocker L161,982 selectively reduced the relative amplitude of peak hyperemia with 
the first SD (21±11 vs. 51±38 %, Intact L161,982 vs. Intact Vehicle), and recurrent SDs (50±21 
vs. 76±37 %, Intact L161,982 vs. Intact Vehicle). In fact, L161,982 lowered the amplitude of 
the hyperemic element of the CBF response to near the level observed for the ischemic group 
(first SD: 21±11 vs. 15±8 %, L161,982 Intact vs. L161,982 Ischemic), as indicated by the loss 
of statistically significant difference otherwise obvious between the intact-ischemic group pairs 
(i.e. Vehicle, NS-398 or SC-560 treated) (Fig. 10B). Further, L161,982 augmented the relative 
amplitude of post-SD oligemia with the first SD (58±13 vs. 40±14 %, Intact L161,982 vs. Intact 
Vehicle) (Figure 10A&C). Based on these results, the selective EP4 receptor blocker L161,982 
appeared to achieve a general loss of a dilatory element prevalent throughout the CBF response, 
as reflected by a reduction of peak hyperemia with a degree matching the deepening of the post-
SD oligemia (Fig. 10A). This observation was confirmed by calculating the flow difference 
between peak hyperemia and the minimum point of post-SD oligemia, providing the exploited 
range of vasoregulation during the CBF response, which was unchanged due to treatments in 
the intact groups (87±32 pp, % in average). 
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Figure 10. The impact of pharmacological treatments on the kinetics of the spreading depolarization (SD)-related 
cerebral blood flow (CBF) response. All panels demonstrate data for the first SD. A, CBF traces are mean±stdev 
for each group presented. B, Maximum amplitude of peak hyperemia; C, Minimum amplitude of post-SD oligemia; 
D, Rate of hyperemia evolution associated with SD; E, Magnitude of hyperemia expressed as area under the curve. 
Data in Panels B-E are given as mean±stdev. Statistical analysis relied on a one-way analysis of variance 
(ANOVA) model followed by a Fisher post hoc test. Statistical significance was determined as p*<0.05 and 
p**<0.01 vs. respective Intact, and p#<0.05 vs. respective Vehicle. Note the selective effect of L161,982 (i.e. EP4 
receptor antagonism) under Intact condition. 
To further prove the selective effect of L161,982 on the SD-related CBF response, hyperemia 
evolution significantly decelerated due to L161,982 treatment as demonstrated by its shallower 
upward slope with the first SD (0.75±0.38 vs. 1.88±1.13 %/s, Intact L161,982 vs. Intact 
Vehicle) (Fig. 10D), and recurrent SDs (1.05±0.43 vs. 1.60±0.70 %/s, Intact L161,982 vs. Intact 
Vehicle). Finally, the magnitude of hyperemia expressed as the area under the curve was also 
significantly decreased by L161,982 for the first SD (874±462 vs. 2885±2543 % x s, Intact 
L161,982 vs. Intact Vehicle) (Fig. 10E), and recurrent SDs (5532±3643 vs. 7448±2072 % x s, 
Intact L161,982 vs. Intact Vehicle). 
The duration of the hyperemic element of the CBF was unchanged by pharmacological 
treatment in the Intact group, while in the ischemic group it was closely related to DC potential 
duration. The coincidence between the duration of depolarization and the associated hyperemia 
was confirmed by a strong, positive correlation (r=0.825**) between these variables, similarly 
to the correlation of ECoG depression and CBF response duration (Figure 8F). 
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Finally, the early hypoperfusion element of the SD-related CBF response did not appear 
consistently, therefore measured values (i.e. amplitude, duration) could not be analyzed 
reliably. 
Pharmacological manipulation proved to be ineffective on the kinetics of SD in physiological 
setting. Conversely, the DC potential signature of SD was markedly and selectively elongated 
by SC-560 and L161,982 but not NS-398 treatment in the Ischemic group.  
5. Discussion 
We investigated the susceptibility of the nervous tissue to SD, focusing on young adults of 
increasing age.  
I. We found, that the electric threshold of SD elicitation in young adult rats significantly 
increased during early adulthood, while incomplete forebrain ischemia decreased the 
susceptibility of the cerebral cortex to SD.  
II. The increasing threshold of SD elicitation coincided with the increasing density of 
dendritic spines of cerebrocortical pyramidal neurons.  
III. The age-related impairment of CBF compensation examined over an hour following 
ischemia onset becomes first apparent at 30 weeks of age in the Sprague-Dawley rat. 
The SD related CBF response was impaired by ischemia, without any detectable impact 
of age in the age-groups investigated.  
IV. The duration of SD-related depression of activity was shorter, specifically on the delta 
and theta bands. The SD-related depression of the alpha and theta frequency bands were 
less pronounced in older animals. 
In a separate study we investigated the role of vasodilator prostanoids (especially PGE2) in the 
regulation of the SD related CBF response. 
I. The pharmacological antagonism of the EP4 receptor of PGE2 decreased hyperemia and 
exacerbated post-SD oligemia under physiological circulation, without influencing 
tissue depolarization. Importantly, pharmacological manipulation had no effect under 
ischemia.  
5.1. The impact of ischemia on SD elicitation 
Our present data clearly demonstrate, that the electric threshold of SD elicitation markedly 
increases with ischemia and that the ischemia-related threshold elevation is increasingly more 
obvious with older age (Fig. 5A). 
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The ischemia-related increase of SD threshold may be the result of the metabolic state of the 
tissue, as indicated by the correspondence between lower CBF taken prior to evoking an SD 
with a higher electric threshold of SD elicitation (Fig. 5B). The supply of glucose and oxygen 
are crucial for the proper working of energy-dependent ion pumps, and thus the effective 
maintenance of resting membrane potential. The first indication that the restricted availability 
of energy substrates facilitates, while surplus glucose impedes SD was delivered by creating 
systemic hypo- and hyperglycemia in rats. Hypoglycemia shortened, while hyperglycemia 
postponed the onset delay of SD in response to hypoxia initiation (Hansen, 1978). Later, 
hyperglycemia (23-24 mM) was also shown to elevate the electric threshold of SD elicitation, 
and to reduce the frequency of high K+-induced recurrent SDs in normally-perfused tissue 
(Hoffmann et al., 2013). Hypoglycemia (2,2 mM), on the other hand, did not alter SD 
susceptibility, but prolonged the cumulative duration of recurrent SDs elicited in the otherwise 
intact cortex (Hoffmann et al., 2013). Interestingly, suppression of glycogen, lactate or glucose 
utilization in the cerebral cortex of mice reduce SD elicitation threshold, suggesting a 
significant role for astrocyte-neuron lactate shuttle during SD (Kilic et al., 2018). In conclusion, 
the unlimited supply of circulating plasma glucose may restrict the repeated occurrence of SD 
in the intact and ischemic cerebral cortex. However, our data on blood glucose level indicated 
normoglycemic conditions (blood glucose concentration around 9-11 mM) in all age groups, 
and revealed no difference between baseline and late ischemia. Therefore, we suggest that the 
higher threshold of SD under ischemia was unrelated to blood glucose concentration. 
It has been long appreciated that mild tissue acidosis  - which typically characterizes ischemic 
penumbra tissue - suppresses SD- For example, pH 6.67–6.97, achieved by HCl or NaOH 
application, the elevation of pCO ⁠2 or withdrawal of bicarbonate in the medium of brain slice 
preparations inhibited SD initiation and reduced the velocity of SD propagation (Tombaugh & 
Somjen, 1996; Tong & Chesler, 2000). Low pH may restrict SD evolution via NMDA receptor 
inhibition (C. M. Tang et al., 1990) or by the adjustment of the conductance and gating 
properties of Kv, Nav, and Cav channels (Tombaugh & Somjen, 1996). Therefore, we suggest 
that the ischemia-related fall of tissue pH could be a key factor in raising the threshold of SD 
elicitation as observed here. Finally, increased K+ conductance and the gradual accumulation 
of extracellular K+ that occur during ischemia generally contribute to membrane 
hyperpolarization and repolarization thereby depressing neuronal excitability (Shah and 
Aizeman, 2014). This ionic imbalance may effectively inhibit SD elicitation as well.  
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5.2. The impact of aging on SD elicitation 
The neonatal brain appears to be too immature to sustain experimentally triggered SD. In the 
intact rat cortex, SD can be first initiated from postnatal days 12-15 (Bures, 1957; Frank Richter 
et al., 1998; Schade, 1959). The threshold of SD elicitation was thought to decrease until 
adulthood, and expected to decrease further with aging, theoretically due to the shrinkage of 
the extracellular space (Somjen, 2001). 
However, the latter view on aging appears to be superseded by accumulating experimental 
evidence. First, the rate of SD propagation was shown to decelerate in the aging rodent brain 
(Guedes et al., 1996). Also, increasingly higher concentration of KCl was required to trigger 
SD in brain slices obtained from middle-aged rats with respect to young adults (Maslarova et 
al., 2011), which was later confirmed by our research group in anesthetized rat cerebral cortex 
(Menyhart et al., 2015; Menyhart et al., 2017). We have previously observed, that the same, 
incessant, standard trigger (1 M KCl) produced a lower number of recurrent SDs in the middle-
aged with respect to the young adult cerebral cortex in anesthetized rats (Farkas et al., 2011).  
In further support for the concept that the aged nervous tissue is less able to sustain SD, 
additional experimental results may be lined up. In the full band ECoG, SD is seen as a transient, 
spreading depression of activity (Leão, 1944) – unless the ECoG is already isoelectric prior to 
SD occurrence due to a severe insult (Hartings et al., 2011a). The duration of the ECoG 
depression in the non-ischemic rat cerebral cortex may last for over 2 min in the young, but for 
only half of this time duration in middle-aged animals (Farkas et al., 2011).  
In the present study, we investigated the susceptibility changes to SD in young rats, 
corresponding to human adolescence and young adulthood (Sengupta, 2013). By using electric 
stimulation, we have precisely defined and confirmed previous results, that the threshold of SD 
initiation increases with age, and we have shown that the susceptibility of the cerebral cortex to 
SD starts to decrease gradually already from adolescence on. 
The increased threshold of SD elicitation with advancing age during early adulthood may be 
linked to structural changes in neuronal networks, which may alter the electrophysiological 
properties of the nervous tissue. Thus, it is conceivable that the stimulus applied is dissipated 
in the tissue before SD is ignited. The formation and retraction of dendritic spines that host the 
post-synaptic element of excitatory synapses dynamically changes with brain maturation 
(Harris, 1992) and aging (Dickstein et al., 2013) is heavily involved in SD propagation 
(Herreras, 1993) and is negatively affected by SD (Risher et al., 2010). Therefore we set out to 
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determine dendritic spine density in the youngest and oldest animals admitted to our study to 
contemplate on any potential link between age-related structural changes in the cortex, and the 
threshold of SD elicitation. Our results exhibited an increased density of dendritic spines on the 
apical dendrites of cortical layer 3 pyramidal neurons at 30 weeks of age with respect to 8 weeks 
of age (Fig. 6), proving that the histological organization of the cortex undergoes detectable 
alterations during the life span investigated in this study.  
Even though a direct link between such fine structural changes and the excitability of neurons 
is challenging to establish, we speculate that the threshold of SD elicitation may increase with 
age during early adulthood because of the histological (and connected biochemical) maturation 
or consolidation of cortical connections. Further on, some evidence suggest that the excitability 
of the aged nervous tissue is lower, because the age-specific increase in the production of 
reactive oxygen species modifies the operation of the redox-sensitive K+ channels (Sesti, 2016) 
(Fig. 11.B). This process may modulate the oligomer formation, permeation and gating 
properties of Kv channels and BK channels (Sesti, 2016), but it remains to be explored whether 
these changes manifest at the level of SD evolution.  
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Figure 11. Conceivable targets of aging, implicated in the susceptibility of the nervous tissue to spreading 
depolarization (SD). A, Schematic illustration of the cellular elements hosting ion channels and transporters that 
are involved in SD evolution. B, Age-related dysfunction of the Na ⁠+/K ⁠+ ATPase may contribute to K ⁠+ accumulation 
in the interstitial space to trigger SD. While little is certain about the impact of aging on voltage-gated Na ⁠+ channels 
(Nav), the augmented production of reactive oxygen species with aging may alter voltage-gated K ⁠+ channel (Kv) 
function to reduce the excitability of the nervous tissue. Finally, aging may suppress the expression of P/Q type 
voltage-gated Ca ⁠2+ channels (Cav) that may increase SD threshold. C, The age-related downregulation of NMDA 
receptor subunits implicated in SD may impair NMDA-based Glu signaling and SD propagation. Potassium 
reuptake may be also hampered by the activity of the Na ⁠+/K ⁠+ ATPase decreased in the aging. D, Clearance 
mechanisms linked to astrocytes, such as Na ⁠+/K ⁠+ ATPase activity, the expression of excitatory amino acid 
transporters (EAAT) and K ⁠+ syphoning through Kir4.1 channels may become ineffective or lower in the aging 
brain, leaving higher concentration of K ⁠+ and glutamate in the extracellular space, and thereby delaying 
repolarization. E, The spatial buffering capacity of astrocytes complementing clearance mechanisms may also be 
altered by age, although direct evidence in support of the suggestion is still to be acquired.  
5.3. The impact of aging on SD evolution and propagation 
As our data have revealed, the shortening of the SD-related ECoG depression appears to be 
evident first in the low frequency components (delta and theta bands) at the end of young 
adulthood (30 weeks) (Fig. 8), and concerns all frequency bands at old age (18 months old) 
(Makra et al., 2018). These data may depict a narrower SD wave front in space, standing for a 
smaller volume of nervous tissue involved in SD at a given point in time. This notion is 
supported by our neuroimaging studies revealing that the wave front of SD in the old cerebral 
cortex appears to be narrower than in the young (Farkas et al., 2011). 
These electrophysiological property changes may be accomplished by the age-related 
modification of Kv and BK channel function (Sesti, 2016). P/Q type Cav channels implicated 
in SD evolution were shown to be affected by aging, as well. Protein levels of P/Q type Cav 
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channels in synaptosomes extracted from the cerebral cortex significantly decreased at 
preserved synaptic density in old rats compared to adults (Iwamoto et al., 2004). Since the 
pharmacological inhibition of P/Q type Cav channels was shown to suppress SD occurrence 
(Hoffmann et al., 2010; F. Richter et al., 2002), the decreased expression of the channel protein 
at old age may also impede SD evolution (Fig. 11B). 
As mentioned above, the ionic movements underlying SD are also accompanied by the release 
of glutamate, which sustains SD by binding to and activating NMDA receptors. The decay of 
NMDA receptor-based signaling with aging has been repeatedly demonstrated in the context of 
suboptimal synaptic neurotransmission and failing cognitive performance (Kumar, 2015). It is 
plausible that NMDA receptor-based signaling is compromised due to oxidative-stress 
mounting to levels relevant for functional deterioration in the aged brain. Declining NMDA 
receptor function was, for example, linked to the oxidation of Ca2+/calmodulin-dependent 
protein kinase II (Bodhinathan et al., 2010). Among a number of potential mechanisms that 
may affect NMDA receptors in aging, the expression of distinct NMDA receptor subunits was 
found to be subject to age-related changes, as well (Kumar, 2015). Importantly, mRNA and 
protein expression of the modulatory NR2A and the NR2B subunits, both implicated in SD 
evolution (Shatillo et al., 2015; M. Wang et al., 2012), appeared to be downregulated in the 
aged brain (Kumar, 2015; Magnusson et al., 2010; Zhao et al., 2009). In summary, the age-
related dysfunction of NMDA receptors may restrict SD evolution (Fig. 11C). 
5.3. The impact of aging on the recovery from SD 
As discussed above, the proper function of neuronal and astrocytic Na+/K+ ATPase, and K+ and 
glutamate clearance mechanisms of astrocytes significantly contribute to the cessation of SD 
(Leis et al., 2005; Major et al., 2017), which is hampered in the old ischemic brain with respect 
to the young (Clark et al., 2014; Menyhart et al., 2015). 
Most studies conducted in this regard agree that the activity of the Na+/K+-ATPase decreases 
in the aging brain (Benzi et al., 1994; Chakraborty et al., 2003; Cohadon & Desbordes, 1986; 
de Lores Arnaiz & Ordieres, 2014; Kocak et al., 2002). Crude microsomal preparations must 
have provided evidence for the combined weakening of neuronal and astrocytic Na+/K+-
ATPase activity, because this approach is not expected to discriminate between cell types 
(Kocak et al., 2002). On the other hand, investigations using synaptosomes demonstrated the 
age-related decline in neuronal Na+/K+-ATPase activity, selectively (Benzi et al., 1994; 
Chakraborty et al., 2003). Moreover, enzyme activity decreasing with age has been linked to 
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oxidative stress, which is enhanced in the aged brain (Chakraborty et al., 2003). It is noteworthy 
that Na+/K+-ATPase hyperactivity in response to ischemia is less obvious in the aging than in 
the adult brain (Villa et al., 2002), in agreement with the slower recovery from SD reported in 
old rats suffering from cerebral ischemia (Clark et al., 2014; Menyhart et al., 2015). 
Apparently, astrocytes in the aged brain display morphological alterations as well as functional 
adaptation (Verkhratsky et al., 2016), and show characteristics of senescence-associated 
secretory phenotype (Salminen et al., 2011). Intuitively, age-related loss of function should 
include the reduction of the efficacy of astrocyte transport mechanisms, but there is only few 
and indirect or conflicting evidence to be lined up. As such, both transcript and protein levels 
of the Kir4.1 channel and the EAAT2 glutamate transporter were shown to be gradually 
downregulated in the pericontusional cortical region over 3 days after experimental TBI in 
mice, which proved to be more pronounced in the old group of animals with respect to adults 
(Gupta & Kanungo, 2013). Yet, in the uninjured cortex of the same mice, aging itself increased 
Kir4.1 and aquaporin-4 transcript and protein levels, interpreted as an adaptive response to 
maintain K+ and water homeostasis (Gupta & Kanungo, 2013). Further, aquaporin-4 channels 
participating in astrocytic K+ uptake appeared to be less polarized (i.e. more dispersed) in 
astrocyte end feet in old mice (Kress et al., 2014). The expression of glial fibrillary acidic 
protein (GFAP) increases with age (Salminen et al., 2011), and the expression of EAAT2 has 
been found to decrease with increasing GFAP content, at least in brain samples of Alzheimer's 
disease patients (Simpson et al., 2010). It is also intriguing that the amplitude of Ca2+ signaling 
in astrocytes in response to the activation of their NMDA receptors was found markedly 
decreased at old age in protoplasmic cells isolated from the rodent cortex (Lalo et al., 2011), 
which may indicate that aging astrocytes are less responsive to glutamate. Altogether, these 
data are suggestive that transport and signaling by astrocytes are altered in the old brain (Fig. 
11D and E). Yet it remains to be investigated to what degree astrocyte aging contributes to the 
recovery from SD, delayed in the old cerebral gray matter, especially under ischemic 
conditions. 
Finally, astrocyte network function that relies on gap junctional contacts between adjacent cells 
may be subject to aging. Even though the level of the most typical astrocytic gap junction 
protein connexin-43 seems to be maintained into old age in the rodent brain and retina, the 
number, size and connexin composition of astrocytic gap junction plaques may change (Cotrina 
et al., 2001; Mansour et al., 2013). Whether these subtle but detectable alterations in gap 
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junction structure contribute to any (mal)adaptation of astrocyte network communication with 
aging is yet to be examined. 
5.4. SDs occurring spontaneously in response to hypoxia/ischemia 
Even though the data presented so far consistently demonstrated that SD events are less likely 
to occur or evolve fully with aging (Fig. 5A), the experiments relied on provoking SD 
experimentally (i.e. by the application of high concentration KCl or electrical stimulation), 
rather than evaluating the likelihood of spontaneous SD evolution as it takes place in acute brain 
injury. The distinction between experimentally triggered and spontaneously generating SDs 
may be important, because their pharmacology is different, and thus the share of specific ion 
channels in their igniting mechanisms may not be identical (Pietrobon & Moskowitz, 2014). In 
addition, the share of ion channels in supporting the generation and propagation of SD is 
dependent on the metabolic conditions of tissue (Dreier & Reiffurth, 2015). This is best 
illustrated by the observations that NMDA receptor antagonism effectively blocks SD in well-
nourished tissue (Marrannes et al., 1988), but fails to do so under severe ischemic conditions 
(Hertle et al., 2012).  
Accordingly, contemplating the age specific pattern of spontaneous SD occurrence adds new 
perspectives. To begin with, the earliest age when spontaneous SD was shown to emerge due 
to asphyxia proved to be as early as postnatal day 4 (Hansen, 1977) – in contrast with postnatal 
days 12-15 determined as the youngest age in which SD cab be triggered experimentally (Bures, 
1957; Frank Richter et al., 1998; Schade, 1959). The impediment for SD to evolve in such a 
young brain was, however, confirmed by a remarkable 20 min delay of SD onset with respect 
to asphyxia initiation, in contrast with the 1.5 min delay observed in adult rats (Hansen, 1977) 
– the longer delay possibly indicating a better tolerance of the nervous tissue against deleterious 
insults.  
Towards the other end of the life span, the frequency of spontaneous, recurrent SDs was, 
likewise, found to be significantly lower in the old (23-25 months old) than in young 
(1.5 months old) and the middle-aged (9 months old) rat brain in a model of focal cerebral 
ischemia (Clark et al., 2014). This finding stands in agreement with the present and the above 
mentioned data, gathered using experimental SD initiation. The reason for the low SD 
frequency at old age could not be identified with certainty, but SDs that are often long-lasting 
in the old brain considerably postponed – if not altogether prevented – the occurrence of 
subsequent SDs, which offered a plausible explanation (Clark et al., 2014). Indeed, the duration 
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of transient SD triggered under ischemia appeared to be longer-lasting in the old rat brain as 
compared with the young (Menyhart et al., 2015). Further, in the focal ischemia model not only 
the higher incidence of long-lasting SDs was characteristic among the old animals than in the 
younger ones, but also the larger cortical surface involved in these prolonged SD events (Clark 
et al., 2014). Apparently, the recovery from SD in the old brain appears to be hampered. This 
may point towards or underlie the increased vulnerability of the old brain to ischemic 
conditions, and the pathophysiologic role SD is suggested to play in injury progression. 
Curiously, in another study, the generation of a spontaneous SD in immediate response to 
bilateral common carotid artery occlusion was more frequently encountered in old animals than 
in their young counterparts (Menyhart et al., 2017). Reflecting on the evidence presented here 
so far, this observation may seem perplexing at first, yet it is, in fact, complementary, and makes 
the interpretation of existing data more subtle. It must be appreciated that the spontaneous 
occurrence of SD in these experiments was strongly associated with a severe drop of perfusion 
(to 7-23 % of baseline flow), rather than with age itself, the serious perfusion deficit being more 
frequent among the old rats (Menyhart et al., 2017). Taken together, we postulate that 
irrespective of the innate, age-related electrophysiological threshold of SD elicitation, a sudden, 
large drop of cortical perfusion (i.e. CBF below 20 %) will inevitably bring on SDs in the old 
brain, as well as in the young. We also believe that even though it is more difficult to trigger 
SDs in the aging brain, once SD is elicited during ischemia, it is persistent in old age, and its 
long duration may indicate increased metabolic crisis (Farkas & Bari, 2014), supporting the 
well-established high mortality and poor functional outcome of older stroke patients (R. L. 
Chen et al., 2010). 
5.5. Susceptibility to SD and neurological diseases 
5.5.1. Migraine and ischemic stroke in young adults 
The age of the animals investigated in the present study (i.e.: 7-10 vs. 30 weeks) corresponds 
well with human adolescence and young adulthood (Sengupta, 2013). Adolescents and young 
adults are at increased risk of developing migraine (Victor et al., 2010). Migraine is a 
multifactorial disease characterized by a unilateral, pulsating headache with moderate to severe 
intensity, lasting 4-72h ("Headache Classification Committee of the International Headache 
Society (IHS) The International Classification of Headache Disorders, 3rd edition," 2018), 
often compelling patients to take sick days off, and considering the relatively high prevalence 
(Smitherman et al., 2013), it has a substantial socioeconomic and psychosocial impact. 
Migraine aura is a complex neurophysiological phenomenon, characterized by mainly visual 
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scotomas, sensory or sometimes speech disturbances, which usually precede the headache. 
Migraine in general can be divided to two types: migraine without aura (MO) and migraine 
with aura (MA), although MA patients may experience attacks with migraine like headache 
without a preceding aura phase, reflecting the complexity of the disease.  
SD has been accepted as the pathophysiological phenomenon behind migraine aura, since post 
SD oligemia was detected by PET and fMRI in migraine patients during MA attacks (S. P. Chen 
& Ayata, 2016; Hadjikhani et al., 2001; Lauritzen et al., 1983) and the velocity of SD has been 
found remarkably similar to that of migraine aura (Goadsby et al., 2017; Milner, 1958). It is 
believed that the concomitant transient depression of cerebral activity (registered via ECoG) is 
likely responsible for the transient neurological symptoms. In addition to triggering aura, SD 
could also be responsible for the evolution of the headache itself (Ayata, 2009), by activating 
the trigemino-vascular system, which promotes SD susceptibility a marker for migraine attack 
patterns in experimental studies (Ayata, 2009). 
Migraine has been long considered benign and void of long-term consequences supported by 
experimental evidence suggesting that SDs under physiological conditions pose close to none 
threat to the nervous tissue (Nedergaard & Hansen, 1988).  Yet, MRI studies have confirmed, 
that motion processing cortical areas (e.g.: V3A) and the somatosensory cortex are significantly 
thicker in migraineurs (both MA and MO). These dysplastic areas might exhibit increased 
cortical excitably, lower local threshold of excitability and act as triggering points of SDs or, 
inversely, be the plastic reaction of the nervous tissue to repetitive pain (DaSilva et al., 2007). 
Intriguingly, the somatosensory cortical area was also recognized as the primary origin of SDs 
in humans following SAH and rodents exposed to focal cerebral ischemia, which was attributed 
to the increased susceptibility of this area due to increased neuron to glia ratio (Bogdanov et 
al., 2016; von Bornstadt et al., 2015). 
More importantly, MA is increasingly accepted as a definitive risk factor for ischemic stroke, 
with meta-analyses showing more than two-fold odds-ratio increase (Schurks et al., 
2009),(Etminan et al., 2005),(Spector et al., 2010), especially in young adults without classical 
stroke risk factors (Pezzini et al., 2011). Other studies involving migraine patients showed, that 
MA may increase stroke mortality by 40% (Gudmundsson et al., 2010) and accelerate ischemic 
lesion consolidation – measured by diffusion/perfusion deficit MRI (Mawet et al., 2015a). In 
addition to raising stroke risk, patients with MA are at increased risk to develop white matter 
lesions in the posterior circulatory and infratentorial region (Kruit et al., 2006; Kruit et al., 
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2004). CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy) is an important cornerstone of the MA/ischemic stroke connection. It is 
a rare genetic disease caused by mutations of the NOTCH3 gene, a cell membrane receptor and 
characterized by a systemic, non-amyloid, non-atherosclerotic vasculopathy, with subcortical 
lacunar infarcts and white matter lesions ("Headache Classification Committee of the 
International Headache Society (IHS) The International Classification of Headache Disorders, 
3rd edition," 2018). One of the earliest symptoms of CADASIL is MA, where the aura can be 
both classical and atypical. The evolution of MA in CADASIL remains incompletely 
understood, however recent experimental findings have shown that intra-arterial air 
microbubbles and microparticles are able to induce SDs in mice with or without generation of 
infarcts (Bere et al., 2014b; Nozari et al., 2010), it is thus conceivable that some migraine attacks 
might be triggered by microlesions of vascular origin. 
Taken together, increased susceptibility to SD might explain the increased stroke risk in 
migraine patients (Mawet et al., 2015b),(Guidetti et al., 2014). Young adults are usually not 
exposed to classical cardiovascular risk factors, and even though SD threshold may be low, an 
SD igniting stimulus is not present. The most common cause of cerebral ischemia in young 
adults are (i) patent foramen ovale (leading to paradox embolization), (ii) connective tissue 
abnormalities (leading to spontaneous carotid dissection) and (iii) inherited/acquired 
hypercoagulable state (Pezzini et al., 2011). In a subset of MA patients, one of these conditions 
might lead to transient regional hypoperfusions (Nozari et al., 2010) or silent microlesions (Bere 
et al., 2014b). In combination with increased neuronal excitability and SD susceptibility at 
young age, these small infarcts may provoke SD, and thus migraine like symptoms. In contrast, 
the relatively higher SD threshold in the elderly is probably counteracted by increased 
cardiovascular risk, vascular rarefication, decrease of collateral circulation and other 
comorbidity leading to worse stroke outcomes (Saposnik et al., 2008). MA patients however 
may retain their SD susceptibility throughout their life, leading to worse stroke outcomes than 
the rest of the population (Gudmundsson et al., 2010), due to the role of SD in secondary injury. 
5.5.2. Subarachnoid hemorrhage  
SAH, especially due to aneurysm rupture, represents an intriguing duality regarding 
epidemiology: SAH has the lowest prevalence out of all the major stroke subtypes (Feigin et 
al., 2003), but still poses considerable threat regarding to the potential years lost, which are 
comparable with that of ischemic stroke or intracerebral hemorrhage (de Rooij et al., 2013; 
Johnston et al., 1998). SAH is one of the most common types of stroke in young adults, and has 
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a high mortality and permanent disability rate. During the days following the initial injury, focal 
neurological deteriorations and new ischemic lesions might arise unpredictably, termed delayed 
cerebral infarctions (DCI), significantly impairing clinical outcome. DCI leads to the worsening 
of neurological symptoms days (typically between 5-14th day) following the hemorrhage, with 
corresponding new ischemic lesions. DCI has been traditionally attributed to vasospasm in the 
proximal large vessels, as vasospasm is present in the vast majority of SAH patients (Rowland 
et al., 2012) Younger age is an established risk factor for proximal large artery vasospasm 
(Charpentier et al., 1999; Rabb et al., 1994) and a probable risk factor for DCI (Crobeddu et al., 
2012; de Rooij et al., 2013; Magge et al., 2010). Vasospasm is more likely to occur at younger 
age, because the loss of vessel wall elasticity, atherosclerotic changes and impaired 
neurovascular coupling typical of old age may collectively hamper the effective control of 
vascular tone, including vasoconstriction (D'Esposito et al., 2003).  
Recent studies however have shown, that proximal vasospasm is but one mechanism implicated 
in the development of DCI. Formation of microthrombi and microvascular hypoperfusion have 
been also recognized to contribute to DCI (Rowland et al., 2012). Importantly, SD clusters, 
which might provoke inverse hemodynamic responses and concomitant tissue hypoxia, have 
been associated with DCI in SAH patients (Dreier et al., 2006), (Bosche et al., 2010; Dreier et 
al., 2009). For example, in a small, prospective cohort, high number of SDs and the total 
depolarized time was closely associated with DCI development, independent of vasospasm 
(Woitzik et al., 2012).  
We have found that the inherent susceptibility of the nervous tissue to SD appears to be the 
lowest in young adults. Taken the evidence provided in the present section, the decreased 
threshold of SD in young patients may put them at a higher risk to develop DCI.  
5.5.3. Traumatic brain injury 
Traumatic brain injury is the leading cause of permanent disability and death in the pediatric 
and adolescent population (Thurman, 2016) and a major cause of symptomatic epilepsy in 
general. In animal models of TBI, SDs occur spontaneously for hours following the initial 
insult. It has been speculated that SDs are triggered by high extracellular K+, low CBF (Sunami 
et al., 1989) or increased intracranial pressure (Rogatsky et al., 2003), complying with the 
association between SD and decreased cerebral perfusion pressure (Sukhotinsky et al., 2008). 
At present, there is no clear evidence of the injurious potential of the early (i.e. within hours 
after the impact) SD events in TBI models, since histological confirmation of any SD-related 
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injury following TBI in mice failed (von Baumgarten et al., 2008). However, a two-photon 
microscopy investigation conducted in a similar model revealed permanent dendritic beading 
following repetitive SDs (Sword et al., 2013).  
The occurrence of SD in the injured human brain was first confirmed in a TBI patient 
(Mayevsky et al., 1996). Since then, TBI patients have become a group of patients most 
represented in SD research, because the frequent need for a craniotomy offers the opportunity 
to place subdural electrodes on the exposed cortical surface to monitor SDs. In these patients, 
SDs are often observed following TBI for at least 7 days and one study recorded recurrent SDs 
in 57% of the patients examined  (Hartings et al., 2011a). The origin of the first SD wave 
following TBI is believed to be the primary injury site (Toth et al., 2016), and the recurrence of 
SDs has been associated with the decrease of mean arterial pressure or the increase in core 
temperature (Hartings et al., 2009). Among the SDs recorded, the prolonged events predict 
significantly poorer long-term outcome (Hartings et al., 2011a; Hartings et al., 2011b). In 
addition, SDs coupled with inverse neurovascular responses were shown to coincide with the 
failure of cerebral autoregulation and the extension of secondary injury (Hinzman et al., 2014).  
TBI has a peak incidence during adolescence due to motor-vehicle accidents (Bruns & Hauser, 
2003). Intriguingly, in one clinical study, SD incidence was found to be higher in younger 
patients following TBI (or ICH) (Fabricius et al., 2006). In view of these reports, our present 
data showing the lowest threshold of SD at adolescent or young adult age underscores the 
importance of SDs in young TBI patients. 
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Figure 12. The age-related alteration in the prevalence of neurological diseases, in which SD is implicated as a 
pathophysiological phenomenon. Gray area highlights the time period, over which the prevalence of neurological 
diseases, such as migraine, traumatic brain injury (TBI) and delayed cerebral ischemia (DCI) following 
subarachnoid hemorrhage (SAH) is increased. Migraine prevalence has a secondary peak around mid-life, whereas 
prevalence of TBI and ischemic stroke steeply rises after 70 years of age (red area). Importantly, even though 
susceptibility to SD decreases with advancing age, ischemic stroke risk increases, together with prolonged SDs 
and worse neurological outcome. Note, that data underscoring the modification of SD susceptibility over the 
lifespan are predominantly based on experimental SD elicitation. In order to compare data from clinical and 
experimental research, the secondary x-axis represents the rat lifespan matched with human (Sengupta, 2013). 
However, even though the longer cumulative duration of recurrent SDs was associated with the 
expansion of tissue damage in focal ischemia (Dijkhuizen et al., 1999), this does not directly 
infer that the longer cumulative duration is the outcome of a higher number of events— indeed, 
the duration of individual SD events can vary considerably (Dreier, 2011). Further, we have 
previously demonstrated that although only a few SDs occur spontaneously in the aged 
ischemic brain, these events cause more damage than a higher number of SDs in the young 
brain, as indicated by a remarkable delay of repolarization after SD and the associated evolution 
of perfusion deficit (Clark et al., 2014). Taken together, the low threshold of SD elicitation 
indicates the brain’s high susceptibility for SD generation at young age, but it may not directly 
put the tissue at higher risk for SD-related injury. This notion needs to be explored further in 
subsequent experimental and clinical studies. 
5.6. Role of prostanoids in the cerebral blood flow response to SD 
SD related CBF response is has been the subject of much investigation (Ayata & Lauritzen, 
2015). Yet, it has remained a considerable challenge to identify the share of individual signaling 
cascades in the regulation of the SD related CBF response, because a great variety of vasoactive 
compounds are released on SD occurrence, including metabolites (e.g. adenosine, lactate), 
neurotransmitters (e.g. glutamate) or peptides (e.g. CGRP) (Ayata & Lauritzen, 2015). We have 
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contemplated on the role of vasodilator prostanoids in the mediation of the CBF response, 
because they account for at least 50% of the functional hyperemia in response to physiological 
somatosensory stimulation (Cauli & Hamel, 2010). In physiological neurovascular coupling, 
the major pathway leading to vasodilator prostanoid synthesis involves COX-2, expressed in 
cortical pyramidal neurons (Lacroix et al., 2015), and located in perivascular nerve terminals 
along intraparenchymal penetrating arterioles and capillaries (H. Wang et al., 2005). COX-2 
derived vasoactive products have emerged as mediators of functional hyperemia to 
somatosensory stimulation (Cauli & Hamel, 2010; Niwa et al., 2000). In contrast with the COX-
2 route, the role of the constitutive COX-1 enzyme (which, in the context of physiological 
neurovascular coupling, is argued to be expressed in astrocytes) in shaping the CBF response 
to neuronal activity has remained controversial (Howarth, 2014). Selective COX-1 inhibition 
blocked the evolution of hyperemia in response to odorant stimulation (Petzold et al., 2008), or 
uncaging of Ca2+ in perivascular astrocytic endfeet (T. Takano et al., 2006), yet it exerted no 
impact on the CBF response to whisker stimulation (Lecrux et al., 2011; Niwa et al., 2001; 
Rosenegger et al., 2015).  
Of the subsequent phases of the CBF response to SD (Ayata & Lauritzen, 2015), we focused 
on the peak hyperemic and post-SD oligemic elements. It is important to note that our 
pharmacological manipulations had no significant effect on pre-SD baseline CBF levels, 
indicating that the results were not affected by cerebral perfusion changes. The first significant 
observation of the current study is that EP4 receptor antagonism reduced peak hyperemia, and 
augmented post-SD oligemia of the CBF response to SD in the intact brain (Fig. 10B & C). 
This indicates that EP4 receptor activation contributes to vasodilation during the CBF response 
to SD. It is a novel finding, as the mediation of the hyperemic element of the CBF response by 
prostanoids was previously thought unlikely, and COX-derived metabolites were attributed a 
vasoconstrictive rather than a vasodilatory role in the CBF response to SD (Ayata & Lauritzen, 
2015; Masaaki Shibata et al., 1992). At the same time, our data are consistent with a number of 
previous reports on the vasodilatory action of EP4 receptor activation by PGE2. For example, 
antagonism of EP4 receptors inhibited the PGE2-induced vasodilation of the middle meningeal 
artery of rats in vivo, and of the middle cerebral artery in vitro (Davis et al., 2004; Myren et al., 
2010). At the concentration used here, L161,982 previously reduced the NMDA-induced 
dilation of cerebral arterioles, functional hyperemia to whisker stimulation (Lacroix et al., 
2015), and glutamate-evoked dilation of microvessels (Hall et al., 2014). Our data thus indicate 
that EP4 receptor activation achieves CBF elevation in response to SD, as well.  
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The selective inhibition of COX-1 and COX-2 enzymes exerted no significant, direct effect on 
any of the elements of the CBF response to SD (Fig. 10), despite the expectation that COX-2 
inhibition by NS-398 would decrease the magnitude of the hyperemic element as it did 
functional hyperemia in response to whisker stimulation previously (Niwa et al., 2000). The 
reason for the absence of the COX-enzyme related vasodilation may well be that during SD, 
the activity of COX enzymes also leads to the marked production of vasoconstrictive 
prostanoids, such as prostaglandin F2α (M. Shibata et al., 1990). Inhibition of the COX enzymes 
as was done in our experiments therefore likely diminishes the SD-related synthesis of both 
vasoconstrictive and vasodilator prostanoids, causing an undiscernible net outcome on the CBF 
response. The results of others and of ours together show, that functional hyperemia to neuronal 
activation is COX-2 dependent (i.e. selective COX-2 inhibition alone reduces the peak of 
hyperemia) (Lacroix et al., 2015; Lecrux et al., 2011; Niwa et al., 2000), while COX-2 
inhibition has no clear impact on the CBF response to SD. These data foster the assumption 
that the CBF response to SD is driven by mechanisms different from physiological 
neurovascular coupling. Taken prostanoid-based cerebral vasoregulation, it is thus conceivable 
that vasoconstrictive COX products are released at insignificant concentration during neuronal 
activation, and their impact is substantial during SD(Masaaki Shibata et al., 1992), obscuring 
the co-existing vasodilator effect of PGE2. 
In the ischemic cortex, our study revealed a considerable reduction of the distinct elements of 
the CBF response to SD, with no detectable impact of COX enzyme inhibition or EP4 receptor 
blockade. Consistent with the data presented here, ischemia is known to impair physiological 
neurovascular coupling as evidenced by the attenuation of functional hyperemia to forepaw 
stimulation (Jackman et al., 2011). In addition, in the acute phase of ischemia (the target of 
investigation here), the abundant release of metabolic mediators of vascular tone, such as 
adenosine, increased ADP/ATP ratio, lactate accumulation, or the dramatically elevated 
concentration of extracellular potassium (Cipolla, 2009) must obscure potentially still effective, 
finer signals of vasoregulation. It may also well be that the prostanoid-based regulation of 
vascular tone becomes more obvious and could prove discernable during the subacute or 
chronic phases of ischemia, because COX-2 mRNA expression becomes upregulated beginning 
6 hours, and endothelial EP4 receptor expression is induced 4 hours after ischemia onset(Li et 
al., 2008; Nogawa et al., 1997). 
In summary, EP4 receptor activation contributes to vasodilation during the CBF response to SD 
in the intact cortex, and is undetectable under the acute phase of ischemia, possibly due to 
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impaired neurovascular coupling, the dominance of metabolic mediators of vascular tone, or 
the upregulation of the receptors only several hours later. 
6. Conclusion  
In the present study we have provided strong evidence, that the susceptibility to SD is highest 
during young adulthood, and that the increase of SD threshold with age coincides with the 
maturation of the cerebral cortex and the narrowing of the SD wave. Further on, we have shown 
for the first time that, in contrast with physiological neurovascular coupling, prostanoid 
synthesis during SD related CBF response is not solely COX-2 dependent and that PGE2 has a 
central role in mediating peak hyperemia and diminishing post-SD oligemia.  
Given the accepted link between SD and migraine with aura, and the increased susceptibility to 
SD during young adulthood, when migraine has a known prevalence peak, further emphasizes 
the role of SD in the evolution of migraine and might provide explanation on the increased 
stroke risk of these patients. Since TBI and DCI following SAH have a peak incidence during 
the most susceptible life-span (e.g. young adulthood), and SD has an increasingly accepted role 
in mediating secondary injury, young TBI or SAH patients may benefit greatly from future 
therapeutic options, targeting SD. Further research, especially SD monitoring in patients is 
needed to verify these data in humans, and to direct future potential drug developments. 
  
50 
References 
 
Aitken, P. G., Jing, J., Young, J., & Somjen, G. G. (1991). Ion channel involvement in hypoxia-induced 
spreading depression in hippocampal slices. Brain Res, 541(1), 7-11.  
Ayata, C. (2009). Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. 
Cephalalgia, 29(10), 1095-1114. doi: 10.1111/j.1468-2982.2009.01982.x 
Ayata, C. (2010). Cortical spreading depression triggers migraine attack: pro. Headache, 50(4), 725-
730. doi: 10.1111/j.1526-4610.2010.01647.x 
Ayata, C., & Lauritzen, M. (2015). Spreading Depression, Spreading Depolarizations, and the Cerebral 
Vasculature. Physiol Rev, 95(3), 953-993. doi: 10.1152/physrev.00027.2014 
Ayata, C., Shimizu-Sasamata, M., Lo, E. H., Noebels, J. L., & Moskowitz, M. A. (2000). Impaired 
neurotransmitter release and elevated threshold for cortical spreading depression in mice with 
mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience, 95(3), 639-645.  
Back, T., Ginsberg, M. D., Dietrich, W. D., & Watson, B. D. (1996). Induction of spreading depression in 
the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on 
infarct morphology. J Cereb Blood Flow Metab, 16(2), 202-213. doi: 10.1097/00004647-
199603000-00004 
Back, T., Kohno, K., & Hossmann, K. A. (1994). Cortical negative DC deflections following middle 
cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue 
oxygenation, and electroencephalogram. J Cereb Blood Flow Metab, 14(1), 12-19. doi: 
10.1038/jcbfm.1994.3 
Balestrino, M., Young, J., & Aitken, P. (1999). Block of (Na+,K+)ATPase with ouabain induces spreading 
depression-like depolarization in hippocampal slices. Brain Res, 838(1-2), 37-44.  
Benzi, G., Gorini, A., Arnaboldi, R., Ghigini, B., & Villa, R. F. (1994). Age-related alterations by chronic 
intermittent hypoxia on cerebral synaptosomal ATPase activities. J Neural Transm Suppl, 44, 
159-171.  
Bere, Z., Obrenovitch, T. P., Bari, F., & Farkas, E. (2014a). Ischemia-induced depolarizations and 
associated hemodynamic responses in incomplete global forebrain ischemia in rats. 
Neuroscience, 260, 217-226. doi: 10.1016/j.neuroscience.2013.12.032 
Bere, Z., Obrenovitch, T. P., Kozak, G., Bari, F., & Farkas, E. (2014b). Imaging reveals the focal area of 
spreading depolarizations and a variety of hemodynamic responses in a rat microembolic 
stroke model. J Cereb Blood Flow Metab, 34(10), 1695-1705. doi: 10.1038/jcbfm.2014.136 
Bodhinathan, K., Kumar, A., & Foster, T. C. (2010). Intracellular redox state alters NMDA receptor 
response during aging through Ca2+/calmodulin-dependent protein kinase II. J Neurosci, 30(5), 
1914-1924. doi: 10.1523/JNEUROSCI.5485-09.2010 
Bogdanov, V. B., Middleton, N. A., Theriot, J. J., Parker, P. D., Abdullah, O. M., Ju, Y. S., . . . Brennan, K. 
C. (2016). Susceptibility of Primary Sensory Cortex to Spreading Depolarizations. J Neurosci, 
36(17), 4733-4743. doi: 10.1523/JNEUROSCI.3694-15.2016 
Bosche, B., Graf, R., Ernestus, R. I., Dohmen, C., Reithmeier, T., Brinker, G., . . . Members of the 
Cooperative Study of Brain Injury, D. (2010). Recurrent spreading depolarizations after 
subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex. Ann Neurol, 
67(5), 607-617. doi: 10.1002/ana.21943 
Bruns, J., Jr., & Hauser, W. A. (2003). The epidemiology of traumatic brain injury: a review. Epilepsia, 
44 Suppl 10, 2-10.  
Bures, J. (1957). The ontogenetic development of steady potential differences in the cerebral cortex in 
animals. Electroencephalogr Clin Neurophysiol, 9(1), 121-130.  
Busch, E., Gyngell, M. L., Eis, M., Hoehn-Berlage, M., & Hossmann, K. A. (1996). Potassium-induced 
cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion 
growth assessed by diffusion-weighted NMR and biochemical imaging. J Cereb Blood Flow 
Metab, 16(6), 1090-1099. doi: 10.1097/00004647-199611000-00002 
51 
Busija, D. W., Bari, F., Domoki, F., Horiguchi, T., & Shimizu, K. (2008). Mechanisms involved in the 
cerebrovascular dilator effects of cortical spreading depression. Prog Neurobiol, 86(4), 379-
395. doi: 10.1016/j.pneurobio.2008.09.008 
Capuani, C., Melone, M., Tottene, A., Bragina, L., Crivellaro, G., Santello, M., . . . Pietrobon, D. (2016). 
Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine 
type 2. EMBO Mol Med, 8(8), 967-986. doi: 10.15252/emmm.201505944 
Carlson, A. P., Abbas, M., Alunday, R. L., Qeadan, F., & Shuttleworth, C. W. (2018). Spreading 
depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple 
crossover trial. J Neurosurg, 1-7. doi: 10.3171/2017.12.JNS171665 
Cauli, B., & Hamel, E. (2010). Revisiting the role of neurons in neurovascular coupling. Front 
Neuroenergetics, 2, 9. doi: 10.3389/fnene.2010.00009 
Cervetto, C., Alloisio, S., Frattaroli, D., Mazzotta, M. C., Milanese, M., Gavazzo, P., . . . Marcoli, M. 
(2013). The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on 
the carboxyl tail. J Neurochem, 124(6), 821-831. doi: 10.1111/jnc.12143 
Chakraborty, H., Sen, P., Sur, A., Chatterjee, U., & Chakrabarti, S. (2003). Age-related oxidative 
inactivation of Na+, K+-ATPase in rat brain crude synaptosomes. Exp Gerontol, 38(6), 705-710. 
doi: 10.1016/s0531-5565(03)00066-4 
Charpentier, C., Audibert, G., Guillemin, F., Civit, T., Ducrocq, X., Bracard, S., . . . Laxenaire, M. C. (1999). 
Multivariate Analysis of Predictors of Cerebral Vasospasm Occurrence After Aneurysmal 
Subarachnoid Hemorrhage. Stroke, 30(7), 1402-1408. doi: 10.1161/01.str.30.7.1402 
Chen, G., Gao, W., Reinert, K. C., Popa, L. S., Hendrix, C. M., Ross, M. E., & Ebner, T. J. (2005). 
Involvement of kv1 potassium channels in spreading acidification and depression in the 
cerebellar cortex. J Neurophysiol, 94(2), 1287-1298. doi: 10.1152/jn.00224.2005 
Chen, R. L., Balami, J. S., Esiri, M. M., Chen, L. K., & Buchan, A. M. (2010). Ischemic stroke in the elderly: 
an overview of evidence. Nat Rev Neurol, 6(5), 256-265. doi: 10.1038/nrneurol.2010.36 
Chen, S. P., & Ayata, C. (2016). Spreading Depression in Primary and Secondary Headache Disorders. 
Curr Pain Headache Rep, 20(7), 44. doi: 10.1007/s11916-016-0574-8 
Cholet, N., Pellerin, L., Magistretti, P. J., & Hamel, E. (2002). Similar perisynaptic glial localization for 
the Na+,K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat 
somatosensory cortex. Cereb Cortex, 12(5), 515-525. doi: 10.1093/cercor/12.5.515 
Cipolla, M. J. (2009). The cerebral circulation. : Morgan & Claypool Life Sciences: San Rafael, CA. 
Clark, D., Institoris, A., Kozak, G., Bere, Z., Tuor, U., Farkas, E., & Bari, F. (2014). Impact of aging on 
spreading depolarizations induced by focal brain ischemia in rats. Neurobiol Aging, 35(12), 
2803-2811. doi: 10.1016/j.neurobiolaging.2014.06.013 
Cohadon, F., & Desbordes, P. (1986). Brain water and aging. Gerontology, 32 Suppl 1, 46-49. doi: 
10.1159/000212827 
Costa, C., Tozzi, A., Rainero, I., Cupini, L. M., Calabresi, P., Ayata, C., & Sarchielli, P. (2013). Cortical 
spreading depression as a target for anti-migraine agents. J Headache Pain, 14, 62. doi: 
10.1186/1129-2377-14-62 
Cotrina, M. L., Gao, Q., Lin, J. H., & Nedergaard, M. (2001). Expression and function of astrocytic gap 
junctions in aging. Brain Res, 901(1-2), 55-61.  
Crobeddu, E., Mittal, M. K., Dupont, S., Wijdicks, E. F., Lanzino, G., & Rabinstein, A. A. (2012). Predicting 
the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid 
hemorrhage. Stroke, 43(3), 697-701. doi: 10.1161/STROKEAHA.111.638403 
Czeh, G., Aitken, P. G., & Somjen, G. G. (1992). Whole-cell membrane current and membrane resistance 
during hypoxic spreading depression. Neuroreport, 3(2), 197-200.  
D'Esposito, M., Deouell, L. Y., & Gazzaley, A. (2003). Alterations in the BOLD fMRI signal with ageing 
and disease: a challenge for neuroimaging. Nat Rev Neurosci, 4(11), 863-872. doi: 
10.1038/nrn1246 
DaSilva, A. F., Granziera, C., Snyder, J., & Hadjikhani, N. (2007). Thickening in the somatosensory cortex 
of patients with migraine. Neurology, 69(21), 1990-1995. doi: 
10.1212/01.wnl.0000291618.32247.2d 
52 
Davis, R. J., Murdoch, C. E., Ali, M., Purbrick, S., Ravid, R., Baxter, G. S., . . . Coleman, R. A. (2004). EP4 
prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J 
Pharmacol, 141(4), 580-585. doi: 10.1038/sj.bjp.0705645 
de Lores Arnaiz, G. R., & Ordieres, M. G. (2014). Brain Na(+), K(+)-ATPase Activity In Aging and Disease. 
Int J Biomed Sci, 10(2), 85-102.  
de Rooij, N. K., Greving, J. P., Rinkel, G. J., & Frijns, C. J. (2013). Early prediction of delayed cerebral 
ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. 
Stroke, 44(5), 1288-1294. doi: 10.1161/STROKEAHA.113.001125 
Di Cesare Mannelli, L., Marcoli, M., Micheli, L., Zanardelli, M., Maura, G., Ghelardini, C., & Cervetto, C. 
(2015). Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain 
mechanism mediated by Pannexin 1. Neuropharmacology, 97, 133-141. doi: 
10.1016/j.neuropharm.2015.05.037 
Dichgans, M., Freilinger, T., Eckstein, G., Babini, E., Lorenz-Depiereux, B., Biskup, S., . . . Strom, T. M. 
(2005). Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic 
migraine. The Lancet, 366(9483), 371-377. doi: 10.1016/s0140-6736(05)66786-4 
Dickstein, D. L., Weaver, C. M., Luebke, J. I., & Hof, P. R. (2013). Dendritic spine changes associated 
with normal aging. Neuroscience, 251, 21-32. doi: 10.1016/j.neuroscience.2012.09.077 
Dijkhuizen, R. M., Beekwilder, J. P., van der Worp, H. B., Berkelbach van der Sprenkel, J. W., Tulleken, 
K. A. F., & Nicolay, K. (1999). Correlation between tissue depolarizations and damage in focal 
ischemic rat brain1Published on the World Wide Web on 12 July 1999.1. Brain Res, 840(1-2), 
194-205. doi: 10.1016/s0006-8993(99)01769-2 
Dreier, J. P. (2011). The role of spreading depression, spreading depolarization and spreading ischemia 
in neurological disease. Nat Med, 17(4), 439-447. doi: 10.1038/nm.2333 
Dreier, J. P., Major, S., Manning, A., Woitzik, J., Drenckhahn, C., Steinbrink, J., . . . group, C. s. (2009). 
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with 
aneurysmal subarachnoid haemorrhage. Brain, 132(Pt 7), 1866-1881. doi: 
10.1093/brain/awp102 
Dreier, J. P., & Reiffurth, C. (2015). The stroke-migraine depolarization continuum. Neuron, 86(4), 902-
922. doi: 10.1016/j.neuron.2015.04.004 
Dreier, J. P., Woitzik, J., Fabricius, M., Bhatia, R., Major, S., Drenckhahn, C., . . . Strong, A. J. (2006). 
Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with 
clusters of spreading depolarizations. Brain, 129(Pt 12), 3224-3237. doi: 10.1093/brain/awl297 
Etminan, M., Takkouche, B., Isorna, F. C., & Samii, A. (2005). Risk of ischaemic stroke in people with 
migraine: systematic review and meta-analysis of observational studies. BMJ, 330(7482), 63. 
doi: 10.1136/bmj.38302.504063.8F 
Fabricius, M., Fuhr, S., Bhatia, R., Boutelle, M., Hashemi, P., Strong, A. J., & Lauritzen, M. (2006). Cortical 
spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. 
Brain, 129(Pt 3), 778-790. doi: 10.1093/brain/awh716 
Farkas, E., & Bari, F. (2014). Spreading depolarization in the ischemic brain: does aging have an impact? 
J Gerontol A Biol Sci Med Sci, 69(11), 1363-1370. doi: 10.1093/gerona/glu066 
Farkas, E., Obrenovitch, T. P., Institoris, A., & Bari, F. (2011). Effects of early aging and cerebral 
hypoperfusion on spreading depression in rats. Neurobiol Aging, 32(9), 1707-1715. doi: 
10.1016/j.neurobiolaging.2009.10.002 
Feigin, V. L., Lawes, C. M. M., Bennett, D. A., & Anderson, C. S. (2003). Stroke epidemiology: a review 
of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. 
The Lancet Neurology, 2(1), 43-53. doi: 10.1016/s1474-4422(03)00266-7 
Feuerstein, D., Backes, H., Gramer, M., Takagaki, M., Gabel, P., Kumagai, T., & Graf, R. (2016). 
Regulation of cerebral metabolism during cortical spreading depression. J Cereb Blood Flow 
Metab, 36(11), 1965-1977. doi: 10.1177/0271678X15612779 
Filosa, J. A., Bonev, A. D., Straub, S. V., Meredith, A. L., Wilkerson, M. K., Aldrich, R. W., & Nelson, M. 
T. (2006). Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat 
Neurosci, 9(11), 1397-1403. doi: 10.1038/nn1779 
53 
Fordsmann, J. C., Ko, R. W., Choi, H. B., Thomsen, K., Witgen, B. M., Mathiesen, C., . . . Lauritzen, M. 
(2013). Increased 20-HETE synthesis explains reduced cerebral blood flow but not impaired 
neurovascular coupling after cortical spreading depression in rat cerebral cortex. J Neurosci, 
33(6), 2562-2570. doi: 10.1523/JNEUROSCI.2308-12.2013 
Gagolewicz, P. J. A., R.D. . (2017). The Elusive Channel Driving Ischemic Spreading Depolarization. . 
Program No. 122.01. Neuroscience Meeting Planner. Washington, DC: Society for 
Neuroscience, 2017. Online.  
Glaser, E. M., & Van der Loos, H. (1981). Analysis of thick brain sections by obverse-reverse computer 
microscopy: application of a new, high clarity Golgi-Nissl stain. J Neurosci Methods, 4(2), 117-
125. doi: 10.1016/0165-0270(81)90045-5 
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). 
Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev, 97(2), 553-622. 
doi: 10.1152/physrev.00034.2015 
Grafstein, B. (1956). Mechanism of spreading cortical depression. J Neurophysiol, 19(2), 154-171. doi: 
10.1152/jn.1956.19.2.154 
Gudmundsson, L. S., Scher, A. I., Aspelund, T., Eliasson, J. H., Johannsson, M., Thorgeirsson, G., . . . 
Gudnason, V. (2010). Migraine with aura and risk of cardiovascular and all cause mortality in 
men and women: prospective cohort study. BMJ, 341, c3966. doi: 10.1136/bmj.c3966 
Guedes, R. C., Amorim, L. F., & Teodosio, N. R. (1996). Effect of aging on cortical spreading depression. 
Braz J Med Biol Res, 29(10), 1407-1412.  
Guidetti, D., Rota, E., Morelli, N., & Immovilli, P. (2014). Migraine and stroke: "vascular" comorbidity. 
Front Neurol, 5, 193. doi: 10.3389/fneur.2014.00193 
Gupta, R. K., & Kanungo, M. (2013). Glial molecular alterations with mouse brain development and 
aging: up-regulation of the Kir4.1 and aquaporin-4. Age (Dordr), 35(1), 59-67. doi: 
10.1007/s11357-011-9330-5 
Hadjikhani, N., Sanchez Del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., . . . Moskowitz, M. A. 
(2001). Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc 
Natl Acad Sci U S A, 98(8), 4687-4692. doi: 10.1073/pnas.071582498 
Hajek, I., Subbarao, K. V., & Hertz, L. (1996). Acute and chronic effects of potassium and noradrenaline 
on Na+, K+-ATPase activity in cultured mouse neurons and astrocytes. Neurochem Int, 28(3), 
335-342.  
Hall, C. N., Reynell, C., Gesslein, B., Hamilton, N. B., Mishra, A., Sutherland, B. A., . . . Attwell, D. (2014). 
Capillary pericytes regulate cerebral blood flow in health and disease. Nature, 508(7494), 55-
60. doi: 10.1038/nature13165 
Hamming, A. M., Wermer, M. J., Umesh Rudrapatna, S., Lanier, C., van Os, H. J., van den Bergh, W. M., 
. . . Dijkhuizen, R. M. (2016). Spreading depolarizations increase delayed brain injury in a rat 
model of subarachnoid hemorrhage. J Cereb Blood Flow Metab, 36(7), 1224-1231. doi: 
10.1177/0271678X15619189 
Hansen, A. J. (1977). Extracellular potassium concentration in juvenile and adult rat brain cortex during 
anoxia. Acta Physiol Scand, 99(4), 412-420. doi: 10.1111/j.1748-1716.1977.tb10394.x 
Hansen, A. J. (1978). The extracellular potassium concentration in brain cortex following ischemia in 
hypo- and hyperglycemic rats. Acta Physiol Scand, 102(3), 324-329. doi: 10.1111/j.1748-
1716.1978.tb06079.x 
Hansen, A. J., & Olsen, C. E. (1980). Brain extracellular space during spreading depression and ischemia. 
Acta Physiol Scand, 108(4), 355-365. doi: 10.1111/j.1748-1716.1980.tb06544.x 
Hansen, A. J., & Zeuthen, T. (1981). Extracellular ion concentrations during spreading depression and 
ischemia in the rat brain cortex. Acta Physiol Scand, 113(4), 437-445. doi: 10.1111/j.1748-
1716.1981.tb06920.x 
Harada, K., Kamiya, T., & Tsuboi, T. (2015). Gliotransmitter Release from Astrocytes: Functional, 
Developmental, and Pathological Implications in the Brain. Front Neurosci, 9, 499. doi: 
10.3389/fnins.2015.00499 
54 
Hardingham, G. E., & Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signalling: 
implications for neurodegenerative disorders. Nat Rev Neurosci, 11(10), 682-696. doi: 
10.1038/nrn2911 
Harreveld, A. V. (1959). Compounds in Brain Extracts Causing Spreading Depression of Cerebral Cortical 
Activity and Contraction of Crustacean Muscle. J Neurochem, 3(4), 300-315. doi: 
10.1111/j.1471-4159.1959.tb12636.x 
Harris, K. M. J., F.E.; Tsao, B. . (1992). Three-dimensional structure of dendritic spines and synapses in 
rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of 
synaptic physiology and long-term potentiation. Journal of Neuroscience, 12(7), 20. doi: 
10.1523/JNEUROSCI.12-07-02685.1992 
Hartings, J. A., Bullock, M. R., Okonkwo, D. O., Murray, L. S., Murray, G. D., Fabricius, M., . . . Co-
Operative Study on Brain Injury, D. (2011a). Spreading depolarisations and outcome after 
traumatic brain injury: a prospective observational study. Lancet Neurol, 10(12), 1058-1064. 
doi: 10.1016/S1474-4422(11)70243-5 
Hartings, J. A., Shuttleworth, C. W., Kirov, S. A., Ayata, C., Hinzman, J. M., Foreman, B., . . . Dreier, J. P. 
(2017). The continuum of spreading depolarizations in acute cortical lesion development: 
Examining Leao's legacy. J Cereb Blood Flow Metab, 37(5), 1571-1594. doi: 
10.1177/0271678X16654495 
Hartings, J. A., Strong, A. J., Fabricius, M., Manning, A., Bhatia, R., Dreier, J. P., . . . Co-Operative Study 
of Brain Injury, D. (2009). Spreading depolarizations and late secondary insults after traumatic 
brain injury. J Neurotrauma, 26(11), 1857-1866. doi: 10.1089/neu.2009-0961 
10.1089/neu.2009.0961 
Hartings, J. A., Watanabe, T., Bullock, M. R., Okonkwo, D. O., Fabricius, M., Woitzik, J., . . . Co-Operative 
Study on Brain Injury, D. (2011b). Spreading depolarizations have prolonged direct current 
shifts and are associated with poor outcome in brain trauma. Brain, 134(Pt 5), 1529-1540. doi: 
10.1093/brain/awr048 
Headache Classification Committee of the International Headache Society (IHS) The International 
Classification of Headache Disorders, 3rd edition. (2018). Cephalalgia, 38(1), 1-211. doi: 
10.1177/0333102417738202 
Helbok, R., Schiefecker, A. J., Friberg, C., Beer, R., Kofler, M., Rhomberg, P., . . . Fabricius, M. (2017). 
Spreading depolarizations in patients with spontaneous intracerebral hemorrhage: 
Association with perihematomal edema progression. J Cereb Blood Flow Metab, 37(5), 1871-
1882. doi: 10.1177/0271678X16651269 
Herreras, O. S., G.G. (1993). Propagation of spreading depression among dendrites and somata of the 
same cell population. Brain Res., 610(2), 6. doi: 10.1016/0006-8993(93)91411-K 
Hertle, D. N., Dreier, J. P., Woitzik, J., Hartings, J. A., Bullock, R., Okonkwo, D. O., . . . Cooperative Study 
of Brain Injury, D. (2012). Effect of analgesics and sedatives on the occurrence of spreading 
depolarizations accompanying acute brain injury. Brain, 135(Pt 8), 2390-2398. doi: 
10.1093/brain/aws152 
Hille, B. (1992). G protein-coupled mechanisms and nervous signaling. Neuron, 9(2), 187-195. doi: 
10.1016/0896-6273(92)90158-a 
Hinzman, J. M., Andaluz, N., Shutter, L. A., Okonkwo, D. O., Pahl, C., Strong, A. J., . . . Hartings, J. A. 
(2014). Inverse neurovascular coupling to cortical spreading depolarizations in severe brain 
trauma. Brain, 137(Pt 11), 2960-2972. doi: 10.1093/brain/awu241 
Hinzman, J. M., DiNapoli, V. A., Mahoney, E. J., Gerhardt, G. A., & Hartings, J. A. (2015). Spreading 
depolarizations mediate excitotoxicity in the development of acute cortical lesions. Exp Neurol, 
267, 243-253. doi: 10.1016/j.expneurol.2015.03.014 
Hoffmann, U., & Ayata, C. (2013). Neurovascular coupling during spreading depolarizations. Acta 
Neurochir Suppl, 115, 161-165. doi: 10.1007/978-3-7091-1192-5_31 
55 
Hoffmann, U., Dilekoz, E., Kudo, C., & Ayata, C. (2010). Gabapentin suppresses cortical spreading 
depression susceptibility. J Cereb Blood Flow Metab, 30(9), 1588-1592. doi: 
10.1038/jcbfm.2010.92 
Hoffmann, U., Sukhotinsky, I., Eikermann-Haerter, K., & Ayata, C. (2013). Glucose modulation of 
spreading depression susceptibility. J Cereb Blood Flow Metab, 33(2), 191-195. doi: 
10.1038/jcbfm.2012.132 
Howarth, C. (2014). The contribution of astrocytes to the regulation of cerebral blood flow. Front 
Neurosci, 8, 103. doi: 10.3389/fnins.2014.00103 
Iwamoto, M., Hagishita, T., Shoji-Kasai, Y., Ando, S., & Tanaka, Y. (2004). Age-related changes in the 
levels of voltage-dependent calcium channels and other synaptic proteins in rat brain cortices. 
Neurosci Lett, 366(3), 277-281. doi: 10.1016/j.neulet.2004.05.048 
Jackman, K. A., Brait, V. H., Wang, Y., Maghzal, G. J., Ball, H. J., McKenzie, G., . . . Sobey, C. G. (2011). 
Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral 
ischaemia-reperfusion in mice. Naunyn Schmiedebergs Arch Pharmacol, 383(5), 471-481. doi: 
10.1007/s00210-011-0611-4 
Johnston, S. C., Selvin, S., & Gress, D. R. (1998). The burden, trends, and demographics of mortality 
from subarachnoid hemorrhage. Neurology, 50(5), 1413-1418.  
Kao, Y. C., Li, W., Lai, H. Y., Oyarzabal, E. A., Lin, W., & Shih, Y. Y. (2014). Dynamic perfusion and diffusion 
MRI of cortical spreading depolarization in photothrombotic ischemia. Neurobiol Dis, 71, 131-
139. doi: 10.1016/j.nbd.2014.07.005 
Karatas, H., Erdener, S. E., Gursoy-Ozdemir, Y., Lule, S., Eren-Kocak, E., Sen, Z. D., & Dalkara, T. (2013). 
Spreading depression triggers headache by activating neuronal Panx1 channels. Science, 
339(6123), 1092-1095. doi: 10.1126/science.1231897 
Kilic, K., Karatas, H., Donmez-Demir, B., Eren-Kocak, E., Gursoy-Ozdemir, Y., Can, A., . . . Dalkara, T. 
(2018). Inadequate brain glycogen or sleep increases spreading depression susceptibility. Ann 
Neurol, 83(1), 61-73. doi: 10.1002/ana.25122 
Kocak, H., Oner, P., & Oztas, B. (2002). Comparison of the activities of Na(+),K(+)-ATPase in brains of 
rats at different ages. Gerontology, 48(5), 279-281. doi: 10.1159/000065249 
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., . . . Nedergaard, M. (2014). 
Impairment of paravascular clearance pathways in the aging brain. Ann Neurol, 76(6), 845-861. 
doi: 10.1002/ana.24271 
Kruit, M. C., Launer, L. J., Ferrari, M. D., & van Buchem, M. A. (2006). Brain stem and cerebellar 
hyperintense lesions in migraine. Stroke, 37(4), 1109-1112. doi: 
10.1161/01.STR.0000206446.26702.e9 
Kruit, M. C., van Buchem, M. A., Hofman, P. A., Bakkers, J. T., Terwindt, G. M., Ferrari, M. D., & Launer, 
L. J. (2004). Migraine as a risk factor for subclinical brain lesions. JAMA, 291(4), 427-434. doi: 
10.1001/jama.291.4.427 
Kumar, A. (2015). NMDA Receptor Function During Senescence: Implication on Cognitive Performance. 
Front Neurosci, 9, 473. doi: 10.3389/fnins.2015.00473 
Lacroix, A., Toussay, X., Anenberg, E., Lecrux, C., Ferreiros, N., Karagiannis, A., . . . Cauli, B. (2015). COX-
2-Derived Prostaglandin E2 Produced by Pyramidal Neurons Contributes to Neurovascular 
Coupling in the Rodent Cerebral Cortex. J Neurosci, 35(34), 11791-11810. doi: 
10.1523/JNEUROSCI.0651-15.2015 
Lalo, U., Palygin, O., North, R. A., Verkhratsky, A., & Pankratov, Y. (2011). Age-dependent remodelling 
of ionotropic signalling in cortical astroglia. Aging Cell, 10(3), 392-402. doi: 10.1111/j.1474-
9726.2011.00682.x 
Lauritzen, M., Hansen, A. J., Kronborg, D., & Wieloch, T. (1990). Cortical spreading depression is 
associated with arachidonic acid accumulation and preservation of energy charge. J Cereb 
Blood Flow Metab, 10(1), 115-122. doi: 10.1038/jcbfm.1990.14 
Lauritzen, M., Skyhoj Olsen, T., Lassen, N. A., & Paulson, O. B. (1983). Changes in regional cerebral 
blood flow during the course of classic migraine attacks. Ann Neurol, 13(6), 633-641. doi: 
10.1002/ana.410130609 
56 
Leão, A. A. P. (1944). Spreading Depression of Activity in the Cerebral Cortex. J Neurophysiol, 7(6), 359-
390. doi: 10.1152/jn.1944.7.6.359 
Lecrux, C., Toussay, X., Kocharyan, A., Fernandes, P., Neupane, S., Levesque, M., . . . Hamel, E. (2011). 
Pyramidal neurons are "neurogenic hubs" in the neurovascular coupling response to whisker 
stimulation. J Neurosci, 31(27), 9836-9847. doi: 10.1523/JNEUROSCI.4943-10.2011 
Leis, J. A., Bekar, L. K., & Walz, W. (2005). Potassium homeostasis in the ischemic brain. Glia, 50(4), 
407-416. doi: 10.1002/glia.20145 
Leo, L., Gherardini, L., Barone, V., De Fusco, M., Pietrobon, D., Pizzorusso, T., & Casari, G. (2011). 
Increased susceptibility to cortical spreading depression in the mouse model of familial 
hemiplegic migraine type 2. PLoS Genet, 7(6), e1002129. doi: 10.1371/journal.pgen.1002129 
Li, J., Liang, X., Wang, Q., Breyer, R. M., McCullough, L., & Andreasson, K. (2008). Misoprostol, an anti-
ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Neurosci Lett, 
438(2), 210-215. doi: 10.1016/j.neulet.2008.04.054 
Liu, F., & McCullough, L. D. (2012). Interactions between age, sex, and hormones in experimental 
ischemic stroke. Neurochem Int, 61(8), 1255-1265. doi: 10.1016/j.neuint.2012.10.003 
Magge, S. N., Chen, H. I., Ramakrishna, R., Cen, L., Chen, Z., Elliott, J. P., . . . Le Roux, P. D. (2010). 
Association of a younger age with an increased risk of angiographic and symptomatic 
vasospasms following subarachnoid hemorrhage. J Neurosurg, 112(6), 1208-1215. doi: 
10.3171/2009.9.JNS081670 
Magnusson, K. R., Brim, B. L., & Das, S. R. (2010). Selective Vulnerabilities of N-methyl-D-aspartate 
(NMDA) Receptors During Brain Aging. Front Aging Neurosci, 2, 11. doi: 
10.3389/fnagi.2010.00011 
Major, S., Petzold, G. C., Reiffurth, C., Windmuller, O., Foddis, M., Lindauer, U., . . . Dreier, J. P. (2017). 
A role of the sodium pump in spreading ischemia in rats. J Cereb Blood Flow Metab, 37(5), 
1687-1705. doi: 10.1177/0271678X16639059 
Makra, P., Menyhart, A., Bari, F., & Farkas, E. (2018). Spectral and Multifractal Signature of Cortical 
Spreading Depolarisation in Aged Rats. Front Physiol, 9, 1512. doi: 10.3389/fphys.2018.01512 
Malarkey, E. B., & Parpura, V. (2008). Mechanisms of glutamate release from astrocytes. Neurochem 
Int, 52(1-2), 142-154. doi: 10.1016/j.neuint.2007.06.005 
Mansour, H., McColm, J. R., Cole, L., Weible, M., 2nd, Korlimbinis, A., & Chan-Ling, T. (2013). Connexin 
30 expression and frequency of connexin heterogeneity in astrocyte gap junction plaques 
increase with age in the rat retina. PLoS One, 8(3), e57038. doi: 10.1371/journal.pone.0057038 
Marrannes, R., Willems, R., De Prins, E., & Wauquier, A. (1988). Evidence for a role of the N-methyl-d-
aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res, 457(2), 226-
240. doi: 10.1016/0006-8993(88)90690-7 
Maslarova, A., Alam, M., Reiffurth, C., Lapilover, E., Gorji, A., & Dreier, J. P. (2011). Chronically epileptic 
human and rat neocortex display a similar resistance against spreading depolarization in vitro. 
Stroke, 42(10), 2917-2922. doi: 10.1161/STROKEAHA.111.621581 
Matsuura, T., & Bureš, J. (1971). The minimum volume of depolarized neural tissue required for 
triggering cortical spreading depression in rat. Experimental Brain Research, 12(3), 238-249. 
doi: 10.1007/bf00237916 
Mawet, J., Eikermann-Haerter, K., Park, K. Y., Helenius, J., Daneshmand, A., Pearlman, L., . . . Ayata, C. 
(2015a). Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-
control study. Neurology, 85(22), 1945-1949. doi: 10.1212/WNL.0000000000002166 
Mawet, J., Kurth, T., & Ayata, C. (2015b). Migraine and stroke: in search of shared mechanisms. 
Cephalalgia, 35(2), 165-181. doi: 10.1177/0333102414550106 
Mayevsky, A., Doron, A., Manor, T., Meilin, S., Zarchin, N., & Ouaknine, G. E. (1996). Cortical spreading 
depression recorded from the human brain using a multiparametric monitoring system. Brain 
Res, 740(1-2), 268-274. doi: 10.1016/s0006-8993(96)00874-8 
Menyhart, A., Farkas, A. E., Varga, D. P., Frank, R., Toth, R., Balint, A. R., . . . Farkas, E. (2018). Large-
conductance Ca(2+)-activated potassium channels are potently involved in the inverse 
57 
neurovascular response to spreading depolarization. Neurobiol Dis, 119, 41-52. doi: 
10.1016/j.nbd.2018.07.026 
Menyhart, A., Makra, P., Szepes, B. E., Toth, O. M., Hertelendy, P., Bari, F., & Farkas, E. (2015). High 
incidence of adverse cerebral blood flow responses to spreading depolarization in the aged 
ischemic rat brain. Neurobiol Aging, 36(12), 3269-3277. doi: 
10.1016/j.neurobiolaging.2015.08.014 
Menyhart, A., Zolei-Szenasi, D., Puskas, T., Makra, P., Orsolya, M. T., Szepes, B. E., . . . Farkas, E. (2017). 
Spreading depolarization remarkably exacerbates ischemia-induced tissue acidosis in the 
young and aged rat brain. Sci Rep, 7(1), 1154. doi: 10.1038/s41598-017-01284-4 
Miettinen, S., Fusco, F. R., Yrjanheikki, J., Keinanen, R., Hirvonen, T., Roivainen, R., . . . Koistinaho, J. 
(1997). Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical 
neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proceedings of 
the National Academy of Sciences, 94(12), 6500-6505. doi: 10.1073/pnas.94.12.6500 
Milner, P. M. (1958). Note on a possible correspondence between the scotomas of migraine and 
spreading depression of Leão. Electroencephalography and Clinical Neurophysiology, 10(4), 
705. doi: 10.1016/0013-4694(58)90073-7 
Misonou, H. (2010). Homeostatic regulation of neuronal excitability by K(+) channels in normal and 
diseased brains. Neuroscientist, 16(1), 51-64. doi: 10.1177/1073858409341085 
Mun-Bryce, S., Wilkerson, A. C., Papuashvili, N., & Okada, Y. C. (2001). Recurring episodes of spreading 
depression are spontaneously elicited by an intracerebral hemorrhage in the swine. Brain Res, 
888(2), 248-255. doi: 10.1016/s0006-8993(00)03068-7 
Myren, M., Baun, M., Ploug, K. B., Jansen-Olesen, I., Olesen, J., & Gupta, S. (2010). Functional and 
molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular 
system in relevance to migraine. Cephalalgia, 30(9), 1110-1122. doi: 
10.1177/0333102409357957 
Nakamura, H., Strong, A. J., Dohmen, C., Sakowitz, O. W., Vollmar, S., Sue, M., . . . Graf, R. (2010). 
Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain, 133(Pt 
7), 1994-2006. doi: 10.1093/brain/awq117 
Nedergaard, M., & Hansen, A. J. (1988). Spreading depression is not associated with neuronal injury in 
the normal brain. Brain Res, 449(1-2), 395-398. doi: 10.1016/0006-8993(88)91062-1 
Nicholls, D., & Attwell, D. (1990). The release and uptake of excitatory amino acids. Trends in 
Pharmacological Sciences, 11(11), 462-468. doi: 10.1016/0165-6147(90)90129-v 
Niwa, K., Araki, E., Morham, S. G., Ross, M. E., & Iadecola, C. (2000). Cyclooxygenase-2 Contributes to 
Functional Hyperemia in Whisker-Barrel Cortex. The Journal of Neuroscience, 20(2), 763-770. 
doi: 10.1523/jneurosci.20-02-00763.2000 
Niwa, K., Haensel, C., Ross, M. E., & Iadecola, C. (2001). Cyclooxygenase-1 Participates in Selected 
Vasodilator Responses of the Cerebral Circulation. Circ Res, 88(6), 600-608. doi: 
10.1161/01.res.88.6.600 
Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997). Cyclo-Oxygenase-2 Gene Expression in 
Neurons Contributes to Ischemic Brain Damage. The Journal of Neuroscience, 17(8), 2746-
2755. doi: 10.1523/jneurosci.17-08-02746.1997 
Nozari, A., Dilekoz, E., Sukhotinsky, I., Stein, T., Eikermann-Haerter, K., Liu, C., . . . Moskowitz, M. A. 
(2010). Microemboli may link spreading depression, migraine aura, and patent foramen ovale. 
Ann Neurol, 67(2), 221-229. doi: 10.1002/ana.21871 
Obrenovitch, T. P., Urenjak, J., & Wang, M. (2002). Nitric oxide formation during cortical spreading 
depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow 
Metab, 22(6), 680-688. doi: 10.1097/00004647-200206000-00006 
Petzold, G. C., Albeanu, D. F., Sato, T. F., & Murthy, V. N. (2008). Coupling of neural activity to blood 
flow in olfactory glomeruli is mediated by astrocytic pathways. Neuron, 58(6), 897-910. doi: 
10.1016/j.neuron.2008.04.029 
Pezzini, A., Grassi, M., Lodigiani, C., Patella, R., Gandolfo, C., Casoni, F., . . . Italian Project on Stroke in 
Young Adults, I. (2011). Predictors of migraine subtypes in young adults with ischemic stroke: 
58 
the italian project on stroke in young adults. Stroke, 42(1), 17-21. doi: 
10.1161/STROKEAHA.110.592246 
Phillips, J. M., & Nicholson, C. (1979). Anion permeability in spreading depression investigated with 
ion-sensitive microelectrodes. Brain Res, 173(3), 567-571.  
Pietrobon, D., & Moskowitz, M. A. (2014). Chaos and commotion in the wake of cortical spreading 
depression and spreading depolarizations. Nat Rev Neurosci, 15(6), 379-393. doi: 
10.1038/nrn3770 
Pinczolits, A., Zdunczyk, A., Dengler, N. F., Hecht, N., Kowoll, C. M., Dohmen, C., . . . Woitzik, J. (2017). 
Standard-sampling microdialysis and spreading depolarizations in patients with malignant 
hemispheric stroke. J Cereb Blood Flow Metab, 37(5), 1896-1905. doi: 
10.1177/0271678X17699629 
Rabb, C. H., Tang, G., Chin, L. S., & Giannotta, S. L. (1994). A statistical analysis of factors related to 
symptomatic cerebral vasospasm. Acta Neurochir (Wien), 127(1-2), 27-31.  
Richter, F., Ebersberger, A., & Schaible, H. G. (2002). Blockade of voltage-gated calcium channels in rat 
inhibits repetitive cortical spreading depression. Neurosci Lett, 334(2), 123-126.  
Richter, F., Lehmenkühler, A., Fechner, R., Manveljan, L., & Haschke, W. (1998). Postnatal conditioning 
for spreading cortical depression in the rat brain. Developmental Brain Research, 106(1-2), 
217-221. doi: 10.1016/s0165-3806(98)00018-2 
Rimmele, T. S., & Rosenberg, P. A. (2016). GLT-1: The elusive presynaptic glutamate transporter. 
Neurochem Int, 98, 19-28. doi: 10.1016/j.neuint.2016.04.010 
Risher, W. C., Ard, D., Yuan, J., & Kirov, S. A. (2010). Recurrent spontaneous spreading depolarizations 
facilitate acute dendritic injury in the ischemic penumbra. J Neurosci, 30(29), 9859-9868. doi: 
10.1523/JNEUROSCI.1917-10.2010 
Risher, W. C., Croom, D., & Kirov, S. A. (2012). Persistent astroglial swelling accompanies rapid 
reversible dendritic injury during stroke-induced spreading depolarizations. Glia, 60(11), 1709-
1720. doi: 10.1002/glia.22390 
Rogatsky, G. G., Sonn, J., Kamenir, Y., Zarchin, N., & Mayevsky, A. (2003). Relationship between 
intracranial pressure and cortical spreading depression following fluid percussion brain injury 
in rats. J Neurotrauma, 20(12), 1315-1325. doi: 10.1089/089771503322686111 
Rosenegger, D. G., Tran, C. H., Wamsteeker Cusulin, J. I., & Gordon, G. R. (2015). Tonic Local Brain 
Blood Flow Control by Astrocytes Independent of Phasic Neurovascular Coupling. J Neurosci, 
35(39), 13463-13474. doi: 10.1523/JNEUROSCI.1780-15.2015 
Rowland, M. J., Hadjipavlou, G., Kelly, M., Westbrook, J., & Pattinson, K. T. (2012). Delayed cerebral 
ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth, 109(3), 
315-329. doi: 10.1093/bja/aes264 
Sakowitz, O. W., Kiening, K. L., Krajewski, K. L., Sarrafzadeh, A. S., Fabricius, M., Strong, A. J., . . . Dreier, 
J. P. (2009). Preliminary evidence that ketamine inhibits spreading depolarizations in acute 
human brain injury. Stroke, 40(8), e519-522. doi: 10.1161/STROKEAHA.109.549303 
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011). Astrocytes in 
the aging brain express characteristics of senescence-associated secretory phenotype. Eur J 
Neurosci, 34(1), 3-11. doi: 10.1111/j.1460-9568.2011.07738.x 
Saposnik, G., Cote, R., Phillips, S., Gubitz, G., Bayer, N., Minuk, J., . . . Stroke Outcome Research Canada 
Working, G. (2008). Stroke outcome in those over 80: a multicenter cohort study across 
Canada. Stroke, 39(8), 2310-2317. doi: 10.1161/STROKEAHA.107.511402 
Satoh, M., Asai, S., Katayama, Y., Kohno, T., & Ishikawa, K. (1999). Real-time monitoring of glutamate 
transmitter release with anoxic depolarization during anoxic insult in rat striatum. Brain Res, 
822(1-2), 142-148.  
Schade, J. P. (1959). Maturational aspects of EEG and of spreading depression in rabbit. J Neurophysiol, 
22(3), 245-257. doi: 10.1152/jn.1959.22.3.245 
Schurks, M., Rist, P. M., Bigal, M. E., Buring, J. E., Lipton, R. B., & Kurth, T. (2009). Migraine and 
cardiovascular disease: systematic review and meta-analysis. BMJ, 339, b3914. doi: 
10.1136/bmj.b3914 
59 
Sengupta, P. (2013). The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med, 4(6), 624-630.  
Sesti, F. (2016). Oxidation of K(+) Channels in Aging and Neurodegeneration. Aging Dis, 7(2), 130-135. 
doi: 10.14336/AD.2015.0901 
Shatillo, A., Salo, R. A., Giniatullin, R., & Grohn, O. H. (2015). Involvement of NMDA receptor subtypes 
in cortical spreading depression in rats assessed by fMRI. Neuropharmacology, 93, 164-170. 
doi: 10.1016/j.neuropharm.2015.01.028 
Shibata, M., Leffler, C. W., & Busija, D. W. (1990). Cerebral hemodynamics during cortical spreading 
depression in rabbits. Brain Res, 530(2), 267-274.  
Shibata, M., Leffler, C. W., & Busija, D. W. (1992). Pial arteriolar constriction following cortical 
spreading depression is mediated by prostanoids. Brain Res, 572(1-2), 190-197. doi: 
10.1016/0006-8993(92)90469-p 
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., . . . Ageing Neuropathology 
Study, G. (2010). Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing 
brain. Neurobiol Aging, 31(4), 578-590. doi: 10.1016/j.neurobiolaging.2008.05.015 
Smitherman, T. A., Burch, R., Sheikh, H., & Loder, E. (2013). The prevalence, impact, and treatment of 
migraine and severe headaches in the United States: a review of statistics from national 
surveillance studies. Headache, 53(3), 427-436. doi: 10.1111/head.12074 
Somjen, G. G. (1979). Extracellular potassium in the mammalian central nervous system. Annu Rev 
Physiol, 41, 159-177. doi: 10.1146/annurev.ph.41.030179.001111 
Somjen, G. G. (2001). Mechanisms of spreading depression and hypoxic spreading depression-like 
depolarization. Physiol Rev, 81(3), 1065-1096. doi: 10.1152/physrev.2001.81.3.1065 
Spector, J. T., Kahn, S. R., Jones, M. R., Jayakumar, M., Dalal, D., & Nazarian, S. (2010). Migraine 
headache and ischemic stroke risk: an updated meta-analysis. Am J Med, 123(7), 612-624. doi: 
10.1016/j.amjmed.2009.12.021 
Spong, K. E., Andrew, R. D., & Robertson, R. M. (2016). Mechanisms of spreading depolarization in 
vertebrate and insect central nervous systems. J Neurophysiol, 116(3), 1117-1127. doi: 
10.1152/jn.00352.2016 
Steffensen, A. B., Sword, J., Croom, D., Kirov, S. A., & MacAulay, N. (2015). Chloride Cotransporters as 
a Molecular Mechanism underlying Spreading Depolarization-Induced Dendritic Beading. J 
Neurosci, 35(35), 12172-12187. doi: 10.1523/JNEUROSCI.0400-15.2015 
Sukhotinsky, I., Dilekoz, E., Moskowitz, M. A., & Ayata, C. (2008). Hypoxia and hypotension transform 
the blood flow response to cortical spreading depression from hyperemia into hypoperfusion 
in the rat. J Cereb Blood Flow Metab, 28(7), 1369-1376. doi: 10.1038/jcbfm.2008.35 
Sun, X. L., & Hu, G. (2010). ATP-sensitive potassium channels: a promising target for protecting 
neurovascular unit function in stroke. Clin Exp Pharmacol Physiol, 37(2), 243-252. doi: 
10.1111/j.1440-1681.2009.05190.x 
Sunami, K., Nakamura, T., Kubota, M., Ozawa, Y., Namba, H., Yamaura, A., & Makino, H. (1989). 
Spreading depression following experimental head injury in the rat. Neurol Med Chir (Tokyo), 
29(11), 975-980.  
Sword, J., Masuda, T., Croom, D., & Kirov, S. A. (2013). Evolution of neuronal and astroglial disruption 
in the peri-contusional cortex of mice revealed by in vivo two-photon imaging. Brain, 136(Pt 
5), 1446-1461. doi: 10.1093/brain/awt026 
Takano, K., Latour, L. L., Formato, J. E., Carano, R. A., Helmer, K. G., Hasegawa, Y., . . . Fisher, M. (1996). 
The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol, 
39(3), 308-318. doi: 10.1002/ana.410390307 
Takano, T., Tian, G. F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2006). Astrocyte-
mediated control of cerebral blood flow. Nat Neurosci, 9(2), 260-267. doi: 10.1038/nn1623 
Takeda, Y., Zhao, L., Jacewicz, M., Pulsinelli, W. A., & Nowak, T. S., Jr. (2011). Metabolic and perfusion 
responses to recurrent peri-infarct depolarization during focal ischemia in the Spontaneously 
Hypertensive Rat: dominant contribution of sporadic CBF decrements to infarct expansion. J 
Cereb Blood Flow Metab, 31(9), 1863-1873. doi: 10.1038/jcbfm.2011.62 
60 
Tang, C. M., Dichter, M., & Morad, M. (1990). Modulation of the N-methyl-D-aspartate channel by 
extracellular H+. Proceedings of the National Academy of Sciences, 87(16), 6445-6449. doi: 
10.1073/pnas.87.16.6445 
Tang, Y. T., Mendez, J. M., Theriot, J. J., Sawant, P. M., Lopez-Valdes, H. E., Ju, Y. S., & Brennan, K. C. 
(2014). Minimum conditions for the induction of cortical spreading depression in brain slices. 
J Neurophysiol, 112(10), 2572-2579. doi: 10.1152/jn.00205.2014 
Thurman, D. J. (2016). The Epidemiology of Traumatic Brain Injury in Children and Youths: A Review of 
Research Since 1990. J Child Neurol, 31(1), 20-27. doi: 10.1177/0883073814544363 
Tombaugh, G. C., & Somjen, G. G. (1996). Effects of extracellular pH on voltage-gated Na+, K+ and Ca2+ 
currents in isolated rat CA1 neurons. The Journal of Physiology, 493(3), 719-732. doi: 
10.1113/jphysiol.1996.sp021417 
Tong, C. K., & Chesler, M. (2000). Modulation of spreading depression by changes in extracellular pH. 
J Neurophysiol, 84(5), 2449-2457. doi: 10.1152/jn.2000.84.5.2449 
Toth, P., Szarka, N., Farkas, E., Ezer, E., Czeiter, E., Amrein, K., . . . Koller, A. (2016). Traumatic brain 
injury-induced autoregulatory dysfunction and spreading depression-related neurovascular 
uncoupling: Pathomechanisms, perspectives, and therapeutic implications. Am J Physiol Heart 
Circ Physiol, 311(5), H1118-H1131. doi: 10.1152/ajpheart.00267.2016 
Tottene, A., Conti, R., Fabbro, A., Vecchia, D., Shapovalova, M., Santello, M., . . . Pietrobon, D. (2009). 
Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading 
depression in Ca(v)2.1 knockin migraine mice. Neuron, 61(5), 762-773. doi: 
10.1016/j.neuron.2009.01.027 
van den Maagdenberg, A. M., Pietrobon, D., Pizzorusso, T., Kaja, S., Broos, L. A., Cesetti, T., . . . Ferrari, 
M. D. (2004). A Cacna1a knockin migraine mouse model with increased susceptibility to 
cortical spreading depression. Neuron, 41(5), 701-710.  
Verkhratsky, A., Zorec, R., Rodriguez, J. J., & Parpura, V. (2016). Astroglia dynamics in ageing and 
Alzheimer's disease. Curr Opin Pharmacol, 26, 74-79. doi: 10.1016/j.coph.2015.09.011 
Victor, T. W., Hu, X., Campbell, J. C., Buse, D. C., & Lipton, R. B. (2010). Migraine prevalence by age and 
sex in the United States: a life-span study. Cephalalgia, 30(9), 1065-1072. doi: 
10.1177/0333102409355601 
Villa, R. F., Gorini, A., & Hoyer, S. (2002). ATPases of synaptic plasma membranes from hippocampus 
after ischemia and recovery during ageing. Neurochem Res, 27(9), 861-870.  
Vinogradova, L. V. (2018). Initiation of spreading depression by synaptic and network hyperactivity: 
Insights into trigger mechanisms of migraine aura. Cephalalgia, 38(6), 1177-1187. doi: 
10.1177/0333102417724151 
von Baumgarten, L., Trabold, R., Thal, S., Back, T., & Plesnila, N. (2008). Role of cortical spreading 
depressions for secondary brain damage after traumatic brain injury in mice. J Cereb Blood 
Flow Metab, 28(7), 1353-1360. doi: 10.1038/jcbfm.2008.30 
von Bornstadt, D., Houben, T., Seidel, J. L., Zheng, Y., Dilekoz, E., Qin, T., . . . Ayata, C. (2015). Supply-
demand mismatch transients in susceptible peri-infarct hot zones explain the origins of 
spreading injury depolarizations. Neuron, 85(5), 1117-1131. doi: 
10.1016/j.neuron.2015.02.007 
Wang, H., Hitron, I. M., Iadecola, C., & Pickel, V. M. (2005). Synaptic and vascular associations of 
neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. 
Cereb Cortex, 15(8), 1250-1260. doi: 10.1093/cercor/bhi008 
Wang, M., Chazot, P. L., Ali, S., Duckett, S. F., & Obrenovitch, T. P. (2012). Effects of NMDA receptor 
antagonists with different subtype selectivities on retinal spreading depression. Br J 
Pharmacol, 165(1), 235-244. doi: 10.1111/j.1476-5381.2011.01553.x 
Woitzik, J., Dreier, J. P., Hecht, N., Fiss, I., Sandow, N., Major, S., . . . group, C. s. (2012). Delayed cerebral 
ischemia and spreading depolarization in absence of angiographic vasospasm after 
subarachnoid hemorrhage. J Cereb Blood Flow Metab, 32(2), 203-212. doi: 
10.1038/jcbfm.2011.169 
61 
Woitzik, J., Hecht, N., Pinczolits, A., Sandow, N., Major, S., Winkler, M. K., . . . group, C. s. (2013). 
Propagation of cortical spreading depolarization in the human cortex after malignant stroke. 
Neurology, 80(12), 1095-1102. doi: 10.1212/WNL.0b013e3182886932 
Wu, Y. J., Boissard, C. G., Greco, C., Gribkoff, V. K., Harden, D. G., He, H., . . . Dworetzky, S. I. (2003). (S)-
N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 
opener with significant activity in a cortical spreading depression model of migraine. J Med 
Chem, 46(15), 3197-3200. doi: 10.1021/jm034073f 
Wulff, H., & Zhorov, B. S. (2008). K+ channel modulators for the treatment of neurological disorders 
and autoimmune diseases. Chem Rev, 108(5), 1744-1773. doi: 10.1021/cr078234p 
Yao, X., Smith, A. J., Jin, B. J., Zador, Z., Manley, G. T., & Verkman, A. S. (2015). Aquaporin-4 regulates 
the velocity and frequency of cortical spreading depression in mice. Glia, 63(10), 1860-1869. 
doi: 10.1002/glia.22853 
Zhao, X., Rosenke, R., Kronemann, D., Brim, B., Das, S. R., Dunah, A. W., & Magnusson, K. R. (2009). 
The effects of aging on N-methyl-D-aspartate receptor subunits in the synaptic membrane and 
relationships to long-term spatial memory. Neuroscience, 162(4), 933-945. doi: 
10.1016/j.neuroscience.2009.05.018 
Zhou, N., Rungta, R. L., Malik, A., Han, H., Wu, D. C., & MacVicar, B. A. (2013). Regenerative glutamate 
release by presynaptic NMDA receptors contributes to spreading depression. J Cereb Blood 
Flow Metab, 33(10), 1582-1594. doi: 10.1038/jcbfm.2013.113 
 
  
62 
Publications related to the PhD thesis 
I. Hertelendy, P., Varga, D. P., Menyhárt, Á., Bari, F., & Farkas, E. 
Susceptibility of the cerebral cortex to spreading depolarization in neurological 
disease states: The impact of aging.  
Neurochemistry International. 2018 In press. doi:10.1016/j.neuint.2018.10.010 
IF: 3.603 
  
Contents lists available at ScienceDirect
Neurochemistry International
journal homepage: www.elsevier.com/locate/neuint
Susceptibility of the cerebral cortex to spreading depolarization in
neurological disease states: The impact of aging
Péter Hertelendya,b, Dániel P. Vargaa, Ákos Menyhárta, Ferenc Baria, Eszter Farkasa,∗
a Department of Medical Physics and Informatics, Faculty of Medicine and Faculty of Science and Informatics, University of Szeged, Korányis Fasor 9, H-6720, Szeged,
Hungary
bDepartment of Neurology Faculty of Medicine, University of Szeged, Semmelweis u. 6, H-6725, Szeged, Hungary
A R T I C L E I N F O
Keywords:
Aging
Brain injury
Ischemia
Migraine
Spreading depolarization
Spreading depression
A B S T R A C T
Secondary injury following acute brain insults signiﬁcantly contributes to poorer neurological outcome. The
spontaneous, recurrent occurrence of spreading depolarization events (SD) has been recognized as a potent
secondary injury mechanism in subarachnoid hemorrhage, malignant ischemic stroke and traumatic brain in-
jury. In addition, SD is the underlying mechanism of the aura symptoms of migraineurs. The susceptibility of the
nervous tissue to SD is subject to the metabolic status of the tissue, the ionic composition of the extracellular
space, and the functional status of ion pumps, voltage-gated and other cation channels, glutamate receptors and
excitatory amino acid transporters. All these mechanisms tune the excitability of the nervous tissue. Aging has
also been found to alter SD susceptibility, which appears to be highest at young adulthood, and decline over the
aging process. The lower susceptibility of the cerebral gray matter to SD in the old brain may be caused by the
age-related impairment of mechanisms implicated in ion translocations between the intra- and extracellular
compartments, glutamate signaling and surplus potassium and glutamate clearance. Even though the aging
nervous tissue is thus less able to sustain SD, the consequences of SD recurrence in the old brain have proven to
be graver, possibly leading to accelerated lesion maturation. Taken that recurrent SDs may pose an increased
burden in the aging injured brain, the beneﬁt of therapeutic approaches to restrict SD generation and propa-
gation may be particularly relevant for elderly patients.
1. Introduction
1.1. Occurrence of spreading depolarization (SD) in neurological diseases
Spreading depolarization (SD) is a wave of massive depolarization
of a critical mass of neurons and presumably glia cells, which – together
with a concomitant depression of spontaneous brain electrical activity –
propagates across the cerebral gray matter at a low rate of 2–8mm/min
(Leao, 1944; Somjen, 2001). Not long after its discovery, SD was
speculated to correspond with scotomas of migraine with aura on the
basis of a similar rate of propagation (Milner, 1958), although no direct
proof could be gathered at the time to indisputably support the claim.
Consequently, SD was considered for decades as an experimental
curiosity, or a model for neurovascular coupling, the latter due to the
evolution of an associated, robust cerebral blood ﬂow (CBF) response.
The CBF response to SD generally consists of an initial, brief vasocon-
striction, followed by a remarkable, transient, and then a less obvious
late hyperemia, which are succeeded by a long lasting oligemia. The
ﬁnal, oligemic element of the CBF response is typically obvious in the
non-ischemic cortex in case a prior SD event was not generated within
the preceding hour. The presence and weight of each, distinct phase in
the CBF response may vary in diﬀerent species, and is subject to the
metabolic state of the tissue, establishing a spectrum of CBF response
types ranging from the spectacular dominance of peak hyperemia to
ruling vasoconstriction known as spreading ischemia (Ayata and
Lauritzen, 2015).
SD in a patient – rather than in experimental model systems – was
ﬁrst captured during the aura phase of a migraine attack. In fact, an
epiphenomenon, spreading oligemia was revealed by positron-emission
tomography (PET) (Lauritzen et al., 1983). Later the full CBF response
to SD (i.e. including both hyperemia and oligemia) was conﬁrmed in
migraine patients by functional magnetic resonance imaging using
blood oxygen level detection (fMRI-BOLD) techniques (Hadjikhani
et al., 2001). The clinical evidence were highly signiﬁcant, but still
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indirect, since the CBF variation characteristic of SD, rather than SD
itself (the primary, electrophysiological event), was identiﬁed. Still, SD
has been justly acknowledged to accompany the aura phase of migraine
(Ayata, 2010), and the associated transient depression of neural activity
has been linked to neurological symptoms such as scintillations and
scotomas (Goadsby et al., 2017; Milner, 1958). Although it is still de-
bated, SD may sensitize the trigeminovascular system, activate me-
ningeal nociceptors, and thereby contribute to migraine headache itself,
as well (Ayata, 2009; Goadsby et al., 2017).
The ﬁrst, direct indication for SD to occur in the human brain was
presented by multiparametric monitoring of the cerebral cortex of se-
vere traumatic brain injury (TBI) patients. The synchronous acquisition
of CBF, extracellular K+ concentration ([K+]e), direct-current (DC)-
potential, electrocorticogram (ECoG) and changes in NADH redox state
unequivocally conﬁrmed that SD, in association with injury, evolves in
a recurrent fashion in the human brain (Mayevsky et al., 1996, 1998).
Subsequently, the systematic monitoring of SD in acute brain injury
patients (i.e. TBI, subarachnoid hemorrhage - SAH, malignant ischemic
stroke) took oﬀ starting with a landmark study (Strong et al., 2002).
The most reliable approach to detect SD has since become the use of
subdural surface electrode strips left in place for up to several days after
the neurosurgical intervention to alleviate the primary traumatic or
ischemic insult (Dreier et al., 2017). Because the recording of SDs with
scalp electrodes requires further validation (Hartings et al., 2014), SD
monitoring at present remains predominantly invasive, limited to acute
brain injury patients requiring craniotomy. These studies keep deli-
vering highly valuable data on the pattern of evolution and injurious
potential of SD, and promote SD as an indicator or mediator of ongoing
secondary damage (Dreier et al., 2017; Hartings et al., 2017).
1.2. Contribution of SD to lesion progression
Following SAH, delayed cerebral infarctions (DCI) (i.e. focal neu-
rological deterioration, new ischemic lesions and related neurological
symptoms) arise unpredictably, typically 5–14 days following the initial
injury. DCI was originally attributed to vasospasm in the proximal large
vessels, but, more recently, the additional contribution of micro-
thrombus formation and microvascular hypoperfusion was revealed
(Rowland et al., 2012). Microvascular hypoperfusion, in particular, was
suggested to be caused by clusters of SD (Dreier et al., 2006). Such SDs
may be coupled with inverse hemodynamic response and concomitant
tissue hypoxia, deepening the metabolic crisis of the tissue and leading
to ischemic lesion progression (Bosche et al., 2010; Dreier et al., 2009).
The inverse hemodynamic response to SD has also been observed in TBI
patients, and presented as a novel mechanism of secondary brain injury
(Hinzman et al., 2014). As further support for the injurious potential of
recurrent SDs, the high number of SDs and the total depolarization time
were closely associated with DCI development, independent of vasos-
pasm (Dreier et al., 2006; Woitzik et al., 2012).
Recently, repetitive SDs – in clusters or alone - have also been
identiﬁed in patients suﬀering malignant ischemic stroke (Pinczolits
et al., 2017; Woitzik et al., 2013). In focal cerebral ischemia, repetitive
SDs are thought to arise from the border of the penumbra and the is-
chemic core (Bere et al., 2014; Kao et al., 2014), probably initiated by
hypotensive or hypoxic transients (von Bornstadt et al., 2015). These
SDs may increase the chance of infarct maturation by converting viable
penumbra tissue to the core beyond repair (Hartings et al., 2017). The
coincidence between the severity of ischemic damage and SD occur-
rence was corroborated by the linear correlation between the total
depolarization time or SD frequency with infarct maturation in rodent
focal ischemia models (Back et al., 1994, 1996; Dijkhuizen et al., 1999;
Takano et al., 1996). In order to determine the direction of causality,
SDs elicited experimentally distant to ischemic foci were shown to
propagate to penumbra-like tissue and increase the size of the ischemic
infarct (Busch et al., 1996), verifying that SDs may contribute to is-
chemic lesion progression.
1.3. Age as a risk factor for neurological diseases in which SD is relevant
Taken that SD emerges as a potent mechanism of secondary brain
injury in patients, it is of great interest what conditions favor SD oc-
currence. In neurological disorders implicating SD (i.e. migraine with
aura, or acute brain injury including TBI, SAH, and malignant ischemic
stroke), age is known as an independent risk factor for the incidence
and prevalence of the disorders (Fig. 1). For example, the age-depen-
dent prevalence of migraine has been shown to be bimodal, as migraine
incidence peaks at the age of 19 and 48 years in men, and at the age of
25 and 50 in women (Victor et al., 2010) (Fig. 1). Among the general
population, TBI has a peak incidence during childhood (falls), adoles-
cence (motor-vehicle accidents) and geriatric age (falls) (Bruns and
Hauser, 2003) (Fig. 1). Further, SAH is one of the most common types
of stroke in young adults, and younger age is an established risk factor
Abbreviations
BK large-conductance Ca2+ activated K+ channel
Cav voltage-gated calcium channel
CBF cerebral blood ﬂow
DC potential direct current potential
DCI delayed cerebral infarctions
EAAT excitatory amino acid transporter
ECoG electrocorticogram
eNOS endothelial nitric oxide synthase
GFAP glial ﬁbrillary acidic protein
IL-1β interleukin-1β
Kir inward rectiﬁer potassium channel
Kv voltage-gated potassium channel
Nav voltage-gated sodium channel
NMDA N-methyl-D-aspartate
NO nitric oxide
nNOS neuronal nitric oxide synthase
SAH subarachnoidal hemorrhage
SD spreading depolarization
TBI traumatic brain injury
TNFα tumor necrosis factor-α
Fig. 1. The age-related alteration of spreading depolarization (SD) suscept-
ibility against the prevalence of neurological diseases, in which SD is implicated
as a pathophysiological phenomenon. Note, that data underscoring the mod-
iﬁcation of SD susceptibility over the lifespan are predominantly based on ex-
perimental SD elicitation. In order to compare data from clinical and experi-
mental research, the secondary x-axis represents the rat lifespan matched with
human (Sengupta, 2013). Gray area highlights the time period, over which
increased SD susceptibility coincides with the increased prevalence of neuro-
logical diseases, such as migraine, traumatic brain injury (TBI) and delayed
cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH).
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for secondary lesion progression in SAH, caused by proximal large ar-
tery vasospasm (Charpentier et al., 1999; Rabb et al., 1994) and DCI
(Crobeddu et al., 2012; de Rooij et al., 2013; Magge et al., 2010)
(Fig. 1). Finally, aging signiﬁcantly predicts poor patient outcomes after
ischemic stroke (Chen et al., 2010; Liu and McCullough, 2012). The
incidence and poor outcome of stroke steeply rises with age (Chen
et al., 2010) (Fig. 1). In this context, the impact of age on stroke pa-
thophysiology has been the target of intensive research in order to
understand the reason for the increased susceptibility of the aged brain
to stroke-related injury, yet the potential contribution of SD has re-
mained largely unexplored.
In recent years, outstanding and comprehensive reviews focusing on
diﬀerent aspects of SD have been published: the pharmacological pro-
ﬁle of SD (Pietrobon and Moskowitz, 2014); the linkage between mi-
graine, stroke and SD (Dreier and Reiﬀurth, 2015); the aspects of he-
modynamic response to SD (Ayata and Lauritzen, 2015) and the pivotal
role of SD during ischemic injury (Hartings et al., 2017). Here we set
out to provide an overview on the susceptibility of the nervous tissue to
SD, with a principal focus on age.
2. Aging and the susceptibility of the nervous tissue to SD
2.1. SD triggered experimentally
The neonatal brain appears to be too immature to sustain experi-
mentally triggered SD. In the intact rat cortex, SD can be ﬁrst initiated
from postnatal days 12–15 (Bures, 1957; Richter et al., 1998; Schade,
1959). The threshold of SD elicitation was thought to decrease until
adulthood, and expected to decrease further with aging, theoretically
due to the shrinkage of the extracellular space (Somjen, 2001). How-
ever, the latter view on aging appears to be superseded by accumulating
experimental evidence. First, the rate of SD propagation was shown to
decelerate in the aging rodent brain (Guedes et al., 1996). Also, in-
creasingly higher concentration of KCl was required to trigger SD in
brain slices obtained from middle-aged rats with respect to young
adults (Maslarova et al., 2011), and in the old versus young anesthe-
tized rat cerebral cortex (Menyhart et al., 2015, 2017b). Further, the
same, incessant, standard trigger (1M KCl) produced a lower number of
recurrent SDs in the middle-aged with respect to the young adult cer-
ebral cortex in anesthetized rats (Farkas et al., 2011). Finally, a more
sensitive, reﬁned experimental approach dissected that between the
ages of 7–30 weeks of rats - corresponding to adolescence and young
adulthood in humans (Sengupta, 2013) – progressively increasing
electrical charge was necessary to elicit SD, especially when the cortex
suﬀered of global forebrain ischemia (Hertelendy et al., 2017). In the
non-ischemic cortex, the elevating electric threshold of SD elicitation
coincided with increasing dendritic spine density, which might outline
an association between SD threshold and the ﬁne histological and
possibly neurochemical organization of the cortex (Hertelendy et al.,
2017).
In further support for the concept that the aged nervous tissue is less
able to sustain SD, additional experimental results may be lined up. In
the full band ECoG, SD is seen as a transient, spreading depression of
activity (Leão, 1944) – unless the ECoG is already isoelectric prior to SD
occurrence due to a severe insult (Hartings et al., 2011). The duration of
the ECoG depression in the non-ischemic rat cerebral cortex may last
for over 2min in the young, but for only half of this time duration in
middle-aged animals (Farkas et al., 2011). The shortening of the SD-
related ECoG depression appears to be evident ﬁrst in the low frequency
components (delta and theta bands) at middle-age (7 months old)
(Hertelendy et al., 2017), and concerns all frequency bands at old age
(18 months old) (Makra, 2018). These data have been interpreted to
depict a narrower SD wave front in space, standing for a smaller volume
of nervous tissue involved in SD at a given point in time (Farkas et al.,
2011; Hertelendy et al., 2017; Makra, 2018).
Another read-out to be taken as an indicator for the susceptibility of
the nervous tissue to SD is the distance covered by SD before coming to
a halt. Indeed, some SD events are gradually extinguished over their
course of propagation, rather than traversing the entire cortical surface,
as demonstrated by multimodal experimental imaging studies (Bere
et al., 2014; Kaufmann et al., 2017; Menyhart et al., 2017a). Even
though not documented so far, we observed that in old (18 months old)
rats, experimentally triggered SDs are more likely to terminate after
having propagated only a few millimeters away from the site of elici-
tation than in young (2 months old) rats.
2.2. SD that occurs spontaneously in response to hypoxia/ischemia
Even though these studies consistently demonstrated that SD events
are less likely to occur or evolve fully with aging (Fig. 1), the experi-
ments relied on provoking SD experimentally (i.e. by the application of
high concentration KCl or electrical stimulation), rather than evaluating
the likelihood of spontaneous SD evolution as it takes place in acute
brain injury. The distinction between experimentally triggered and
spontaneously generating SDs may be important, because their phar-
macology is diﬀerent, and thus the share of speciﬁc ion channels in
their igniting mechanisms may not be identical (Pietrobon and
Moskowitz, 2014). In addition, the share of ion channels in supporting
the generation and propagation of SD is dependent on the metabolic
conditions of tissue (Dreier and Reiﬀurth, 2015). This is best illustrated
by the observations that NMDA receptor antagonism eﬀectively blocks
SD in well-nourished tissue (Marrannes et al., 1988), but fails to do so
under severe ischemic conditions (Hertle et al., 2012). Accordingly,
contemplating the age speciﬁc pattern of spontaneous SD occurrence
adds new perspectives. To begin with, the earliest age when sponta-
neous SD was shown to emerge due to asphyxia proved to be as early as
postnatal day 4 (Hansen, 1977) – in contrast with postnatal days 12–15
determined as the youngest age in which SD can be triggered experi-
mentally (Bures, 1957; Richter et al., 1998; Schade, 1959). The im-
pediment for SD to evolve in such a young brain was, however, con-
ﬁrmed by a remarkable 20min delay of SD onset with respect to
asphyxia initiation, in contrast with the 1.5min delay observed in adult
rats (Hansen, 1977) – the longer delay possibly indicating a better
tolerance of the nervous tissue against deleterious insults. Towards the
other end of the life span, the frequency of spontaneous, recurrent SDs
was, likewise, found signiﬁcantly lower in the old (23–25 months old)
than in young (1.5 months old) and the middle-aged (9 months old) rat
brain in a model of focal cerebral ischemia (Clark et al., 2014). This
ﬁnding stands in agreement with the above data gathered using ex-
perimental SD initiation. The reason for the low SD frequency at old age
could not be identiﬁed with certainty, but SDs that are often long-
lasting in the old brain considerably postponed – if not altogether
prevented – the occurrence of subsequent SDs, which oﬀered a plau-
sible explanation (Clark et al., 2014). Indeed, the duration of transient
SD triggered under ischemia appeared to be longer-lasting in the old rat
brain as compared with the young (Menyhart et al., 2015). Further, in
the focal ischemia model not only the higher incidence of long-lasting
SDs was characteristic among the old animals than in the younger ones,
but also the larger cortical surface involved in these prolonged SD
events (Clark et al., 2014). Apparently, the recovery from SD in the old
brain appears to be hampered. This may point towards or underlie the
increased vulnerability of the old brain to ischemic conditions, and the
pathophysiologic role SD is suggested to play in injury progression.
Curiously, in another study, the generation of a spontaneous SD in
immediate response to bilateral common carotid artery occlusion was
more frequently encountered in old animals than in their young
counterparts (Menyhart et al., 2017b). Reﬂecting on the evidence
presented here so far, this observation may seem perplexing at ﬁrst, yet
it is, in fact, complementary, and makes the interpretation of existing
data more subtle. It must be appreciated that the spontaneous occur-
rence of SD in these experiments was strongly associated with a severe
drop of perfusion (to 7–23% of baseline ﬂow), rather than with age
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itself, the serious perfusion deﬁcit being more frequent among the old
rats (Menyhart et al., 2017b). Taken together, we postulate that irre-
spective of the age-related electrophysiological threshold of SD elici-
tation (which has proven to be higher at old age), a sudden, large drop
of cortical perfusion (i.e. blood ﬂow plunging below 20%) will in-
evitably bring on SDs in the old brain, as well as in the young. We also
believe that even though it is more diﬃcult to trigger SDs in the aging
brain, once SD is elicited during ischemia, it is persistent at old age, and
its long duration may indicate metabolic crisis (Farkas and Bari, 2014).
The experimental research conducted so far has thus provided
compelling evidence for the impact of age on the susceptibility of the
cerebral gray matter to SD (Fig. 1), yet clinical studies are sparse in this
regard, probably due to the inherent limitation of having to consider a
high number of risk factors other than age. Still, SDs were reported to
occur at higher incidence in young compared to older patients who
suﬀered acute brain injury (Fabricius et al., 2006), which observation is
in harmony with the experimental results.
In order to understand what cellular pathways may be altered to
account for the higher resistance of the old nervous tissue against SD,
the determining factors of SD occurrence will be examined next.
3. Mechanisms behind SD susceptibility
It has been inferred above that various parameters can be taken to
express SD susceptibility, such as (i) the latency of SD occurrence with
respect to the stimulus, (ii) the frequency of recurrent SD events, (iii)
the rate of SD propagation, (iv) the distance SD covers over its course of
propagation, or (v) the duration of ECoG depression. Some of these
parameters concern SD initiation (i.e. latency with respect to igniting
stimulus), others essentially characterize propagation (i.e. rate and
distance covered, duration of ECoG depression), or represent a mixture
of both initiation and propagation (i.e. frequency of recurrent SDs). The
capability of the nervous tissue to recover from SD may be a relevant
factor to consider as well, since delayed repolarization may postpone
the occurrence of subsequent SD events, and is expected to reduce SD
frequency. The network of astrocytes is thought to contribute to this
process. In addition, the buﬀering capacity of astrocytes may also
modulate the delay necessary to reach the neurochemical threshold of
SD elicitation. Understanding what mechanisms drive SD initiation,
propagation, and repolarization is a ﬁrst step to appreciate how aging
may impact on SD susceptibility.
3.1. SD elicitation
In the healthy mammalian brain, extracellular K+ concentration is
kept close to 3–4mM, independent of ﬂuctuations in blood serum levels
(Somjen, 1979), but local changes in extracellular K+ levels do occur
following neuronal activity. In the injured brain, the concentration of
K+ (10–15mM) suﬃcient to induce SD is presumably determined by
the balance between K+ eﬄux and the eﬃcacy of K+ clearance (Spong
et al., 2016). In the context of spontaneous SD occurrence under hy-
poxia or ischemia, an initial outward K+ current – which is also re-
ﬂected by the slow depolarization preceding SD (Hansen, 1977; Hansen
and Zeuthen, 1981) – may be, in part, a key trigger. This progressive
accumulation of extracellular K+ is thought to build up due to the re-
duced availability of ATP, which opens ATP-sensitive K+ channels to
hyperpolarize neurons via K+ eﬄux (Sun and Hu, 2010), and, more
importantly, reduces the eﬃciency of neuronal Na+/K+-ATPase and
thus K+ reuptake (Hajek et al., 1996). In addition, extracellular levels
of K+ typical of the ischemic penumbra were shown also to decrease
Na+/K+-ATPase activity by 50% (Major et al., 2017), therefore K+
itself may amplify its extracellular accumulation. The central role of
Na+/K+-ATPase in SD initiation is clearly supported by the fact that
tissue exposure to ouabain, a Na+/K+-ATPase inhibitor, readily pro-
duces SD (Balestrino et al., 1999). Ultimately, the excess K+ in the
extracellular space amounts to a depolarizing stimulus that, by the
gradual shift in membrane potential, opens voltage-gated Na+ channels
to give way to Na+ inﬂux. The experimental elicitation of SD with high
concentration KCl or electrical stimulation takes advantage of the ar-
tiﬁcial elevation of extracellular K+ as well.
When a critical threshold of K+ levels is reached, the self-propa-
gating SD cycle takes oﬀ and invades neighboring tissue (Grafstein,
1956). However, the critical threshold of K+ concentration appears to
be subject to other, variable conditions such as the degree of metabolic
impairment or the maturation of the brain, and a set threshold value
that would be uniformly valid cannot be determined. To illustrate the
variability of SD threshold from the perspective of aging, the extra-
cellular concentration of K+ suﬃcient for the spontaneous occurrence
of SD due to asphyxia in adult rats (i.e. > 24 weeks old) ranged around
10–12mM, but was over 20mM in 12-week-old rats, and could be as
high as 30mM in 4-day-old pups (Hansen, 1977).
In migraine with aura, the progressive accumulation of K+ to high
concentration as it takes place in injured tissue is unlikely, therefore an
increased sensitivity or hyperexcitability of neurons may stand in the
center of SD elicitation (Vinogradova, 2018). In addition, hyper-
excitablity may be relevant for ischemia-related SD, as well, since
theoretically such a condition may predict SD occurrence at a lower
threshold. Neuronal excitability is partly regulated by neuronal voltage-
dependent Na+ (Nav), K+ (Kv), and Ca2+ (Cav) channels (Misonou,
2010). Structural variations, modulation by second messengers and
genetic dysfunction of these channels might inﬂuence the SD threshold,
the latter being implicated, for example, in familial hemiplegic mi-
graine (FHM) type 1 (FHM1) and 3 (FHM3) (Dichgans et al., 2005; van
den Maagdenberg et al., 2004). As such, FHM3 has been linked to a
mutation of the α1 subunit of Nav 1.1 (encoded by the SNCA1A gene),
which elicits neuronal hyperexcitability and might decrease SD
threshold (Dichgans et al., 2005). Neuronal hyperexcitability, on the
other hand, is prevented by the activation of Kv1 type delayed-rectiﬁer
K+ channels (Hille, 1992). Interestingly, the selective pharmacological
blockade of cerebellar Kv 1.1 and Kv1.2 channels – highly expressed in
the cerebellar cortex and Purkinje-cells – was shown to decrease sig-
niﬁcantly the threshold of spreading acidiﬁcation and depression in the
cerebellar cortex, a phenomenon sharing similarities with SD (Chen
et al., 2005). Another type of Kv channel to suppress neuronal excit-
ability is the Kv7.2 (KCNQ2) ion channel (Wulﬀ and Zhorov, 2008).
Kv7.2 agonism was found to decrease the frequency of KCl-induced SDs
in a dose-dependent manner, probably by promoting membrane hy-
perpolarization (Wu et al., 2003). Finally, a dominant-negative muta-
tion in the TWIK-related spinal cord K+ (TRESK) channel caused hy-
perexcitability in trigeminal neurons (Liu et al., 2013), and was linked
to migraine with aura (Enyedi et al., 2012), but the contribution of
TRESK channels to SD elicitation has not been demonstrated yet.
Neuronal excitability may be modulated by Cav channels as well.
FHM1 is characterized by a mutation in the CACNA1A gene encoding
the P/Q type Ca2+ channel (van den Maagdenberg et al., 2004), in-
creasing its opening probability. In mice, the gain of function mutation
was shown to lower electrical SD threshold in vivo in two diﬀerent
variants, S218L and R192Q, both of which were previously shown to be
present in FHM patients. The decreased threshold of SD together with
increased neuronal excitability is probably mediated by the higher
opening probability of the channels at presynaptic terminals (Tottene
et al., 2009).
Taken together, these experimental data suggest, that voltage-gated
cation channels that tune neuronal excitability contribute to setting the
threshold of SD elicitation.
3.2. SD evolution and propagation
Irrespective of whether SD is elicited experimentally or occurs
spontaneously, the rapid and marked increase of extracellular K+ is a
powerful trigger, which depolarizes a critical volume of tissue of about
1mm3 (Matsuura and Bureš, 1971; Tang et al., 2014). The mass cellular
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depolarization leads then to a near-complete breakdown of neuronal
transmembrane potential (Somjen, 2001). More speciﬁcally, at any
point of the tissue involved in SD, the inﬂux of Na+ leads the depo-
larization, causing a reduction of extracellular Na+ concentration from
140 to 150 to 50–70mM, accompanied by a sudden extracellular surge
of K+ from 3 to 4 to 30–60Mm, a concurrent decrease of extracellular
Ca2+ levels from 1 to 1.5 to 0.2–0.8 mM and that of Cl− from 130 to
74mM (Hansen and Zeuthen, 1981; Pietrobon and Moskowitz, 2014).
Intracellular ion concentrations obviously change in the opposite di-
rection.
The channels mediating K+ eﬄux during depolarization are still to
be explored, but it is reasonable to suggest that Kv channels must be
involved, because the wide spectrum K+ channel blocker tetra-
ethylammonium (a drug that acts on inward rectifying and delayed
outward rectifying K+ channels) (Cook, 1990); and 4-aminopyridine (a
blocker of inward rectiﬁer and A-type K+ channels) partially limited
K+ eﬄux with SD (Aitken et al., 1991; Somjen, 2001). Recent evidence
indicates that large-conductance Ca2+-activated K+ (BK) channels
contribute to the K+ surge with SD (Menyhart et al., 2018), and ATP-
sensitive K+ channels that open under metabolic stress could also be
involved (Somjen, 2001). Finally, it is suspected that during hypoxia/
ischemia, massive nonselective Na+(Ca2+)/K+ conductances take
place with SD, via a yet unidentiﬁed channel (Czeh et al., 1992, 1993;
Gagolewicz, 2017).
Ca2+ inﬂux with SD may take place through P/Q type Cav channels,
which was tested by the application of gabapentine, an anticonvulsant
agent, with P/Q type Ca2+ channel inhibitory potential. Gabapentin
infusion eﬀectively suppressed SD susceptibility in the intact rat cortex
(Hoﬀmann et al., 2010). Likewise, the topical application of the P/Q
type Cav channel blocker ω-agatoxin was also found to remarkably
reduce the frequency of repetitive SDs (Richter et al., 2002).
In addition to the ion dislocations, interstitial glutamate con-
centration also increases from 3–3.5 to 10–11 μM with SD induced by
KCl in normal rat cortex (Hinzman et al., 2015), or well over 100 μM in
the striatum during anoxia (Satoh et al., 1999). The accumulation of
glutamate may manifest via various pathways. Considering SD trig-
gered experimentally in well-nourished tissue, the ﬁrst results obtained
with mutant P/Q type Cav mice suggested that Ca2+ inﬂux with SD
through these channels liberates glutamate and contributes to SD evo-
lution (Ayata et al., 2000; Pietrobon and Moskowitz, 2014). Glutamate
release with SD later was shown to be linked to presynaptic N-methyl-
D-aspartate (NMDA) receptor-dependent vesicular exocytosis (Zhou
et al., 2013). Further, SD has been found to open neuronal pannexin-1
channels (Karatas et al., 2013) that may also mediate the release of
glutamate to some extent (Cervetto et al., 2013; Di Cesare Mannelli
et al., 2015). Conversely, the pharmacologic inhibition of the P2X7-
pannexin-1pore complex suppressed SD, which was suggested to alle-
viate the release of K+, glutamate and pro-inﬂammatory cytokines
(Chen et al., 2017). Glutamate may also originate from astrocytes
through pathological processes, including the possibility that increased
extracellular K+ concentration reverses excitatory amino acid trans-
porters (EAATs) (Harada et al., 2015; Malarkey and Parpura, 2008;
Nicholls and Attwell, 1990).
Once glutamate builds up to high concentrations, it may over-
stimulate NMDA receptors, thereby deepening the depolarization, and
contributing to SD propagation by the further accumulation of K+ and
glutamate (Harreveld, 1959). Although the NMDA receptor is con-
sidered the primary glutamate receptor involved in SD facilitation,
some recent studies indicate the role of α-amino-3-hydroxy-5-methyl-4-
isoxazole propionate (AMPA) receptors (Costa et al., 2013) and extra-
synaptic NMDA receptors (Hardingham and Bading, 2010) as well.
Furthermore, recent investigations have suggested the speciﬁc in-
volvement of NMDA receptor subtypes NR2A and NR2B in SD sus-
ceptibility (Shatillo et al., 2015; Wang et al., 2012). The involvement of
the NMDA receptor in the sustenance of SD is underscored by inﬂu-
ential clinical studies disclosing that the administration of ketamine, an
NMDA receptor antagonist to patients of acute brain injury inhibits SD
occurrence eﬀectively (Carlson et al., 2018; Sakowitz et al., 2009). Fi-
nally, the volatile anesthetics isoﬂurane and N2O, which also dampen
NMDA receptor-based excitatory neurotransmission, were shown to
suppress SD susceptibility in rats (Kudo et al., 2008). It must be noted,
however, that SD evolving in response to anoxia/ischemia cannot be
blocked by NMDA receptor antagonism, suggesting the negligible in-
volvement of NMDA receptors in SD propagation under severe meta-
bolic stress (Pietrobon and Moskowitz, 2014).
The volume of the extracellular space also adjusts the concentration
of substances present in the extracellular ﬂuid. Water passively follows
the ﬂuxes of Na+ and especially Cl− via Cl−-coupled transporters
(Steﬀensen et al., 2015) to cause swelling of dendrites (termed “den-
dritic beading”) and astrocytes (Risher et al., 2012), with a concomitant
shrinkage of the extracellular space. This may increase the concentra-
tions of extracellular K+ and glutamate even further (Hansen and
Olsen, 1980; Phillips and Nicholson, 1979).
All these results testify that once SD has been elicited, the levels of
K+ and glutamate, which facilitate SD, progressively rise. The propa-
gation of SD, therefore, is thought to be self-sustained, advocated by the
volume transmission of high concentration K+ and glutamate generated
by SD itself.
3.3. Recovery from SD
SD is a transient event – although its duration depends on the actual
tissue metabolic conditions. The repolarization phase of SD, or recovery
of the tissue from SD is mediated by neuronal Na+/K+-ATPase to serve
K+ reuptake (Major et al., 2017). Importantly, surplus K+ is also re-
moved eﬀectively by astrocytes, utilizing various mechanisms in-
cluding, for instance, astrocytic Na+/K+-ATPase, and K+ siphoning via
Kir 4.1 inwardly rectifying K+ channels or water ﬂux mediated through
aquaporin-4 channels (Leis et al., 2005). Similar to K+ clearance, glu-
tamate buﬀering is an equally important factor in SD evolution. Glu-
tamate clearance is mainly mediated by excitatory amino acid trans-
porters 1 and 2 (EAAT1 and EAAT2), which are ion- and voltage-
dependent, predisposing glutamate reuptake highly susceptible to
changes in the ionic composition of the cellular environment and
transmembrane potential. For example, EAAT2 is not only co-localized
with Na+/K+-ATPase, but is also highly dependent on the ion gradient
it generates (Cholet et al., 2002). Among EAAT subtypes, the glial
speciﬁc EAAT2 appears to be responsible for more than 90% of gluta-
mate reuptake in the forebrain (Rimmele and Rosenberg, 2016). The
eﬀective involvement of astrocytic buﬀering in SD management was
proven by deleting aquaporin-4 channels, or hindering glutamate
clearance. As such, the genetic knock-out of aquaporin-4 channels in
mice decreased the rate of the K+ surge and K+ reuptake with SD, in
association with a slower rate of SD propagation, and lower SD fre-
quency (Yao et al., 2015). On the other hand, EAAT2-mediated gluta-
mate clearance hampered in the absence of the α2 subunit of the as-
trocytic Na+/K+ ATPase was associated with the facilitation of SD
initiation (Capuani et al., 2016). Moreover, mice carrying the genetic
knock-in of an astrocytic Na+/K+ ATPase α2 subunit loss-of-function
mutation – as it occurs in FHM2 patients – were prone to decreased SD
threshold and increased rate of SD propagation (Leo et al., 2011).
Conversely, ceftriaxone, one of the β-lactam antibiotics, stimulated the
expression of EAAT2 in astrocytes and concurrently raised SD threshold
in FHM2 mutant mice, while inhibition of EAAT2 in wild type mice
lowered SD threshold (Capuani et al., 2016). These results collectively
suggest that EAAT2 – in tight coupling with Na+/K+ ATPase – is es-
sential for glutamate clearance by astrocytes with SD.
The capacity of astrocytes to remove excessive K+ and glutamate
might be enhanced by spatial dispersion via the astrocyte syncytium,
shown to be eﬀective during physiological neuronal activation (Kofuji
and Newman, 2004; Pannasch and Rouach, 2013). Astrocytes (among
other cell types) are linked by gap-junctions formed by two
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hemichannels, which consist of pore forming proteins termed con-
nexins. Gap junctions are permeable to small molecules, ions and
second messengers, and serve as the structural basis for gliotransmis-
sion (Rovegno and Saez, 2018). Gap junctions might be assembled of
diﬀerent connexin isoforms, which determines the role and expression
pattern of the pore, placing connexins in the position of indicating in-
tercellular communication. The exact role of connexins in SD initiation
and propagation has yet to be explored (Rovegno and Saez, 2018), but
the hypothesis may be formulated that the inter-astrocytic movement or
redistribution of ions and messengers may facilitate ion or glutamate
removal, and thus reduce SD susceptibility. In contrast with this view,
exposure to non-speciﬁc connexin inhibitors (halothane, octanol and
heptanol) blocked SD initiation in the isolated chicken retina
(Nedergaard et al., 1995), suggesting that connexin-based channels
may enable the intercellular diﬀusion of ions, and support the propa-
gation of SD. However, much of the work that focused on the in-
volvement of connexins in SD evolution must be interpreted with
caution, because the non-selective inhibition of connexins probably
impaired inter-neuronal in addition to astrocyte network communica-
tion. Also, apart from gap junctions, connexins form unpaired hemi-
channels, which are large and non-speciﬁc pores at the intra- and ex-
tracellular interface. Their contribution is often not discriminated at
data interpretation (Rovegno and Saez, 2018).
Among the numerous connexin isoforms, connexin-43 has emerged
as a constituent of astrocyte gap junctions. Focusing on the glial syn-
cytium alone, the genetic inactivation of connexin-43 selective for as-
trocytes markedly reduced astrocyte network communication, and in-
creased the rate of SD propagation in the hippocampus of adult mice
(Theis et al., 2003). This reﬁned approach does support the hypothesis
posited above, conﬁrming the ability of intact astrocyte network func-
tion to keep SD in check.
A recent study also revealed that tonabersat, a migraine prophy-
lactic drug that inhibits SD (Goadsby et al., 2009) does not only mod-
ulate neuron-satellite glia signaling in the trigeminal ganglion by acting
on connexin-26 (Damodaram et al., 2009), but also blocks connexin-43
hemichannels in isolated human cerebral microvascular endothelial
cells during simulated ischemia (Kim et al., 2017). The collective evi-
dence that a connexin-43 hemichannel blocker drug inhibits SD may be
contradictory to the ﬁnding that connexin-43 deletion in astrocytes
facilitates SD, but again, the disparity of model systems (i.e. intact
mouse brain vs. endothelial cell culture under simulated ischemia; gap
junction vs. hemichannel) may render the satisfactory integration of the
existing data challenging.
4. The impact of aging on the mechanisms involved in SD
evolution
4.1. The impact of aging on SD elicitation
The aging brain appears to be increasingly resistant to SD initiation,
as indicated by the higher threshold of experimental SD elicitation
(Hertelendy et al., 2017; Maslarova et al., 2011; Menyhart et al., 2015).
Less is known about the generation of spontaneous SDs, so – aware of
the limitations – we infer here that data obtained with experimental SD
initiation – whether in the intact or the ischemic gray matter – also
applies for spontaneous SDs. The reasons behind the increased
threshold of SD elicitation at old age may be manifold. It is conceivable
that the stimulus applied is dissipated in the tissue before SD is ignited.
Some evidence suggest that the excitability of the aged nervous tissue is
lower, because the age-speciﬁc increase in the production of reactive
oxygen species modiﬁes the operation of the redox-sensitive K+ chan-
nels (Sesti, 2016) (Fig. 2B). This process may modulate the oligomer
formation, permeation and gating properties of Kv channels and BK
channels (Sesti, 2016), but it remains to be explored whether these
changes manifest at the level of SD evolution. Age may also hamper the
recruitment of the minimum tissue volume required for SD initiation.
Indeed, the wave front of SD in the old cerebral cortex appears to be
narrower than in the young, as seen in imaging studies, and possibly
reﬂected by the shorter transient ECoG depression typical of SD (Farkas
et al., 2011; Hertelendy et al., 2017; Makra, 2018).
4.2. The impact of aging on SD evolution and propagation
In addition to the age-related modiﬁcation of Kv and BK channel
function mentioned above (Sesti, 2016), P/Q type Cav channels im-
plicated in SD evolution were shown to be aﬀected by aging, as well.
Protein levels of P/Q type Cav channels in synaptosomes extracted from
the cerebral cortex signiﬁcantly decreased at preserved synaptic density
Fig. 2. Conceivable targets of aging, implicated in
the susceptibility of the nervous tissue to spreading
depolarization (SD). A, Schematic illustration of the
cellular elements hosting ion channels and trans-
porters that are involved in SD evolution. B, Age-
related dysfunction of the Na+/K+ ATPase may
contribute to K+ accumulation in the interstitial
space to trigger SD. While little is certain about the
impact of aging on voltage-gated Na+ channels
(Nav), the augmented production of reactive oxygen
species with aging may alter voltage-gated K+
channel (Kv) function to reduce the excitability of
the nervous tissue (Sesti et al., 2016). Finally, aging
may suppress the expression of P/Q type voltage-
gated Ca2+ channels (Cav) (Iwamoto et al., 2004)
that may increase SD threshold. C, The age-related
downregulation of NMDA receptor subunits im-
plicated in SD (Kumar et al., 2015; Shatillo et al.,
2015; Wang et al., 2012) may impair NMDA-based
glutamate (Glu) signaling and SD propagation. Po-
tassium reuptake may be also hampered by the ac-
tivity of the Na+/K+ ATPase decreased in the aging
brain (Benzi et al., 1994; Chakraborty et al., 2003;
Cohadon and Desbordes, 1986; de Lores Arnaiz and Ordieres, 2014; Kocak et al., 2002). D, Clearance mechanisms linked to astrocytes, such as Na+/K+ ATPase
activity, the expression of excitatory amino acid transporters (EAAT) and K+ syphoning through Kir4.1 channels may become ineﬀective or lower in the aging brain,
leaving higher concentration of K+ and glutamate in the extracellular space, and thereby delaying repolarization. E, The spatial buﬀering capacity of astrocytes
complementing clearance mechanisms may also be altered by age, although direct evidence in support of the suggestion is still to be acquired. Note, that the concept
put forward here is not meant to be comprehensive, and may provoke further thoughts.
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in old rats compared to adults (Iwamoto et al., 2004). Since the phar-
macological inhibition of P/Q type Cav channels was shown to suppress
SD occurrence (Richter et al., 2002; Hoﬀmann et al., 2010), the de-
creased expression of the channel protein at old age may also impede
SD evolution (Fig. 2B).
The ionic movements underlying SD are also accompanied by the
release of glutamate, which sustains SD by binding to and activating
NMDA receptors. The decay of NMDA receptor-based signaling with
aging has been repeatedly demonstrated in the context of suboptimal
synaptic neurotransmission and failing cognitive performance (Kumar,
2015). It is plausible that NMDA receptor-based signaling is compro-
mised due to oxidative stress mounting to levels relevant for functional
deterioration in the aged brain. Declining NMDA receptor function was,
for example, linked to the oxidation of Ca2+/calmodulin-dependent
protein kinase II (Bodhinathan et al., 2010). Among a number of po-
tential mechanisms that may aﬀect NMDA receptors in aging, the ex-
pression of distinct NMDA receptor subunits was found to be subject to
age-related changes, as well (Kumar, 2015). Importantly, mRNA and
protein expression of the modulatory NR2A and the NR2B subunits,
both implicated in SD evolution (Shatillo et al., 2015; Wang et al.,
2012), appeared to be downregulated in the aged brain (Kumar, 2015;
Magnusson et al., 2010; Zhao et al., 2009). In summary, the age-related
dysfunction of NMDA receptors may restrict SD evolution (Fig. 2C).
4.3. The impact of aging on the recovery from SD
The proper function of neuronal and astrocytic Na+/K+ ATPase,
and K+ and glutamate clearance mechanisms of astrocytes signiﬁcantly
contribute to the cessation of SD (Leis et al., 2005; Major et al., 2017),
which is hampered in the old ischemic brain with respect to the young
(Clark et al., 2014; Menyhart et al., 2015).
Most studies conducted in this regard agree that the activity of the
Na+/K+-ATPase decreases in the aging brain (Benzi et al., 1994;
Chakraborty et al., 2003; Cohadon and Desbordes, 1986; de Lores
Arnaiz and Ordieres, 2014; Kocak et al., 2002). Crude miscrosomal
preparations must have provided evidence for the combined weakening
of neuronal and astrocytic Na+/K+-ATPase activity, because this ap-
proach is not expected to discriminate between cell types (Kocak et al.,
2002). On the other hand, investigations using synaptosomes demon-
strated the age-related decline in neuronal Na+/K+-ATPase activity,
selectively (Benzi et al., 1994; Chakraborty et al., 2003). Moreover,
enzyme activity decreasing with age has been linked to oxidative stress,
which is enhanced in the aged brain (Chakraborty et al., 2003). It is
noteworthy that Na+/K+-ATPase hyperactivity in response to ischemia
is less obvious in the aging than in the adult brain (Villa et al., 2002), in
agreement with the slower recovery from SD reported in old rats suf-
fering from cerebral ischemia (Clark et al., 2014; Menyhart et al.,
2015).
Apparently, astrocytes in the aged brain display morphological al-
terations as well as functional adaptation (Verkhratsky et al., 2016),
and show characteristics of senescence-associated secretory phenotype
(Salminen et al., 2011). Intuitively, age-related loss of function should
include the reduction of the eﬃcacy of astrocyte transport mechanisms,
but there is only few and indirect or conﬂicting evidence to be lined up.
As such, both transcript and protein levels of the Kir4.1 channel and the
EAAT2 glutamate transporter were shown to be gradually down-
regulated in the pericontusional cortical region over 3 days after ex-
perimental TBI in mice, which proved to be more pronounced in the old
group of animals with respect to adults (Gupta and Prasad, 2013). Yet,
in the uninjured cortex of the same mice, aging itself increased Kir4.1
and aquaporin-4 transcript and protein levels, interpreted as an adap-
tive response to maintain K+ and water homeostasis (Gupta and
Kanungo, 2013). Further, aquaporin-4 channels participating in astro-
cytic K+ uptake appeared to be less polarized (i.e. more dispersed) in
astrocyte end feet in old mice (Kress et al., 2014). The expression of
glial ﬁbrillary acidic protein (GFAP) increases with age (Salminen et al.,
2011), and the expression of EAAT2 has been found to decrease with
increasing GFAP content, at least in brain samples of Alzheimer's dis-
ease patients (Simpson et al., 2010). It is also intriguing that the am-
plitude of Ca2+ signaling in astrocytes in response to the activation of
their NMDA receptors was found markedly decreased at old age in
protoplasmic cells isolated from the rodent cortex (Lalo et al., 2011),
which may indicate that aging astrocytes are less responsive to gluta-
mate. Altogether, these data are suggestive that transport and signaling
by astrocytes are altered in the old brain (Fig. 2D and E). Yet it remains
to be investigated to what degree astrocyte aging contributes to the
recovery from SD, delayed in the old cerebral gray matter, especially
under ischemic conditions.
Finally, astrocyte network function that relies on gap junctional
contacts between adjacent cells may be subject to aging. Even though
the level of the most typical astrocytic gap junction protein connexin-43
seems to be maintained into old age in the rodent brain and retina, the
number, size and connexin composition of astrocytic gap junction
plaques may change (Cotrina et al., 2001; Mansour et al., 2013).
Whether these subtle but detectable alterations in gap junction struc-
ture contribute to any (mal)adaptation of astrocyte network commu-
nication with aging is yet to be examined.
5. Additional factors that modulate SD susceptibility: relevance
for brain injury
5.1. Metabolic status of the tissue
The metabolic status of the tissue has already been alluded to in the
previous chapters as an important factor to modulate SD evolution, but
its distinct aspects have not been discussed so far. The supply of glucose
and oxygen are crucial for the proper working of energy-dependent ion
pumps, and thus the eﬀective maintenance of resting membrane po-
tential. The ﬁrst indication that the restricted availability of energy
substrates facilitates, while surplus glucose impedes SD was delivered
by creating systemic hypo- and hyperglycemia in rats. Hypoglycemia
shortened, while hyperglycemia postponed the onset delay of SD in
response to hypoxia initiation (Hansen, 1978). Later, hyperglycemia
was also shown to elevate the electric threshold of SD elicitation, and to
reduce the frequency of high K+-induced recurrent SDs in normally-
perfused tissue (Hoﬀmann et al., 2013). Hypoglycemia, on the other
hand, did not alter SD susceptibility, but prolonged the cumulative
duration of recurrent SDs elicited in the otherwise intact cortex
(Hoﬀmann et al., 2013). Interestingly, suppression of glycogen, lactate
or glucose utilization in the cerebral cortex of mice reduce SD elicita-
tion threshold, suggesting a signiﬁcant role for astrocyte-neuron lactate
shuttle during SD (Kilic et al., 2018). In conclusion, the unlimited
supply of circulating plasma glucose may restrict the repeated occur-
rence of SD in the intact and ischemic cerebral cortex.
While hyperglycemia thus appeared to suppress SD, hyperoxia did
not aﬀect the duration of SD, neither did hypoxia in anesthetized,
normotensive rats (Sukhotinsky et al., 2010). Yet, in a model of focal
cerebral ischemia, episodic hypoxia or sensory stimulation causing
neural activation was associated with the elicitation of spontaneous SDs
in the somatosensory cortex (von Bornstadt et al., 2015). The me-
chanisms suggested to be involved include a worsening mismatch be-
tween increasing O2 demand against a reduced O2 supply in ischemic
penumbra tissue (von Bornstadt et al., 2015).
Anaerobic metabolism in ischemic tissue produces lactic acidosis
(Katsura et al., 1991), which is considerably augmented by SDs emer-
ging (Menyhart et al., 2017b; Selman et al., 2004). It has been long
appreciated that mild tissue acidosis suppresses SD, because pH
6.67–6.97, achieved by HCl or NaOH application, the elevation of pCO2
or withdrawal of bicarbonate in the medium of brain slice preparations
inhibited SD initiation and reduced the velocity of SD propagation
(Tombaugh and Somjen, 1996; Tong and Chesler, 2000). Low pH may
restrict SD evolution via NMDA receptor inhibition (Tang et al., 1990)
P. Hertelendy et al. Neurochemistry International xxx (xxxx) xxx–xxx
7
or by the adjustment of the conductance and gating properties of Kv,
Nav, and Cav channels (Tombaugh and Somjen, 1996). Recent analysis
has reﬁned the view that acidosis impedes SD by presenting that lower
tissue pH predicted smaller SD amplitude in the normally perfused
cerebral cortex only, while the positive correlation between tissue pH
and SD amplitude was lost under ischemia in anesthetized rats
(Menyhart et al., 2017a). In the ischemic tissue, the SD suppressing
eﬀect of tissue acidosis was proposed to be obscured by glutamate and
K+, present at high concentration.
5.2. Neuroinﬂammation
Neuroinﬂammation has been recognized as a central pathogenic
component of cerebral ischemia. Microglia, the resident immune cells
of the brain are heavily implicated in mediating the inﬂammatory re-
sponse. SD is known to activate microglia (Shibata and Suzuki, 2017),
and evidence has also been accumulating recently that activated mi-
croglia may, in turn, promote SD generation. Of note, the selective
elimination of microglia was found to elevate SD threshold in brain
slices (Pusic et al., 2014), and to reduce the incidence of spontaneous
SDs in mice subjected to focal cerebral ischemia (Szalay et al., 2016).
Particularly, the M1 polarization of microglia may contribute to SD
initiation (Pusic et al., 2014). Activated microglia are the source of pro-
inﬂammatory cytokines such as tumor necrosis factor-α (TNFα) and
interleukin-1β (IL-1β), which may mediate the microglia-related po-
tentiation of SD. Experimental data addressing the role of TNFα in SD
susceptibility remain, however, inconclusive. Exposing brain slices to
TNFα for 3 days prior to SD elicitation decreased the threshold of SD
(Grinberg et al., 2013), yet the acute, topical administration of TNFα on
the cortical surface of anesthetized rodents reduced SD amplitude,
probably by augmenting GABA release via the activation of TNFα re-
ceptor type-2 (Richter et al., 2014). The action of IL-1β in a similar
experimental setting was found dose dependent, as only the lower dose
used attenuated SD amplitude (Richter et al., 2017). Microglia-derived
cytokines may, therefore, modulate SD susceptibility in various, com-
plex ways, which deserve further examination.
5.3. Nitric oxide
Acute cerebral ischemia gives rise to nitric oxide (NO) production,
partially in response to the release of pro-inﬂammatory cytokines
(Willmot et al., 2005; Murphy and Gibson, 2007). While NO produced
by the neuronal and inducible isoforms of nitric oxide synthase (nNOS
and iNOS, respectively) were shown to be neurotoxic (Huang et al.,
1994; Zhao et al., 2000), NO from endothelial source (eNOS) may be
protective against injury (Huang et al., 1996). From the perspective of
SD susceptibility, the non-selective pharmacological blockade of NOS
lowered SD threshold (Petzold et al., 2008), while the selective in-
hibition of nNOS did not signiﬁcantly alter SD initiation (Petzold et al.,
2008; Urenjak and Obrenovitch, 2000). Complementary experiments
relying on the use of eNOS or nNOS knock-out mice revealed that
particularly eNOS-derived NO upheld the physiological threshold of SD
elicitation. The availability of NO from an endothelial source may,
therefore, ﬁne-tune the susceptibility of injured tissue to SD.
All these data attest that the network of pathways that are capable
of the modulation of SD susceptibility intersect and are rather complex.
Obviously, a therapeutical approach to lessen SD occurrence in patients
may be most eﬀective if a number of SD suppressing approaches were to
be combined and tailored to the unique conditions of speciﬁc groups of
patients.
6. Conclusions
The last ﬁfteen years witnessed a rapid advance in our under-
standing of the pathophysiologic role SD plays in migraine with aura
(Goadsby et al., 2017), and particularly in the progression of secondary
lesions in acute brain injury (Dreier et al., 2017; Hartings et al., 2017).
Recurrent SDs evolving from minutes up to weeks following the pri-
mary insult have been recognized to contribute to the growth of sec-
ondary injury of ischemic nature, and worsen clinical outcome of
neurological conditions.
Even though aging may reduce the susceptibility of the nervous
tissue to SD (Clark et al., 2014; Farkas et al., 2011; Hertelendy et al.,
2017; Maslarova et al., 2011; Menyhart et al., 2015), the consequences
of SD recurrence in the old brain have proven to be graver (Farkas and
Bari, 2014). For example, tissue acidosis implicated in ischemic neu-
rodegeneration is associated with SD, and is disproportionately more
pronounced in the old brain than in the young (Menyhart et al., 2017a,
2017b). The cerebral blood ﬂow response to SD may turn into dele-
terious spreading ischemia in the injured tissue (Dreier, 2011), which is
more probable in the aged cerebral cortex than in the young (Clark
et al., 2014; Menyhart et al., 2015). In fact, SDs coupled with spreading
ischemia appear to cause an overall reduction of cerebral blood ﬂow in
the old brain, over a period when partial ﬂow compensation should
take place (Clark et al., 2014; Menyhart et al., 2015). Finally, prolonged
SD indicative of scarcer metabolic resources of the tissue covers larger
tissue volume in the old as compared with the young cerebral cortex in
experimental focal ischemia (Clark et al., 2014). All these results un-
derscore the augmented pathogenic potential of SD in the aging brain.
The suppression of recurrent SDs or counteracting SD associated
spreading ischemia is a realistic approach for neuroprotection, and is
expected to be beneﬁcial for injury outcome after SAH, malignant is-
chemic stroke or TBI. A number of experimental studies conducted to
this end have presented evidence that NMDA receptor blockade
(Sanchez-Porras et al., 2015; Reinhart and Shuttleworth, 2018), or the
inhibition of P/Q type Ca2+ channels potentially reduces SD suscept-
ibility (Hoﬀmann et al., 2010). On the other hand, L-type voltage-gated
Ca2+ channel antagonism was shown to reverse spreading ischemia to
hyperemia (Dreier et al., 1998), and lessen the weight of early hypo-
perfusion in the full cerebral blood ﬂow response to SD (Menyhart
et al., 2018). The ﬁrst clinical trials to prevent repeated SD occurrence
by the application of ketamine are promising (Carlson et al., 2018;
Sakowitz et al., 2009). Taken that recurrent SDs may pose an increased
burden in the aging injured brain, the beneﬁt of therapeutic approaches
to restrict SD generation and propagation may be particularly relevant
for elderly patients.
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Advancing age and ischemia elevate
the electric threshold to elicit spreading
depolarization in the cerebral cortex
of young adult rats
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Abstract
Spreading depolarizations of long cumulative duration have been implicated in lesion development and progression in
patients with stroke and traumatic brain injury. Spreading depolarizations evolve less likely in the aged brain, but it
remains to be determined at what age the susceptibility to spreading depolarizations starts to decline, especially in
ischemia. Spreading depolarizations were triggered by epidural electric stimulation prior and after ischemia induction in
the cortex of 7–30 weeks old anesthetized rats (n¼ 38). Cerebral ischemia was achieved by occlusion of both common
carotid arteries. Spreading depolarization occurrence was confirmed by the acquisition of DC potential and electrocor-
ticogram. Cerebral blood flow variations were recorded by laser-Doppler flowmetry. Dendritic spine density in the
cortex was determined in Golgi-COX stained sections. Spreading depolarization initiation required increasingly greater
electric charge with older age, a potential outcome of consolidation of cortical connections, indicated by altered den-
dritic spine distribution. The threshold of spreading depolarization elicitation increased with ischemia in all age groups,
which may be caused by tissue acidosis and increased Kþ conductance, among other factors. In conclusion, the brain
appears to be the most susceptible to spreading depolarizations at adolescent age; therefore, spreading depolarizations
may occur in young patients of ischemic or traumatic brain injury at the highest probability.
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Introduction
Spreading depolarization (SD) has been implicated in
the progressive expansion of primary lesions and neural
injury subsequent to the primary insult in patients of
subarachnoid hemorrhage, ischemic stroke, and trau-
matic brain injury.1–4
SD is an intense, local depolarization of a critical
mass of cells, which propagates to adjacent cell
populations in the cerebral gray matter by means of
increasing extracellular Kþ or glutamate concentration,
involving both neuronal somata and dendritic arboriza-
tions.5 The dominating element of the cerebral blood
ﬂow (CBF) response following SD in the intact tissue is
a remarkable, transient hyperemia; yet in the ischemic
brain, the CBF response may undergo a gradual
transformation to uncover ruling vasoconstrictive elem-
ents.6 This atypical SD-associated CBF variation
during ischemia is believed to aggravate the metabolic
supply-demand mismatch in the tissue and is thought to
mediate the SD-related expansion of ischemic brain
injury.4,6,7
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While the incidence of ischemic stroke and sub-
arachnoid hemorrhage steadily increases with age,8,9
traumatic brain injury most often occurs among the
young, including children, adolescents and, most of
all, young adults.10 Because higher SD frequency or
longer total SD duration is thought to usher the pro-
gress of brain injury during ischemia,11,12 it is of
importance to determine which age group is the most
susceptible for the evolution of SD. This, in turn, could
help to identify a segment of the population being at the
highest risk for SD-related injury.
The neonatal nervous tissue appears to be too
immature to sustain SD; in the intact rat brain, SD
can ﬁrst be induced experimentally between postnatal
days 12–15.13 On the other hand, the aging nervous
tissue proves to be increasingly resistant to experimen-
tal SD elicitation, requiring rising concentration of Kþ
to trigger SD.14,15 Similarly, the likelihood of spontan-
eous SD occurrence in the ischemic rat cortex decreases
with age.16 It is, however, uncertain at what age the
threshold of SD elicitation starts to rise, especially in
ischemic tissue.
It is generally assumed that ischemia-induced SDs
impose neurodegeneration by the insuﬃciency of the
associated CBF response, which deprives the tissue at
risk of essential nutrients required to maintain the ionic
balance across neuronal cell membranes.6 We have
recently demonstrated that the ischemic cerebral
cortex of aged rats—in contrast with young adult
ones—is excessively prone to the evolution of inverse
neurovascular coupling with SD,15 which is possibly
responsible for the intensiﬁed expansion of ischemic
damage in the aged brain. Yet, it remains to be
shown whether the kinetics of the SD-associated CBF
response varies during young adulthood.
One of the most obvious features of SD propagation
is the transient silencing of spontaneous and evoked
synaptic activity, seen as a transient depression of the
electrocorticogram (ECoG).17 We have previously
shown that the SD-related ECoG depression is shor-
tened in 10-month-old as compared with 2-month-old
rats but its functional signiﬁcance remained elusive.18
Taken together, here, we set out to determine the
electric threshold of SD elicitation under non-ischemic
and ischemic condition in young adult rats of increas-
ing age. We also searched for any link between the
threshold of SD elicitation and dendritic structure in
the cortex. Further, we aimed to determine any poten-
tial variation in the SD-related CBF response in asso-
ciation with the advancing age during young
adulthood. Finally, we implemented a detailed spectral
analysis of the ECoG to identify the speciﬁc frequency
bands that may be selectively aﬀected by SD or by the
progression of lifetime.
Materials and methods
Surgical procedures
The experimental procedures were approved by the
National Food Chain Safety and Animal Health
Directorate of Csongra´d county, Hungary. The proced-
ures were performed according to the guidelines of the
Scientiﬁc Committee of Animal Experimentation of the
Hungarian Academy of Sciences (updated Law and
Regulations on Animal Protection: 40/2013. (II. 14.)
Gov. of Hungary), following the EU Directive 2010/
63/EU on the protection of animals used for scientiﬁc
purposes and reported in compliance with the ARRIVE
guidelines.
Young adult male Sprague-Dawley rats (n¼ 38) of
increasing age (Table 1) were used in the study. The
animals were purchased from the Charles River
Laboratories, Hungary, were group-housed under a
normal 12/12 h light/dark cycle, and had free access
to food and drinking water. On the day of experiments,
the animals were anesthetized with 1.5–2% isoﬂurane
in N2O:O2 (70%:30%) and were allowed to breathe
spontaneously throughout the experiment. Body tem-
perature was maintained at 37C with a servo-regulated
heating pad. Atropine (0.1%, 0.05ml) was adminis-
tered intramuscularly shortly before surgical
procedures to avoid the production of airway mucus.
A catheter was inserted into the right femoral artery to
monitor the mean arterial blood pressure (MABP) con-
tinuously and the arterial blood gas levels before the
elicitation of the ﬁrst SD and before termination of the
experiment (i.e., anesthetic overdose).
Next, a midline incision was made in the neck and
both common carotid arteries were delicately separated
from the surrounding tissue, including the vagal nerves.
Lidocain (1%) was administered topically before open-
ing each tissue layer. A silicone coated ﬁshing line used
Table 1. Composition of experimental age groups.
Age of rats
included in the
study (weeks)
Body
weight (g) n
Age groups defined
for data analysis n
7 276 14 5 7–10 weeks 21
8 332 11 4
9 348 11 5
10 377 10 7
12 403 19 6 12–16 weeks 12
16 465 12 6
30 608 37 5 30 weeks 5
Note: Data are given as mean stdev.
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as occluder was looped around each artery for later
induction of cerebral ischemia. Rats were transferred
to a stereotactic frame and ﬁxed in prone position.
Two cranial windows (3 3mm) 1mm apart were
prepared over the right parietal cortex. The bone was
carefully thinned using a dental drill (Technobox, Bien
Air 810) and gently peeled away to reveal the dura sur-
face. In the caudal window, a small hole was carefully
cut on the dura for the positioning of an intracortical
microelectrode and an adjacent laser-Doppler probe
positioned above the cortical surface.
Recording of electrophysiological variables
For the concomitant recording of ECoG and slow cor-
tical or direct current (DC) potential, a glass capillary
electrode (20 mm outside tip diameter) ﬁlled with
physiological saline was inserted 800–1000 mm deep
into the cerebral cortex at the caudal window. An Ag/
AgCl reference electrode was implanted under the skin
of the animal’s neck. DC potential and ECoG were
recorded via a high input impedance pre-ampliﬁer
(NL102G, NeuroLog System, Digitimer Ltd., United
Kingdom), connected to a diﬀerential ampliﬁer
(NL106, NeuroLog System, Digitimer Ltd., United
Kingdom) with associated ﬁlter and conditioner sys-
tems (NL125, NL530, NeuroLog System, Digitimer
Ltd., United Kingdom). Potential line frequency noise
(50 Hz) was removed by a high quality noise eliminator
(HumBug, Quest Scientiﬁc Instruments Inc., Canada)
without any signal attenuation. The resulting signal was
digitalized by an analog/digital (A/D) converter
(MP150, Biopac Systems Inc., USA) and continuously
acquired at a sampling frequency of 1 kHz using the
software ACQKNOWLEDGE 4.2.0 (Biopac Systems Inc.,
USA).
Monitoring local cerebral blood flow
SD-associated changes in local CBF were recorded
using laser-Doppler ﬂowmetry (LDF). A laser
Doppler needle probe (Probe 403 connected to
PeriFlux 5000; Perimed AB, Sweden) was positioned
right above the cortical surface at the penetration site
of the glass capillary electrode with a micromanipula-
tor, avoiding any large pial vessels. The signal was digi-
tized and acquired, together with the DC potential and
ECoG, essentially as described above.
Ischemia induction and SD elicitation
Following a baseline period of over an hour, persistent
incomplete global forebrain ischemia was induced by
occluding both common carotid arteries permanently
(‘‘2-vessel occlusion,’’ 2VO): occluders were pulled on
until resistance was felt and then secured in place.
Successful ischemia induction was conﬁrmed by a
sharp drop of the LDF signal.
A concentric bipolar needle electrode (tip size:
40 mm, Neuronelektro´d Kft., Hungary) was placed
upon the dura in the rostral window for SD elicitation.
It was connected to an opto-coupled stimulus isolator
with a constant current output (NL 800, Digitimer
Ltd., United Kingdom), a pulse generator (NL301), a
with-delay panel (NL405), and a pulse buﬀer (NL510),
which enabled the adjustment of amplitude and
duration of the stimuli at will. Stimulation was
implemented with a single, cathodal, and rectangular
pulse. The charge delivered was quantiﬁed as
Q½C ¼ I½mA  t½ms, and it was raised stepwise
with an interstimulus interval of 2min until SD was
observed. Whenever necessary, the position of the
needle electrode was adjusted to optimize the contact
between the electrode tip and the tissue. Successful
elicitation of SD was conﬁrmed by a negative DC-
shift of an amplitude greater than 5mV acquired by
the recording electrode or by the obvious ECoG
depression.
Three SDs were elicited during the baseline period,
at an inter-SD interval of at least 20min. Additional
three SDs were generated during ischemia, the ﬁrst
triggered 20-min after ischemia onset or after the spon-
taneous occurrence of an SD event associated with
ischemia induction (Figure 1).
Figure 1. Representative, synchronous traces of the ECoG,
DC potential, and CBF, acquired from an 8-week-old animal.
Depression of the ECoG synchronous with a transient, negative
shift of the DC potential and associated functional hyperemia
together indicate SD occurrence. The label 2VO (bilateral
common carotid artery occlusion, ‘‘2-vessel occlusion’’) desig-
nates ischemia induction. Short vertical lines on the DC potential
trace show the delivery of current to evoke SD (upward gray
arrows). Ischemia induction was immediately followed by the
occurrence of a single spontaneous SD.
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Histology
In order to assess whether dendritic spine density
changes with advancing age during young adulthood,
additional 8-week-old (n¼ 5) and 30-week-old (n¼ 5)
rats were deeply anesthetized with an overdose of chlor-
ale hydrate (i.p.). The animals were transcardially
perfused with ice cold saline, decapitated, and the
brains quickly removed. The forebrains were cut in
the coronal plane into two pieces of equal size and
immersed in Golgi-COX solution mixed of the follow-
ing stock solutions: (i) 5% potassium dichromate
(Molar Chemicals Kft., Hungary), (ii) 5% potassium
chromate (Molar Chemicals Kft, Hungary), and (iii)
5% mercuric chloride (VWR International, LLC).19
The tissue blocks were incubated for 10 days at room
temperature, the solution being refreshed every 2–3
days. The brain samples were then transferred to 30%
sucrose to be stored for at least 10 days at 4C. Coronal
slices of 200 mm were cut with a vibrating microtome,
mounted on gelatin-coated microscopic slides, and
stored overnight in a dark humidity chamber. Finally,
the staining was developed with 30% ammonium
hydroxide followed by Carestream Kodak Fixer
(Sigma). Sections were then dehydrated and cover-
slipped with Eukitt (O. Kindler, Germany).
The stained brain slices were examined by a light
microscope (Nikon Eclipse E600). Fifteensixteen
cortical pyramidal neurons in layer 3 were studied in
samples of each animal. Dendritic spine density of
second- or third-order dendrites of the proximal
apical dendrite was analyzed on a 50-mm-long segment.
Serial z stack images of selected dendritic segments
were created using a SPOT RT Slider digital camera
(1600 1200 dpi in 8 bits) connected to the light micro-
scope (Nikon Eclipse E600) and a computer equipped
with an image processing software (Image Pro Plus 4.5;
Media Cybernetics, Bethesda). Dendritic spines were
counted by four independent investigators blind to
the experimental groups, using the software IMAGE J
(v1.44, National Institute of Health, Bethesda).
Data analysis
All variables (i.e., DC potential, ECoG, LDF signal
and MABP) were simultaneously acquired, displayed
live, and stored using a personal computer equipped
with a dedicated software (AcqKnowledge 4.2 for MP
150, Biopac Systems, Inc., USA). Data analysis was
assisted by the inbuilt tools of the software.
Raw LDF recordings were downsampled to 1Hz
and then expressed relative to baseline by using the
average CBF value preceding the ﬁrst evoked SD
(100%) and the recorded biological zero obtained
after terminating the experiment (0%) as reference
points.
The hyperemic elements of the SD-related CBF
response were characterized by the magnitude of hyper-
emia, which was expressed as peak amplitude with
respect to baseline. Hyperemia duration was deter-
mined at half amplitude.
ECoG spectral power analysis was applied for indi-
vidual frequency bands as described previously.15 The
parameters obtained were the following: (i) level of
baseline (the mean spectral power for the 60-s interval
preceding the onset of an SD); (ii) level of depression
(the arithmetic mean between the endpoints of the
downward and upward segments); (iii) duration of
depression; and (iv) level of recovery (the mean spectral
power for the 60-s interval following recovery). Along
with the 30-week-old group (n¼ 5), six of the youngest
animals (7/8 weeks) with clean ECoG trace (i.e., min-
imal noise) were selected for the analysis.
In order to determine dendritic spine density, the
spine count of 15–16 dendritic segments assessed in
each animal was averaged, and, thereby, a single
value was taken for each rat for further statistical
analysis.
Data are given as mean stdev. The software SPSS
(IBM SPSS Statistics for Windows, Version 22.0, IBM
Corp.) was used for statistical analysis. A one-way ana-
lysis of variance (ANOVA) model was used for the
evaluation of dendritic spine density, the SD-associated
CBF response, baseline ECoG power, and the duration
of SD-related ECoG depression. A two-way ANOVA
paradigm was applied for the evaluation of data con-
cerning the electric threshold of SD elicitation (factors:
age and ischemia) and ECoG power during the SD-
related depression (factors: age and ischemia). A
repeated measures ANOVA (factor: age) was used for
the analysis of resting CBF, taken at selected time
points over the course of experiments, and ECoG
power variations over the course of experiments.
Wherever appropriate, a Fisher post hoc test was
used to reveal the diﬀerences between the experimental
groups. Pearson two-tailed correlation analysis was
carried out to test potential association between data
sets. Levels of signiﬁcance were deﬁned as p< 0.05* and
p< 0.01**.
Results
Preliminary screening of the acquired data sets revealed
no age-related diﬀerence between the 7–10-week-old
animals and the 12–16-week-old animals (inserts in
Figure 3(a)), therefore, three age groups were created
by uniting the 7–10-week-old and the 12–16-week-old
populations (Table 1). MABP during baseline was stat-
istically not diﬀerent across groups (98 4, 95  3, and
107 10mmHg, 7–10-week-old, 12–16-week-old, and
30-week-old, respectively). Ischemia elevated MABP
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slightly but not signiﬁcantly, without any notable
impact of age (105 5, 96 4, and 114 2mmHg, 7–
10-week-old, 12–16-week-old, and 30-week-old,
respectively). Arterial blood gases were typically
within the physiological range, with no signiﬁcant
eﬀect of ischemia or age on either pCO2 or pH.
Arterial blood glucose concentration taken during
baseline and late ischemia was similar (e.g., 9.23 1.7
vs. 9.20 1.2mmol/l, ischemia vs. baseline in 7–10-
week-old) but signiﬁcantly increased with advancing
age (e.g., 11.95 1.6 vs. 10.08 1.0 vs.
9.2 1.2mmol/l, 30-week-old vs. 12–16-week-old vs.
7–10-week-old during baseline).
SDs occurred reliably upon electric stimulation of
the cortex. In a number of experiments (25 of 38), a
single, spontaneous SD evolved immediately after
ischemia induction (Figure 1). The analysis of the DC
potential signature of SDs demonstrated that the amp-
litude of spontaneous SDs (23.1 7.8mV) was statis-
tically not diﬀerent from SDs evoked during baseline
(24.5 3.8mV) or ischemia (28.8 5.8mV). However,
with spontaneous SDs, the duration at half amplitude
of the DC shift was considerably longer—albeit with
excessive variation (220.9 316.0 s), as compared with
SDs evoked during baseline (19.9 5.1 s) or ischemia
(80.7 80.8 s). Such spontaneous events were not
distinctively prevalent for any of the age groups,
although only 2 of the 25 events were recorded in the
30-week-old group. Spontaneous SDs were not
included in further data analysis.
The CBF response to SDs evoked was invariably
hyperemic in all age groups under both baseline and
ischemia. The CBF response to the ﬁrst SD in each
experiment diﬀered from subsequent SDs in that hyper-
emia was often preceded by a short drop in CBF and
was always followed by long-lasting oligemia.
Ischemia evolution and compensation for the
reduction of cerebral blood flow after ischemia onset
In order to estimate how compensation for the reduc-
tion of CBF evolved following ischemia induction,
CBF values were obtained prior to and shortly after
ischemia onset, and in between SD events evoked
during ischemia (Figure 2). In the youngest, 7–10-
week-old group, CBF dropped to 18 6% immediately
after 2VO onset, recovered to 37 12% before the
elicitation of the ﬁrst SD under ischemia, and was
maintained over 30% throughout the ischemic period.
In contrast, CBF fell to 11 6% after ischemia induc-
tion, recovered to 20 13% before initiation of the ﬁrst
ischemic SD, and remained at around only 20% in the
30-week-old group, implying signiﬁcantly less eﬃcient
compensation in the 30-week-old group with respect to
the 7–10-week-old group.
Electric threshold of SD elicitation
The electric threshold of SD elicitation was expressed as
the lowest electric charge suﬃcient to trigger SD in the
cortex (Figure 3(a)). We chose to trigger SDs by electric
stimulation as opposed to high concentration Kþ appli-
cation, because the electric charge delivered can be
ﬁnely tuned. This oﬀers the accurate estimation of the
electric threshold of SD elicitation to uncover any ﬁne
variations between age groups of a few weeks
diﬀerence.
In all age groups, the threshold of SD elicitation was
signiﬁcantly higher during ischemia, as compared with
baseline. The initiation of SD required increasingly
greater electric charge with older age during both base-
line (4743 1282 vs. 3076 915 vs. 1661 649 mC, 30-
week-old vs. 12–16-week-old vs. 7–10-week-old) and
ischemia (8447 1763 vs. 5343 2170 vs.
2514 1032mC, 30-week-old vs. 12–16-week-old vs.
7–10-week-old). Finally, with advancing age, the
threshold during ischemia progressively departed from
the threshold determined for the respective baseline: in
other words, the diﬀerence between ischemia and base-
line thresholds was approximately ﬁve times greater in
the 30-week-old as compared with the 7–10-week-old
Figure 2. Level of local CBF in the youngest (7–10-week-old)
and oldest (30-week-old) age groups, taken at selected time
points of the experimental protocol: (a) prior bilateral common
carotid artery occlusion (2VO), after the passage of the last SD
elicited during baseline; (b) transient drop immediately after
2VO; (c) shortly before the first ischemic SD; (d) shortly before
the second ischemic SD; (e) shortly before the third ischemic SD;
(f) late ischemia, after the passage of the last SD elicited during
ischemia. Data are presented as mean stdev. A repeated
measures analysis of variance (ANOVA) paradigm considering
age as a factor was applied for statistical analysis. Level of sig-
nificance was defined as p< 0.01**. Post hoc analysis for group
comparison at each time point revealed significant difference at
(c) and (d). Level of significance was defined as p< 0.05*.
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group (threshold diﬀerence of 4278 2352 vs.
853 839mC, 30-week-old vs. 7–10-week-old).
Next, we set out to determine any potential associ-
ation between the electric threshold of SD elicitation
and CBF or the cortex’ SD-related electrical activity.
Lower CBF taken prior SD elicitation predicted higher
threshold of SD elicitation (r¼ –0.403**) (Figure 3(b)).
The threshold of SD elicitation positively correlated
with the duration of SD-related depression of the
high frequency alpha and beta bands (r¼ 0.373** and
0.478**, respectively) (Figure 3(c)) but not with the low
frequency delta and theta bands (r¼ 0.247 and 0.234,
respectively). No association with any other ECoG
variable (i.e., power of baseline, depression, or recov-
ery) emerged.
Density of dendritic spines
We set out to test the hypothesis that the increase in the
threshold of SD elicitation due to brain maturation is
determined—at least in part—by the dynamic struc-
tural development of the cortex, reﬂected by the mor-
phological plasticity of dendritic spines. The animals
admitted to the analysis were naive (i.e., neither ische-
mia nor SD was induced prior to sampling), therefore,
potential dendritic spine density changes due to ische-
mia or SD propagation were not studied.
Dendritic spines on second- or third-order dendritic
branches of layer 3 pyramidal neuronal apical dendrites
were investigated (Figure 4(a)). In general, den-
dritic spines tended to be arranged in clusters rather
than individually and appeared to be larger and more
complex in shape in the 30-week-old group than in the
8-week-old group (Figure 4(b)). Dendritic spine density
signiﬁcantly increased in the 30-week-old group with
respect to the 8-week-old group (55 4 vs. 51 2
spines/50 mm dendritic segment, 30-week-old vs.
8-week-old) (Figure 4(c)).
Features of the cerebral blood flow response
associated with SD
For the evaluation of the SD-associated CBF response,
SDs were sorted into three distinct categories: (i) SD1,
(ii) subsequent SDs evoked during baseline, and (iii)
SDs initiated under ischemia (Figure 5(a)).
As presented in Figure 5(b), CBF prior to the onset
of baseline SDs was 10–15% lower than that prior to
SD1 in all age groups (e.g., 90 30 vs. 102 12%,
baseline SDs vs. SD1 in 7–10-week-old). The CBF
Figure 3. Electric threshold of SD elicitation, and its association with CBF and the SD-related depression of the ECoG. (a) Electric
threshold of SD elicitation prior and during incomplete forebrain ischemia (baseline: open symbols, ischemia: closed symbols). The 7–
10-week-old animals and 12-16-week-old animals were treated as single groups, because no impact of age was observed on threshold
values (see inserts). Data are represented as mean stdev. For the evaluation of statistical significance, a two-way ANOVA paradigm
considering age and ischemia as its factors was followed by a Fisher post hoc test for age. Level of significance for the ANOVA was
defined as p< 0.01**, and for the post hoc test as p< 0.01##, vs. 7–10 week-old and p< 0.05þþ, vs. 12–16 week-old. (b) Negative
correlation between the electric threshold of SD elicitation and CBF prior SD evolution; each evoked SD was considered for the
analysis. Pearson two-tailed correlation analysis including all age groups as one data pool indicated significant association between the
threshold and CBF (p< 0.01**). (c) Correlation between the electric threshold of SD elicitation and the duration of SD-related
depression on the beta frequency band of the ECoG. Data acquired from animals selected for ECoG spectral analysis are shown.
Pearson two-tailed correlation analysis revealed significant association between the data sets (p< 0.01**).
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response with SDs under ischemia took oﬀ from a
markedly lower level (39 15 and 38 11%, 7–10-
week-old, and 12–16-week-old, respectively), especially
in the 30-week-old group (23 14%). The SD-asso-
ciated hyperemia peaked at around 160–170% in all
age groups during baseline (i.e., 163 45, 160 61,
and 170 69%, 7–10-week-old, 12–16-week-old, and
30-week-old, respectively), approximately 20–30%
higher than with SD1 (129 23, 131 17, and
149 24%, 7–10-week-old, 12-16-week-old, and 30-
week-old, respectively). During ischemia, the peak
amplitude of the CBF response reached a considerably
lower level (59 23 and 61 18%, %, in 7–10-week-
old, and 12–16-week-old, respectively) with the lowest
value measured in the 30-week-old group (39 22%).
Conspicuously, in the 30-week-old group, the CBF
response with ischemic SDs set oﬀ from the lowest
CBF level and reached the lowest peak (not even
exceeding the resting CBF prior to SD elicitation in
the 7–10- or the 12-16-week-old groups) (Figure 5(b)),
although with no statistically signiﬁcant reduction with
respect to the younger age groups.
Figure 5(c) shows that the duration of the SD-
related CBF response was shortest with SD1 (30 12,
33 7, and 39 23 s, 7–10-week-old, 12–16-week-old,
and 30-week-old, respectively), increased with
subsequent SDs elicited during baseline (58 14,
56 11, and 50 10 s, 7–10-week-old, 12–16-week-
old, and 30-week-old, respectively), and more than
doubled with SDs triggered under ischemia (154 61,
137 68 and 150 52 s, 7-10-week-old, 12-16-week-old
and 30-week-old, respectively). No impact of age on the
duration of the SD-associated CBF response was
observed.
Spectral analysis of the distinct ECoG frequency
bands
Baseline ECoG power was assessed at the very begin-
ning of the experiments, prior to any intervention, to
test whether anesthesia aﬀects the two age groups dif-
ferently. No age-related diﬀerence was observed con-
cerning any of the frequency bands studied (Figure
6(a)). ECoG power repeatedly sampled prior to SD
events demonstrated that ischemia itself imposed a con-
siderable power decrease on the overall ECoG, which
was particularly prominent after the passage of the ﬁrst
SD evoked under ischemia. This is illustrated in
Figure 6(b) for the theta band.
The novel ﬁndings of spectral analysis concerned the
SD-related transient depression of the ECoG. Although
the power of the four frequency bands during depression
was similar under baseline and ischemia (i.e., ischemia
exerted no impact), the selectively greater power of the
alpha and theta bands in the 30-week-old group as com-
pared with the 7/8-week-old group (e.g., theta band:
0.005 0.003 vs. 0.0025 0.001 V2, 30-week-old vs. 7/
8-week-old) indicated incomplete depression of these
two bands with the maturation of the brain, under
both baseline and ischemic conditions (Figure 6(c)).
As expected, ischemia considerably extended the
duration of ECoG depression on all four frequency
Figure 4. Dendritic spine density on second- or third-order dendritic branches of apical dendrites of layer 3 pyramidal neurons. (a)
Schematic drawing of a cortical pyramidal neuron to illustrate the position of dendritic segments investigated. (b) Representative
images of 50-mm-long segments of second- or third-order dendrites in the 8-week-old and the 30-week-old groups. Images were
obtained of original z-stack images by the enhancement of contrast and brightness in order to eliminate background. (c) Dendritic
spine density on the selected dendritic segments. Data are given as mean stdev. A one-way ANOVA model was used for statistical
analysis (n¼ 5 for each group, F¼ 6.263, p< 0.05*).
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bands (e.g., alpha band in the 7/8-week-old: 271 126
vs. 139 40 s, ischemia vs. baseline). Curiously, during
baseline, the lower frequency delta and theta bands
started to recover from the SD-related depression
sooner than the higher frequency alpha and beta
bands in the 30-week-old group, in contrast with the
7/8-week-old group (e.g., duration of theta band:
123 52 vs. 132 34 s, 30-week-old vs. 7/8-week-old)
(Figure 6(d)).
The duration of the SD-related ECoG depression
appeared to be associated with the SD-coupled CBF
response: the relative peak of SD-associated hyperemia
correlated negatively with the duration of ECoG
depression on all four frequency bands, as illustrated
for the theta band in Figure 6(e) (r¼ –0.550**). At the
same time, the longer duration of hyperemia was
strongly linked to the longer duration of ECoG depres-
sion on all four frequency bands, being most prominent
on the delta and theta bands (r¼ 0.733** and
r¼ 0.703**, respectively) (Figure 6(f)).
Discussion
Relevance of the findings to human brain injury
Recurrent SDs spontaneously occur in patients of sub-
arachnoid hemorrhage, ischemic stroke, and traumatic
brain injury.1–3 The ﬁndings of the present study can be
interpreted in the context of both ischemic and trau-
matic brain injury for the following reasons. We stu-
died the brain’s susceptibility to SD under two
conditions: (i) in the intact and (ii) in the ischemic
brain. The results obtained under ischemia are pro-
posed to be relevant to cerebral ischemia evolving in
patients of stroke or subarachnoid hemorrhage. The
experiments done in the intact brain have revealed
that increasing age, by itself, has a signiﬁcant eﬀect
on the elicitation threshold of SD. Thus, the age-
related overall susceptibility of the brain to SD may
be a factor to determine the frequency of SD occur-
rence in any pathophysiological condition, traumatic
brain injury being one of them.
In the present study, we relied on electric stimula-
tion to elicit SDs and quantify the electric threshold
of SD elicitation with precision. Yet, in the injured
brain of patients, SDs occur spontaneously. The
exact conditions that give rise to SD generation
under ischemia are not absolutely clear but worsening
oxygen supply-demand mismatch as a result of som-
atosensory activation, episodic hypoxemia, or hypo-
tension has been shown to promote SD occurrence.20
Taken together, the risk of SD occurrence in the
injured brain must be dependent on a combination
of several factors, such as the severity of ischemia,
insuﬃciency of oxygen delivery, and, as proposed
here, the brain’s age-related susceptibility to sustain
SD. Our argument is also supported by a previous
study of ours showing that spontaneous SDs occur
signiﬁcantly less likely in the aged ischemic brain with
respect to the young.16
Figure 5. Quantitative analysis of the CBF response associated
with SD. (a) Schematic drawings depicting the variables under
study: CBF response to SD1, subsequent SDs during baseline
(baseline SDs), and SDs evoked during ischemia (ischemic SDs).
CBF level prior SD elicitation, peak amplitude, and duration at
half amplitude were evaluated. (b) Peak CBF amplitude (bars)
respective to CBF baseline prior SD elicitation (base of bars). (c)
The duration of hyperemia at half amplitude. Data are expressed
as mean stdev. For the evaluation of statistical significance, a
one-way ANOVA paradigm followed by a Fisher post hoc test
was used for each age group. Level of significance for the ANOVA
was defined as p< 0.01**, and the F-values are given in each bar
chart. Level of significance for the post hoc analysis is indicated as
p< 0.05* and p< 0.01** vs. SD1; and p< 0.01## vs. baseline SDs.
1770 Journal of Cerebral Blood Flow & Metabolism 37(5)
Life span targeted
The present study aimed at investigating the electric
threshold of SD elicitation and the evolution of the SD-
coupled hemodynamic response in 7–30-week-old rats,
with or without cerebral ischemia. This life span corres-
ponds to human adolescence and young adulthood.21
The interpretation of the age-related aspects of the results
with respect to previous reports is challenging: Studies on
cerebral ischemia, which tackle the issue of age focus
mainly either on the very early phase of life (i.e., birth
and maturation) or old age (i.e., aging). The data pre-
sented here, therefore, may shed light on signiﬁcant
neurophysiological changes that take place during
young adulthood.
Figure 6. Spectrum analysis of the ECoG for individual frequency bands during SD events. (a) ECoG power of each frequency band,
for 60 s baseline at the very start of the experimental protocol, prior to any intervention. No significant difference between age groups
was observed, for any of the frequency bands examined (one-way ANOVA). Note that the weight of low frequency bands in the
spectrum is greater than that of higher frequency waves, which mainly reflects an inherent feature of ECoG spectra. Because the
ECoG frequency bands represent a power spectrum, their values will vary exponentially, meaning the lower-frequency bands will have
exponentially greater values than the higher-frequency bands. (b) Baseline ECoG power of the theta band, assessed repeatedly prior to
events, in order to follow the distribution of baseline over the course of the experimental protocol. The first pair of symbols
corresponds with theta in Panel A. Repeated measures ANOVA revealed that the ECoG power of baseline decreased, especially
during ischemia, irrespective of age. (c) ECoG power of distinct frequency bands, calculated for the period of SD-related ECoG
depression. The power of individual frequency bands is represented by bars positioned behind each other. Two-way ANOVA con-
sidering age and ischemia as its factors revealed that age significantly elevated the power of the alpha and theta bands selectively,
irrespective of ischemia. Level of significance was defined as p< 0.05* and p< 0.01**. (d) Duration of ECoG depression with SDs
evoked under baseline condition. The low frequency bands start to recover significantly sooner than the high frequency bands in the
30-week-old group (one-way ANOVA followed by a Fisher post hoc test, p< 0.05# vs. alpha, p< 0.05* and p< 0.01** vs. beta). (e)
Negative correlation between the duration of the SD-related depression on the theta band of the ECoG, and the relative peak of SD-
coupled hyperemia. Pearson two-tailed correlation analysis revealed significant association between these data sets (p< 0.01**). (f)
Positive correlation between the duration of the SD-related depression on the theta band of the ECoG, and the duration of SD-
coupled hyperemia. Pearson two-tailed correlation analysis indicated significant association between the data sets (p< 0.01**).
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Electric threshold to elicit spreading depolarization
Our recent studies have demonstrated that the thresh-
old of SD elicitation increases with age: In the intact
cortex, Kþ-induced, recurrent SDs occurred less fre-
quently in 10-month-old rats as compared with their
2-month-old counterparts,18 and increasing concentra-
tion of Kþ was required to evoke SDs in 2-year-old as
compared with 2-month-old rats.15 In addition, spon-
taneous SDs in the ischemic cortex of 2-year-old rats
emerged less likely with respect to 9-month-old ani-
mals.16 These ﬁndings urged us to determine at what
exact age the threshold of SD elicitation starts to rise,
especially in ischemic tissue.
Our present data clearly demonstrate that the elec-
tric threshold of SD elicitation markedly increases with
ischemia as well as with the progression of lifetime
during early adulthood (Figure 3(a)). Furthermore,
the ischemia-related threshold elevation is increasingly
more obvious with older age.
The ischemia-related increase of SD threshold may
be the result of the metabolic state of the tissue, as
indicated by the correspondence between lower CBF
taken prior to evoking an SD with a higher electric
threshold of SD elicitation (Figure 3(b)). The availabil-
ity of glucose or the level of tissue pH may reﬂect tissue
metabolic conditions. As such, high concentration of
blood glucose (23–24mmol/l) was shown to make the
tissue resistant to SD in rats.22 Yet, our data on blood
glucose level indicated normoglycemic conditions (blood
glucose concentration around 9–11mmol/l) in all age
groups and revealed no diﬀerence between baseline
and late ischemia. Therefore, we suspect that factors
other than the availability of glucose must determine
the ischemia-related inhibition of SD elicitation as seen
here. Indeed, a study relying on live brain slices proved
that tissue acidosis (i.e., pH 6.67–6.97, achieved by the
elevation of pCO2 or withdrawal of bicarbonate) inhib-
ited the induction and propagation of Kþ-induced SD.23
Decreasing pH possibly hampers SD propagation by
inhibiting the activity of NMDA receptors.24 Tissue
acidosis is widely accepted to prevail in cerebral ische-
mia; 2VO as imposed here shifts extracellular pH in the
rat cerebral cortex from pH 7.3 to as low as pH 6.8 (our
own measurements in the model used here). Therefore,
we suggest that the ischemia-related fall of tissue pH
could be a key factor in raising the threshold of SD
elicitation as observed here. Finally, increased Kþ con-
ductance and the gradual accumulation of extracellular
Kþ that occur during ischemia generally contribute to
membrane hyperpolarization and repolarization thereby
depressing neuronal excitability.25 This ionic imbalance
may eﬀectively inhibit SD elicitation as well.
The increased threshold of SD elicitation with
advancing age during early adulthood may be linked
to structural changes in neuronal networks, which
may alter the electrophysiological properties of the ner-
vous tissue. The formation and retraction of dendritic
spines that host the post-synaptic element of excitatory
synapses dynamically changes with brain maturation26
and aging,27 is heavily involved in SD propagation,28
and is negatively aﬀected by SD.29 Therefore, we set
out to determine the dendritic spine density in the
youngest and the oldest animals admitted to our
study to contemplate on any potential link between
age-related structural changes in the cortex, and the
threshold of SD elicitation. Our results exhibited an
increased density of dendritic spines on the apical den-
drites of cortical layer 3 pyramidal neurons at 30 weeks
of age with respect to 8 weeks of age (Figure 4), proving
that the histological organization of the cortex
undergoes detectable alterations during the life span
investigated in this study. Even though a direct link
between such ﬁne structural changes and the excitabil-
ity of neurons is challenging to establish, we speculate
that the threshold of SD elicitation may increase with
age during early adulthood because of the histological
(and connected biochemical) maturation or consolida-
tion of cortical connections.
CBF compensation following ischemia induction
and CBF response to SD
Vascular occlusion is immediately followed by a sharp
drop of perfusion pressure below the autoregulatory
range and a marked reduction of CBF causing ische-
mia. In turn, the reduced level of ATP opens KATP
channels on vascular smooth muscle cells, causing
hyperpolarization and thus vasodilation. In addition,
hypoxia rapidly increases adenosine production locally,
also promoting vasodilation.30 This, together with com-
pensating collateral ﬂow or vascular remodeling contrib-
utes to a partial recovery of perfusion.31 Our previous
work focusing on aging demonstrated that the ischemia-
related perfusion deﬁcit progressively deepened—rather
than partially recovered—in the brain of 2-year-old ani-
mals as opposed to young adults in global and focal
ischemia models.15,16 Here, we show that the impairment
in ﬂow compensation becomes ﬁrst detectable as early as
30 weeks of age in the Sprague-Dawley rat (Figure 2).
Taken the young adult age screened here, declining CBF
compensation is suspected to root in altered vasoreactiv-
ity, rather than an age-related rarefaction of collateral
vascular networks.32 Possibly, altered characteristics of
KATP channel opening, ineﬀective adenosine signaling or
restricted NO availability could potentially account for
the less eﬃcient ﬂow compensation shortly after ische-
mia onset in our oldest age group.
The present results on the kinetics of the SD-related
CBF response conﬁrmed that the amplitude of
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hyperemia decreased, while the duration of hyperemia
increased under ischemia in the young adult brain.15,33
Nevertheless, inverse neurovascular coupling, as
encountered frequently in the aged ischemic brain ear-
lier,15,16 did not evolve. Instead, an augmented, ische-
mia-related insuﬃciency of the SD-related CBF
response was implied in the 30-week-old animals by
the lowest absolute peak of the SD-associated hyper-
emia under ischemia (Figure 5(b)). Clearly, the failing
ﬂow compensation to ischemia set the scene for the
reduced absolute amplitude of hyperemia in the 30-
week-old group. At the same time, the relative ampli-
tude of hyperemia appeared similar across age groups.
Taken together, we conclude that neurovascular cou-
pling during SD was impaired by ischemia, but this
impairment was not enhanced by increasing age in
young adult rats.
Distinct features of the ECoG power spectrum
Our data demonstrate that the alpha and theta fre-
quency bands are less depressed during SD in the 30-
week-old group as compared with the 7/8-week-old
group (Figure 6(c)). ECoG was acquired through a
glass capillary electrode inserted into the cortex, also
used for the recording of the DC potential. The
ECoG signal, therefore, represented a local ﬁeld poten-
tial that contains both action potentials and other
membrane potential-derived ﬂuctuations in a small
neuronal volume, approximately within a few hundred
micrometers from the electrode tip.34 A very important
factor determining the ECoG signal as recorded here is
the cellular-synaptic architectural organization of the
neuronal network.34 Here, we show that the dendritic
spine density, for example, is age-dependent in young
adulthood. It is thus conceivable that the age-related
alterations of dendritic geometry may impact on select-
ive frequencies of the ECoG power during the SD-
related depression, which might be represented in the
less obvious depression of given frequency bands
(Figure 6(c)).
The duration of SD-related depression appeared
shorter speciﬁcally on the delta and theta bands in the
30-week-old group, as compared with the 7/8-week-old
group (Figure 6(d)). This suggests that the electrical
activity in the low frequency range resumed sooner
after the passage of SD at older age. These data are
in full agreement with our previous report showing
that the SD-related silence of the full ECoG is shor-
tened in 10-month-old as compared with 2-month-old
rats.18 Earlier, we speculated that the shorter ECoG
depression with SD in the older animals could indicate
the involvement of fewer neurons at any given time
during SD propagation, thereby creating a narrower
wave of depression. Taken that the low frequency
component of the ECoG is thought to arrive at the
tip of the recording electrode from more distant
sites,34 the current data showing the shorter depression
of the low frequency ECoG components support the
concept of a narrower SD-related depression wave
with older age.
The duration of ECoG depression appears to be
associated with the features of the SD-coupled CBF
response. The present correlation analyses demonstrate
that a larger peak of SD-related hyperemia coincides
with shorter depression of the ECoG (Figure 6(e)). This
is complementary to previous reports describing that
deeper initial hypoperfusion of the CBF response coin-
cides with longer ECoG depression,18 and that longer
duration of the initial hypoperfusion corresponds with
longer DC shift duration with SD, in experimental
models, as well as in patients of aneurysmal subarach-
noid haemorrhage.35,36 Taken together, a more prom-
inent dilator component in the CBF response (i.e.,
smaller magnitude of initial hypoperfusion or larger
amplitude of hyperemia) appears to facilitate the
faster return of the cortex’ electrical activity after the
passage of SD.
Longer ECoG depression with SD was also asso-
ciated with longer hyperemia (Figure 6(f)). Likewise,
longer duration of the DC shift indicative of SD coin-
cided with longer hyperemia.15 Since the recovery of
resting membrane potential and thus normal electrical
activity of the nervous tissue require the activity of the
ATP-consuming Naþ pump,4 the return of CBF to
baseline after hyperemia may be postponed by the con-
tinuing energy need, reﬂected by the longer duration of
the electric silence with SD.
Conclusions
Recurrent SDs occur in ischemic and traumatic brain
injury at high incidence and are thought to usher the
expansion of tissue damage.1,2,4,37,38 The data presented
here reveal that the susceptibility of the nervous tissue
to SD is highest at adolescent or young adult age; yet,
the prospect of successful recovery from ischemic or
traumatic brain injury is considerably better for
young as compared with old patients.39,40 These
pieces of information would be apparently conﬂicting
if all SDs possessed equally injurious potential.
Researchers now agree that SDs coupled with
spreading ischemia promote lesion progression.4 Yet,
individual SDs with hyperemic CBF response have
not been explicitly proven either harmless or injurious
in tissue at risk, especially because the SD-coupled CBF
response, which appears hyperemic at the site of detec-
tion might turn into spreading ischemia as it propagates
in areas not screened. Further, even though the longer
cumulative duration of recurrent SDs was associated
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with the expansion of tissue damage in focal ischemia,11
this does not directly infer that the longer cumulative
duration is the outcome of a higher number of events—
indeed, the duration of individual SD events can vary
considerably.4 Finally, we have previously demon-
strated that although only a few SDs occur spontan-
eously in the aged ischemic brain, these events cause
more damage than a higher number of SDs in the
young brain, as indicated by a remarkable delay of
repolarization after SD and the associated evolution
of perfusion deﬁcit.16
Taken together, the low threshold of SD elicitation
indicates the brain’s high susceptibility for SD gener-
ation at young age, but it may not directly put the tissue
at higher risk for SD-related injury. This notion needs
to be explored further in subsequent experimental and
clinical studies.
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Contribution of prostanoid 
signaling to the evolution of 
spreading depolarization and the 
associated cerebral blood flow 
response
Dániel Péter Varga*, Tamás Puskás*, Ákos Menyhárt, Péter Hertelendy, Dániel Zölei-Szénási, 
Réka Tóth, Orsolya Ivánkovits-Kiss, Ferenc Bari & Eszter Farkas
The significance of prostanoid signaling in neurovascular coupling during somatosensory stimulation is 
increasingly more appreciated, yet its involvement in mediating the cerebral blood flow (CBF) response 
to spreading depolarization (SD) has remained inconclusive. Selective cyclooxygenase (COX) enzyme 
inhibitors (NS-398, SC-560) or an antagonist (L161,982) of the EP4 type prostaglandin E2 receptor 
were applied topically to a cranial window over the parietal cortex of isoflurane-anesthetized Sprague-
Dawley rats (n = 60). Global forebrain ischemia was induced by occlusion of both common carotid 
arteries in half of the animals. SDs were triggered by the topical application of 1M KCl. SD occurrence 
was confirmed by the acquisition of DC potential, and CBF variations were recorded by laser-Doppler 
flowmetry. EP4 receptor antagonism significantly decreased peak hyperemia and augmented post-SD 
oligemia in the intact but not in the ischemic cortex. COX-1 inhibition and EP4 receptor blockade 
markedly delayed repolarization after SD in the ischemic but not in the intact brain. COX-2 inhibition 
achieved no significant effect on any of the end points taken. The data suggest, that activation of EP4 
receptors initiates vasodilation in response to SD in the intact brain, and – together with COX-1 derived 
prostanoids – shortens SD duration in the acute phase of ischemia.
Recurrent spreading depolarizations (SDs) are slowly propagating waves of electrical silence in the cerebral gray 
matter1 that occur spontaneously in the injured brain2,3. Recurrent SD events have recently been recognized to 
exacerbate ischemic brain injury in patients of subarachnoid hemorrhage, stroke or traumatic brain injury4, and 
are being promoted as a causal biomarker assessed in neurocritical care to indicate the degree of metabolic failure 
in the brain tissue5.
SDs are coupled with typical changes in local cerebral blood flow (CBF)6. In the rat - and most probably in 
human - the physiological pattern of the SD-associated CBF response includes four sequential components: (i) an 
initial, brief hypoperfusion; (ii) a marked, transient peak hyperemia; (iii) a less obvious late hyperemia; and (iv) 
a sustained hypoperfusion also known as spreading oligemia or post-SD oligemia6. The duration and magnitude 
of these four elements in the CBF response is variable, with the peak hyperemic component being the most con-
spicuous. In the ischemic brain, the CBF response to SD is more dominated by vasoconstrictive elements, leading 
to diminishing hyperemia and more prevalent hypoemia7–10. In the most severe form, the hypoemic element 
completely outweighs hyperemia, and turns into spreading ischemia11. This atypical SD-associated CBF variation 
in the injured brain aggravates metabolic supply-demand mismatch in the tissue, and can delay recovery from SD 
thereby increasing the risk of irreversible depolarization and neuronal cell death.
The regulation of the SD-related CBF response appears to be rather complex, and the discrimination of any 
specific individual mediator poses a considerable challenge6. In physiological neurovascular coupling during 
somatosensory stimulation, prostanoids have emerged as potent vasoactive metabolites12,13. A major pathway 
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leading to vasodilator prostanoid synthesis involves cyclooxygenase-2 (COX-2), a rate limiting, inducible enzyme 
using arachidonic acid as its substrate. COX-2 is expressed in cortical pyramidal neurons14, and is located in 
perivascular nerve terminals along intraparenchymal penetrating arterioles and capillaries15. Most importantly, 
COX-2 products have emerged as mediators of functional hyperemia to somatosensory stimulation13,16. A COX-2 
derived vasoactive mediator produced by the downstream enzyme prostaglandin E synthase is prostaglandin E2 
(PGE2)17, which causes vasodilation by binding to its receptors (EP2 and EP4 receptors) located in the vascular 
wall in the brain13,14,18. In contrast with the COX-2 route, the role of the constitutive COX-1 enzyme (which, in 
the context of physiological neurovascular coupling, is argued to be expressed in astrocytes)19 in shaping the CBF 
response to neuronal activity has remained controversial19. Selective COX-1 inhibition blocked the evolution of 
hyperemia in response to odorant stimulation20, or uncaging of Ca2+ in perivascular astrocytic endfeet21, yet it 
exerted no impact on the CBF response to whisker stimulation22–24.
Arachidonc acid metabolites could possibly play a central role in mediating the CBF response to SD because 
spreading depolarization coincides with a considerable accumulation of arachidonic acid in the cortex25, and a 
significant elevation of prostanoid concentration (e.g. PGE2) in the cerebrospinal fluid26. Yet, in contrast with 
the dominant vasodilator effect of prostaglandins in response to somatonsensory stimulation13, arachidonic 
acid metabolites released due to SD were found to be vasoconstrictive: First, the non-selective inhibition of 
COX enzymes (i.e. application of indomethacin) caused pial vasodilation with SD, and diminished vasocon-
striction underlying the post-SD oligemia26, Second, synthesis of the vasoconstrictive hydroxyeicosatetraeonic 
acid (20-HETE) by the P450 epoxygenase enzyme located in vascular smooth muscle cells was demonstrated 
in response to SD, and the pharmacological blockade of its synthesis ameliorated the post SD oligemia27. 
Nonetheless, the selective effect of COX-1 or COX-2 products on the SD-associated CBF response has not been 
revealed, although the potential involvement of COX-2 is conceivable, because COX-2 mRNA and protein were 
found upregulated in cortical neurons in association with SD28.
In summary, even though the significance of the COX-2 pathway in neurovascular coupling during soma-
tosensory stimulation is getting increasingly more appreciated12,13, its involvement in mediating the CBF response 
to SD has remained inconclusive and is far from being understood6. In addition, COX-2 is remarkably upregu-
lated in the ischemic brain during the period over which deleterious SDs occur spontaneously in rodent ischemia 
models29, but there is essentially no evidence as to whether the ischemia-related COX-2 elevation modulates the 
CBF response to SD.
Taken together, here we set out to determine systematically whether COX-2 or COX-1 derived metabolites - 
specifically the vasodilator PGE218,30 - contribute to the evolution of the SD-coupled hyperemia in the intact or 
the ischemic rat cerebral cortex. We also sought to assess any potential involvement of prostanoid signaling in the 
evolution of SD itself.
Results
General physiological variables. Topical application of drugs was chosen in order to avoid potential 
systemic side effects. Measured values of mean arterial blood pressure (MABP) and the outcome of blood gas 
analysis confirmed no difference in the systemic variables assessed in various treatment groups. Specifically, 
Fig. 1A demonstrates that MABP did not change significantly over the experimental protocol, and was simi-
lar across experimental groups. Arterial blood gas analysis showed that all investigated variables were within 
the physiological range at the start of the experiments (i.e. pO2: 133 ± 28 mmHg, pCO2: 32 ± 6 mmHg, pH: 
7.39 ± 0.02, HCO3: 19.19 ± 4.54 mmol/l, glucose: 5.21 ± 1.71 mmol/l) and prior to the termination of the exper-
iments (i.e. pO2: 125 ± 29 mmHg, pCO2: 38 ± 11 mmHg, pH: 7.37 ± 0.08, HCO3: 21.49 ± 3.44 mmol/l, glucose: 
6.11 ± 1.92 mmol/l). Baseline CBF was obviously reduced significantly due to ischemia induction (from 112 ± 15 
to 27 ± 13% as an average), but the various treatments did not exert any significant impact (Fig. 1B).
Figure 1. Mean arterial blood pressure (MABP; in (A) and drift of local cerebral blood flow (CBF; in (B) over 
the experimental protocol. Selected time points for sampling have been defined as follows: (a) at 35 min after the 
initiation of pharmacological treatments; (b) immediately before ischemia induction; (c) MABP (A) or CBF  
(B) minimum after ischemia induction; (d) prior to SD1; (e) prior to SD2; (f) prior to SD3; (g) prior to SD4. 
Data are given as mean ± stdev. Statistical analysis relied on a repeated measures paradigm followed by a 
Fisher post hoc test. Ischemia – but not treatment - had a significant effect on the baseline drift of CBF. Level of 
significance was determined as * *p < 0.01 vs. respective Intact group.
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Direct current potential signature of spreading depolarization. Pharmacological manipulation 
proved to be ineffective on the kinetics of SD in the Intact groups. Conversely, the DC potential signature of SD 
was markedly and selectively altered by SC-560 and L161,982 treatment in the Ischemic group (Fig. 2A). As such, 
the duration of the negative DC shift at half amplitude was substantially increased for both the first SD (117 ± 32 
and 95 ± 64, vs. 43 ± 15 s; Ischemic SC-560 and Ischemic L161,982 vs. Ischemic Vehicle), and recurrent SDs 
(154 ± 58 and 120 ± 79, vs. 42 ± 14 s; Ischemic SC-560 and Ischemic L161,982 vs. Ischemic Vehicle) (Fig. 2B). 
Similarly, the magnitude of the DC shift characterized by the area under the curve greatly increased due to SC-560 
and L161,982 treatment in combination with ischemia, for both the first SD (1499 ± 340 and 1478 ± 1263, vs. 
574 ± 384 mV x s; Ischemic SC-560 and Ischemic L161,982 vs. Ischemic Vehicle), and recurrent SDs (2104 ± 1056 
and 1958 ± 1357, vs. 598 ± 281 mV x s; Ischemic SC-560 and Ischemic L161,982 vs. Ischemic Vehicle) (Fig. 2C). 
In addition, SC-560 and L161,982 treatment markedly reduced the amplitude of post-SD hyperpolarization 
(e.g. recurrent SDs: 1.16 ± 0.50 and 1.40 ± 0.62, vs. 2.65 ± 0.39 mV; Ischemic SC-560 and Ischemic L161,982 vs. 
Ischemic Vehicle), which also concerned only the ischemic animals but not the intact ones. In contrast, NS-398 
treatment proved to be statistically ineffective for all the above variables as compared with Vehicle.
Cerebral blood flow response to spreading depolarization. In contrast with the analysis of the DC 
potential signature of SD, the impact of pharmacological treatments on the CBF response could be discriminated 
in the intact – but not in the ischemic - animals. The selective COX enzyme inhibitors NS-398 and SC-560 did not 
exert any clear influence on the evolution of the SD-related CBF response, as all the examined variables remained 
unaltered by the treatments.
On the other hand, the EP4 receptor blocker L161,982 selectively reduced the relative amplitude of peak hyper-
emia with the first SD (21 ± 11 vs. 51 ± 38%, Intact L161,982 vs. Intact Vehicle), and recurrent SDs (50 ± 21 vs. 
76 ± 37%, Intact L161,982 vs. Intact Vehicle). In fact, L161,982 lowered the amplitude of the hyperemic element 
of the CBF response to near the level observed for the ischemic group (first SD: 21 ± 11 vs. 15 ± 8%, L161,982 
Intact vs. L161,982 Ischemic), as indicated by the loss of statistically significant difference otherwise obvious 
between the intact-ischemic group pairs (i.e. Vehicle, NS-398 or SC-560 treated) (Fig. 3B). Further, L161,982 
augmented the relative amplitude of post-SD oligemia with the first SD (58 ± 13 vs. 40 ± 14%, Intact L161,982 
vs. Intact Vehicle) (Fig. 3A,C). Based on these results, the selective EP4 receptor blocker L161,982 appeared to 
achieve a general loss of a dilatory element prevalent throughout the CBF response, as reflected by a reduction 
Figure 2. The impact of pharmacological treatments on the kinetics of the spreading depolarization 
(SD)-related, transient negative shift of the direct current (DC) potential. All panels demonstrate data for 
recurrent SDs. (A) DC potential traces are mean ± stdev, standing for Vehicle, SC-560, and L161,982 treatment 
under ischemia. (B) Duration of the negative shift of the DC potential taken at half amplitude. (C) Area under 
the curve of the negative shift of the DC potential. Note the selective impact of COX-1 inhibition (SC-560) and 
EP4 receptor blockade (L161,982) under ischemia. (D) Duration of the cerebral blood flow (CBF) response 
to SD taken at half amplitude of peak hyperemia. (E) Correlation between the duration of the SD-related 
negative DC shift and the associated CBF response; all groups are shown. Data shown in Panels B-D are given 
as mean ± stdev. Statistical analysis relied on a one-way analysis of variance (ANOVA) model followed by a 
Fisher post hoc test. Statistical significance was determined as * *p < 0.01 vs. respective Ischemia, and #p < 0.05 
or ##p < 0.01 vs. respective Vehicle. The correlation presented in Panel E was tested with a Pearson one-tailed 
correlation analysis (* *p < 0.01).
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of peak hyperemia with a degree matching the deepening of the post-SD oligemia (Fig. 3A). This observation 
was confirmed by calculating the flow difference between peak hyperemia and the minimum point of post-SD 
oligemia, providing the exploited range of vasoregulation during the CBF response, which was unchanged due to 
treatments in the intact groups (87 ± 32 pp, % in average).
To further prove the selective effect of L161,982 on the SD-related CBF response, hyperemia evolution sig-
nificantly decelerated due to L161,982 treatment as demonstrated by its shallower upward slope with the first 
SD (0.75 ± 0.38 vs. 1.88 ± 1.13%/s, Intact L161,982 vs. Intact Vehicle) (Fig. 3D), and recurrent SDs (1.05 ± 0.43 
vs. 1.60 ± 0.70%/s, Intact L161,982 vs. Intact Vehicle). Finally, the magnitude of hyperemia expressed as the 
area under the curve was also significantly decreased by L161,982 for the first SD (874 ± 462 vs. 2885 ± 2543% 
x s, Intact L161,982 vs. Intact Vehicle) (Fig. 3E), and recurrent SDs (5532 ± 3643 vs. 7448 ± 2072% x s, Intact 
L161,982 vs. Intact Vehicle).
The duration of the hyperemic element of the CBF response appeared to deserve separate consideration, as 
the changes due to pharmacological treatments seemed to be consistent with the results derived from the DC 
potential signature of SD (Fig. 2), rather than other variables assessed for the CBF response (Fig. 3). Indeed, the 
duration of hyperemia markedly elongated in the ischemic animals, especially due to treatment with SC-560 and 
L161,982 (e.g. recurrent SDs: 316 ± 122 and 240 ± 89 vs. 143 ± 67 s; Ischemic SC-560 and Ischemic L161,982 vs. 
Ischemic Vehicle) (Fig. 2D). The coincidence between the duration of depolarization and the associated hyper-
emia was confirmed by a strong, positive correlation (r = 0.825* * ) between these variables (Fig. 2E).
Finally, the early hypoperfusion element of the SD-related CBF response did not appear consistently, therefore 
measured values (i.e. amplitude, duration) could not be analyzed reliably.
The impact of L161,982 treatment on ischemia outcome. In addition to its vasoconstrictive poten-
tial as detailed above, L161,982 administration caused the greatest deviation in all assessed variables, and contrib-
uted to the evolution of severe ischemia in a third of the animals assigned to L161,982 treatment (Table 1). Such 
severe ischemia did not occur in any of the other treatment groups. The most obvious signs of the adverse effect 
of L161,982 administration were (i) the occurrence of spontaneous SDs within minutes after ischemia onset - and 
their long duration, (ii) the inability of the tissue to sustain subsequent, triggered SDs, (iii) the lack of detectable 
CBF response to these SDs, (iv) lower CBF levels at all time points after ischemia onset as compared with any 
other groups, and (v) occasional, lethal outcome before the termination of the experimental protocol (n = 2).
Figure 3. The impact of pharmacological treatments on the kinetics of the spreading depolarization (SD)-
related cerebral blood flow (CBF) response. All panels demonstrate data for the first SD. A, CBF traces are 
mean ± stdev for each group presented. (B) Maximum amplitude of peak hyperemia; (C) Minimum amplitude 
of post-SD oligemia; (D), Rate of hyperemia evolution associated with SD; (E), Magnitude of hyperemia 
expressed as area under the curve. Data in Panels B-E are given as mean ± stdev. Statistical analysis relied on 
a one-way analysis of variance (ANOVA) model followed by a Fisher post hoc test. Statistical significance was 
determined as *p < 0.05 and * *p < 0.01 vs. respective Intact, and #p< 0.05 vs. respective Vehicle. Note the 
selective effect of L161,982 (i.e. EP4 receptor antagonism) under Intact condition.
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Discussion
Here we set out to discriminate the potential involvement of prostanoids, particularly PGE2 in the regulation 
of the CBF response to SD. Two experimental approaches have been utilized. First, we selectively inhibited the 
COX-1 and COX-2 enzymes, which produce the precursor for PGE2 synthesis and thereby regulate the availabil-
ity of PGE2 (Fig. 4). In support of this approach, the inhibition of COX-2 was previously shown to significantly 
reduce functional hyperemia in response to whisker stimulation16. Next, we pharmacologically blocked the EP4 
receptors of PGE2 (Fig. 4), because EP4 receptors expressed in cerebral arteries were shown to mediate the vasodi-
latory effect of PGE218,30, and their activation contributed to functional hyperemia in response to somatosensory 
stimulation14. Because PGE2 synthetized via COX-2 suppresses neuronal excitability31 and the COX-2 - EP4 sign-
aling pathway has been implicated in the progression of ischemic injury32,33, we assessed the impact of the chosen 
pharmacological treatments on the DC signature of SD, as well. Finally, the neuronal or vascular upregulation of 
COX-2 and EP4 receptors established in cerebral ischemia29,33 prompted us to investigate whether the kinetics of 
SD or the related CBF response are modulated by this signaling pathway in the ischemic brain. This is particularly 
relevant, as spontaneous, recurrent SDs have been implicated in the progression of ischemic injury2–5.
Of the subsequent phases of the CBF response to SD6, we focused on the peak hyperemic and post-SD 
oligemic elements. The first significant observation of the current study is that EP4 receptor antagonism reduced 
peak hyperemia, and augmented post-SD oligemia of the CBF response to SD in the intact brain (Fig. 3B,C). This 
indicates that EP4 receptor activation contributes to vasodilation during the CBF response to SD (Fig. 4). It is 
a novel finding, as the mediation of the hyperemic element of the CBF response by prostanoids was previously 
thought unlikely, and COX-derived metabolites were attributed a vasoconstrictive rather than a vasodilatory role 
in the CBF response to SD6,26. At the same time, our data are consistent with a number of previous reports on 
the vasodilatory action of EP4 receptor activation by PGE2. For example, antagonism of EP4 receptors inhibited 
the PGE2-induced vasodilation of the middle meningeal artery of rats in vivo, and of the middle cerebral artery 
in vitro18,30. At the concentration used here, L161,982 previously reduced the NMDA-induced dilation of cerebral 
arterioles, functional hyperemia to whisker stimulation14, and glutamate-evoked dilation of microvessels34. Our 
data thus indicate that EP4 receptor activation achieves CBF elevation in response to SD, as well.
The selective inhibition of COX-1 and COX-2 enzymes exerted no significant, direct effect on any of the 
elements of the CBF response to SD (Fig. 3), despite the expectation that COX-2 inhibition by NS-398 would 
decrease the magnitude of the hyperemic element as it did functional hyperemia in response to whisker 
Experimental protocol 
completed (n = 8)
Experimental protocol 
aborted (n = 4)
Minimum CBF after ischemia onset (%) 33.68 ± 19.75 12.32 ± 6.96
Occurrence of spontaneous SD no (0/8) yes (3/4)
Duration of first evoked SD (completed 
protocol) or spontaneous SD (aborted 
protocol) (s)
95 ± 64 520 ± 328
Successful elicitation of subsequent 
recurrent SDs yes no
Type of CBF response to first evoked SD 
(completed protocol) or spontaneous 
SD (aborted protocol)
hyperemic no detectable CBF response
CBF prior to the termination of the 
experiment (%) 25.11 ± 15.00 15.10 ± 10.90
Table 1.  Two distinct subpopulations of experiments carried out to assess the impact of L161,982 
treatment (EP4 receptor antagonism) on SD evolution during ischemia. Data are given as mean ± stdev. 
Abbreviations: CBF, cerebral blood flow; SD, spreading depolarization.
Figure 4. Schematic illustration of the metabolic signaling pathway targeted in the present study, and 
its suggested involvement in modulating spreading depolarization and the related cerebral blood flow 
response. Red arrowheads indicate the sites of pharmacological interventions used. Abbreviations: PLA2, 
phospholipase A2; COX, cyclooxygenase; EP4, receptor type for prostaglandin E2; PGES, prostaglandin E 
synthase.
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stimulation previously16. The reason for the absence of the COX-enzyme related vasodilation may well be that 
during SD, the activity of COX enzymes also leads to the marked production of vasoconstrictive prostanoids, such 
as prostaglandin F2α 26. Inhibition of the COX enzymes as was done in our experiments therefore likely dimin-
ishes the SD-related synthesis of both vasoconstrictive and vasodilator prostanoids, causing an undiscernible net 
outcome on the CBF response. The results of others and of ours together show, that functional hyperemia to neu-
ronal activation is COX-2 dependent (i.e. selective COX-2 inhibition alone reduces the peak of hyperemia)14,16,23, 
while COX-2 inhibition has no clear impact on the CBF response to SD. These data foster the assumption that 
the CBF response to SD is driven by mechanisms different from physiological neurovascular coupling. Taken 
prostanoid-based cerebral vasoregulation, it is thus conceivable that vasoconstrictive COX products are released 
at insignificant concentration during neuronal activation, but their impact is substantial during SD26, obscuring 
the co-existing vasodilator effect of PGE2.
In the ischemic cortex, our study revealed a considerable reduction of the distinct elements of the CBF 
response to SD, with no detectable impact of COX enzyme inhibition or EP4 receptor blockade. Consistent with 
the data presented here, ischemia is known to impair physiological neurovascular coupling as evidenced by the 
attenuation of functional hyperemia to forepaw stimulation35. In addition, in the acute phase of ischemia (the 
target of investigation here), the abundant release of metabolic mediators of vascular tone, such as adenosine, 
increased ADP/ATP ratio, lactate accumulation, or the dramatically elevated concentration of extracellular 
potassium36 must obscure potentially still effective, finer signals of vasoregulation. It may also well be that the 
prostanoid-based regulation of vascular tone becomes more obvious and could prove discernable during the sub-
acute or chronic phases of ischemia, because COX-2 mRNA expression becomes upregulated beginning 6 hours, 
and endothelial EP4 receptor expression is induced 4 hours after ischemia onset29,37.
In summary, EP4 receptor activation contributes to vasodilation during the CBF response to SD in the intact 
cortex, and is undetectable under the acute phase of ischemia, possibly due to impaired neurovascular coupling, 
the dominance of metabolic mediators of vascular tone, or the upregulation of the receptors only several hours 
later.
The present study revealed that the selective pharmacological inhibition of COX-1 or the antagonism of 
EP4 receptors in the ischemic cortex both hamper the recovery of the nervous tissue from SD (as indicated by 
increased SD duration, Fig. 2A,B), while the inhibition of COX-2 remained ineffective in this respect. It has been 
firmly established that COX-2 expression is markedly upregulated during cerebral ischemia, and COX-2 inhibi-
tion is neuroprotective - despite cardiovascular side effects38. In our hands, COX-2 inhibition was ineffective on 
the neurophysiological end points taken, most certainly because in this early phase of ischemia COX-2 was not 
yet upregulated29. Instead, the role of COX-1 in promoting repolarization after SD has emerged. These results of 
ours stand in harmony with the report that ischemia-related hippocampal PGE2 production in a gerbil ischemia 
model was potently reduced by COX-1 rather than COX-2 inhibition during the early phase of reperfusion in 
contrast with 24 hours later, when COX-2 appeared to be the dominant source of PGE239. Despite the daunting 
complexity of prostanoid signaling, it is tempting to speculate, that COX-1 derived PGE2 should activate neuronal 
EP4 receptors during SD in the acute phase of ischemia, and thereby promote neuronal repolarization (Fig. 4). 
This would be an effective means of neuronal survival consistent with previous data demonstrating that longer SD 
duration predicts more extensive ischemic injury40 and genetic inactivation of neuronal EP4 receptors worsens 
stroke outcome33. In fact, shortened SD duration mediated by neuronal EP4 receptors could possibly account for 
smaller infarct volume reported to be achieved by selective EP4 receptor agonism33,41.
Even though our results focus on EP4 receptors, PGE2 was shown to achieve neuroprotection by activating 
the EP242 and possibly the EP3 receptors, although there is no consensus on whether EP3 receptor activation is 
protective under all circumstances43,44. It is therefore plausible that COX-1 derived PGE2 could achieve the short-
ening of SD duration through EP2 and perhaps EP3 receptors, as well.
In the ischemic cortex, the duration of hyperemia in response to SD increased synchronously with elongated 
SD duration imposed by COX-1 inhibition or EP4 receptor antagonism (Fig. 2B,D). The synchronicity was con-
firmed by the strong positive correlation between SD and hyperemia duration (Fig. 2E). Earlier we postulated 
based on similar observations that the return of CBF to baseline after hyperemia may be postponed by the con-
tinuing energy need to restore membrane potential10. For this reason, it is conceivable that increased hyperemia 
duration seen as a result of COX-1 inhibition or EP4 receptor antagonism must have been achieved indirectly, by 
increasing the duration of SD itself.
Here we applied the EP4 receptor blocker L161,982 in a concentration that weakens neurovascular coupling 
in the intact nervous tissue14,34. In addition to our present results that EP4 receptor antagonism delayed tissue 
recovery after SD during ischemia (see above), we found a major, detrimental impact of EP4 receptor antago-
nism on ischemia outcome in a subpopulation of animals assigned to the treatment (Table 1). The symptoms 
revealed both vascular and neurophysiological impairment (i.e. spontaneous SD occurrence with no detectable 
CBF response, markedly reduced baseline CBF during ischemia) indicative of the interaction of these elements, 
or the potential involvement of both neuronal and vascular EP4 receptors32,33. Our data confirm the notion that 
EP4 receptor activation is necessary for neuronal survival and better ischemia outcome as previously shown by 
methods including agonism of EP4 receptors, EP4 receptor deletion, and the assessment of EP4 receptor expres-
sion in various experimental models of cerebral ischemia32,33,41. Even though our data are thus consistent with 
previous reports, the severe outcome due to L161,982 treatment was unexpected, as neurovascular coupling stud-
ies reported no such risk14,34 and no previous investigations have evaluated the impact of L161,982 administration 
on neurophysiological outcome after ischemia. Finally, we suggest that SD evolution may be a critical component 
of infarct development related to the inactivation of EP4 receptors, as implied by the spontaneous occurrence of 
long-lasting SD in these animals.
The restriction of SD evolution in neurological intensive care patients has become a central objective, which 
is driven by the recognition that spontaneously occurring recurrent SDs of long cumulative duration worsen the 
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outcome of ischemic or traumatic brain injury4,5. So far, the inhibition of NMDA receptors by ketamine adminis-
tration has been the only strategy of promise to decrease the likelihood of SD occurrence45. PGE2 and its specific 
receptors have long been implicated in mediating neuronal death or survival under ischemia, but have not been 
associated with SD evolution. The data presented here demonstrate for the first time that the inhibition of COX-1 
or the blockade of the EP4 receptors of PGE2 remarkably increases SD duration in the early phase of cerebral 
ischemia. These significant observations may initiate a new line of investigation to dissect specific components of 
prostanoid signaling that may play a defining role in sustaining or aborting SD in the ischemic nervous tissue. In 
the long run, specific elements of prostanoid signaling may present new, effective targets in addition to NMDA 
receptors to restrict SD evolution and thereby lessen SD-related injury.
Materials and Methods
The experimental procedures were approved by the National Food Chain Safety and Animal Health Directorate of 
Csongrád County, Hungary. The procedures conformed to the guidelines of the Scientific Committee of Animal 
Experimentation of the Hungarian Academy of Sciences (updated Law and Regulations on Animal Protection: 
40/2013. (II. 14.) Gov. of Hungary), following the EU Directive 2010/63/EU on the protection of animals used for 
scientific purposes, and reported in compliance with the ARRIVE guidelines.
Surgical procedures. Surgical procedures were similar to what was previously described46. Young adult 
male Sprague-Dawley rats (n = 60, body weight: 302 ± 31 g) were used in the study. The animals were purchased 
from the Charles River Laboratories, Hungary, were group-housed under a normal 12/12 h light/dark cycle, and 
had free access to food and drinking water. On the day of experiments, the animals were anesthetized with 1.5–2% 
isoflurane in N2O:O2 (70%:30%), and breathed spontaneously through a head mask throughout the experiment. 
Body temperature was maintained at 37 °C with a servo-regulated heating pad. Atropine (0.1%, 0.05 ml) was 
administered intramuscularly shortly before surgical procedures to avoid the production of airway mucus. A 
catheter was inserted into the left femoral artery to monitor mean arterial blood pressure (MABP) continuously, 
and arterial blood gas levels at the start of each experimental protocol, and before termination of the experiments.
Next, a midline incision was made in the neck and both common carotid arteries were delicately separated 
from the surrounding muscle and the vagal nerves. Lidocain (1%) was administered topically before opening 
each tissue layer. A silicone coated fishing line used as occluder was looped around each artery for later induction 
of cerebral ischemia. Rats were transferred to a stereotactic frame and fixed in prone position. Two craniotomies 
(5 mm lateral from midline, − 3 mm and − 7 mm caudal from bregma) were prepared over the right parietal 
cortex using a dental drill (Technobox, Bien Air 810). A doughnut shape ring of acrylic dental cement was built 
around the rostral craniotomy for the latter topical application of drugs to the cortical surface. The dura in each 
craniotomy was carefully dissected, and the craniotomies were regularly irrigated with artificial cerebrospinal 
fluid (aCSF; mM concentrations: 126.6 NaCl, 3 KCl, 1.5 CaCl2, 1.2 MgCl, 24.5 NaHCO3, 6.7 urea, 3.7 glucose bub-
bled with 95% O2 and 5% CO2 to achieve a constant pH of 7.4). In the rostral window, an intracortical glass 
capillary microelectrode (outer tip diameter = 20 μ m) was lowered 800–1000 μ m into the cortex, and an Ag/AgCl 
electrode was implanted under the skin of the animal’s neck to be used as reference. In order to assess changes 
in local CBF, a laser-Doppler needle probe (Probe 402 or 403 connected to Perimed 4001 Master or PeriFlux 
5000; Perimed AB, Sweden) was positioned near the cortical surface, adjacent to the intracortical microelectrode, 
avoiding any large pial vessels. The caudal craniotomoy was later used for SD elicitation.
Electrophysiology and cerebral blood flow measurement. Direct current (DC) potential was 
recorded via a high input impedance pre-amplifier (NL102G or NL100AK, NeuroLog System, Digitimer Ltd, 
United Kingdom), connected to a differential amplifier (NL106 or NL107, NeuroLog System, Digitimer Ltd, 
United Kingdom) with associated filter and conditioner systems (NL125, NL144 or NL530, NeuroLog System, 
Digitimer Ltd, United Kingdom). Potential line frequency noise (50 Hz) was removed by a high quality noise 
eliminator (HumBug, Quest Scientific Instruments Inc., Canada) without any signal attenuation. The resulting 
signal was digitalized either by an analog/digital (A/D) converter (MP150, Biopac Systems Inc., USA) and con-
tinuously acquired at a sampling frequency of 1 kHz or 500 Hz using the software AcqKnowledge 4.2.0 (Biopac 
Systems Inc., USA), or another dedicated A/D converter card (NI USB-6008/6009, National Instruments, Austin, 
Texas, USA) controlled through a custom-made software, written in Labview (National Instruments, Austin, 
Texas, USA). The laser Doppler signal was digitized and acquired, together with the DC potential, essentially as 
described above.
Drug administration. Drug solutions or vehicle of equal volume (1.5% DMSO in 10 ml aCSF) were super-
fused on the cortical surface free of dura in the rostral cranial window after taking DC potential and CBF baseline 
for 5 min under aCSF. Drug concentrations were carefully selected based on dose response curves, selectivity and 
efficacy reported previously14,16,18,34. The following drugs were applied topically: the selective COX-2 inhibitor 
NS-398 (100 μ M; Cayman)16, the selective COX-1 inhibitor SC-560 (25 μ M; Cayman)22, or the selective PGE2 
receptor (EP4) antagonist L161,982 (1 μ M; Sigma)14,34. The pharmacological treatment was initiated 40 min prior 
ischemia induction or the elicitation of the first SD event (i.e. sham-operated group)16 and incubation persisted 
till the end of the experimental protocol.
Ischemia induction and SD elicitation. Following the 40-min incubation period, persistent incomplete 
global forebrain ischemia was induced in half of the animals, by occluding both common carotid arteries perma-
nently (“2-vessel occlusion”, 2VO): occluders were pulled on until resistance was felt and then secured in place. 
Successful ischemia induction was confirmed by a sharp drop of the laser Doppler signal. As control for ischemia, 
the remaining animals were used as a sham-operated group (SHAM), in which the occluders were not pulled but 
left in place.
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Forty minutes after the start of drug incubation, 4 SDs with an inter-SD interval of 15 minutes were triggered 
by placing a 1 M KCl-soaked cotton ball on the exposed cortical surface in the caudal cranial window. The cotton 
ball was removed and the caudal cranial window rinsed with aCSF immediately after each successful SD elicita-
tion. Experiments were terminated by the overdose of the anesthetic agent, 20 min after triggering the last SD. The 
combination of pharmacological treatment and ischemia induction resulted in 8 experimental groups (Table 2).
Data analysis. All variables (i.e. DC potential, CBF and MABP) were simultaneously acquired, displayed live, 
and stored using a personal computer equipped with a dedicated software (AcqKnowledge 4.2 for MP 150, Biopac 
Systems, Inc., USA). Data analysis was assisted by the inbuilt tools of the same software, or was transferred into a 
MATLAB environment (MathWorks Inc., USA). Both DC potential and CBF recordings were first downsampled 
to 1 Hz. The transient negative DC shift indicative of SD was analyzed to assess: amplitude of depolarization, 
duration of depolarization at half amplitude, area under the curve of the negative DC shift, slope of depolariza-
tion, slope of repolarization, and amplitude of post-SD hyperpolarization.
Raw CBF recordings were expressed relative to baseline by using the average CBF value of the first 5 min 
under aCSF (100%) and the recorded biological zero obtained after terminating the experiment (0%) as reference 
points. Drifting of baseline was determined by sampling a 5-min average 30–35 min after the start of drug incu-
bation, a 10 s average prior ischemia induction and during the drop after ischemia induction, and 5-min averages 
prior each SD elicited. The following elements of the SD-related CBF response were characterized: amplitude and 
duration of early hypoperfusion, amplitude and duration of hyperemia, magnitude of hyperemia (area under the 
curve), and the amplitude of post-SD oligemia.
The data were evaluated separately for the first SD, and subsequent, recurrent SDs, because of the obvious 
differences in the kinetics of the SD-associated CBF response. Data of the 3 recurrent SDs were averaged for each 
animal, thus a single value per animal of each read-out was taken for statistical analysis.
Data are given as mean ± stdev. The software SPSS (IBM SPSS Statistics for Windows, Version 22.0, IBM 
Corp.) was used for statistical analysis. A one-way analysis of variance (ANOVA) model was applied for the eval-
uation of variables derived from the DC potential signature of SD, and the associated CBF response. A repeated 
measures paradigm was used to evaluate MABP variation and CBF baseline drift. Correlation analysis relied on a 
one-tailed Pearson test. Levels of significance were defined as p < 0.05* and p < 0.01* * .
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Experimental 
group Pharmacological treatment
Ischemia induction 
(SHAM or 2VO) n
1
Vehicle (1.5% DMSO in aCSF)
SHAM 8
2 2VO 7
3
100 μ M NS-398 (COX-2 inhibition)
SHAM 7
4 2VO 6
5
25 μ M SC-560 (COX-1 inhibition)
SHAM 7
6 2VO 7
7
1 μ M L161,982 (EP4 receptor antagonism)
SHAM 6
8 2VO 12
Table 2.  Composition of experimental groups. Abbreviations: 2VO, permanent, bilateral common carotid 
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